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Preface to “Advances and Applications of 
Nano-antimicrobial Treatments” 
The development of novel nature-inspired antimicrobial agents and nano-structured 
antimicrobial materials is an extremely appealing topic for both researchers and companies 
interested in innovation and nanotechnologies. In particular, in the biomedical field, efforts in the 
production of antibacterial devices are strongly encouraged by the increased resistance 
demonstrated by many bacteria to conventional antibiotics and by the failure of antibiotic therapies 
against some infectious diseases. The adhesion and proliferation of bacterial biofilm on many 
biomedical devices still represent a huge concern related to infected catheters, prosthesis, wound
dressings etc., which are associated to increased mortality and high healthcare costs. For this 
purpose, many studies address the incorporation of antibacterial agents or the deposition of 
antibacterial coatings on different biomedical devices through advanced nanotechnology 
approaches. By exploiting the excellent biological properties of some natural materials at nanoscale, 
for example, zinc, copper and silver, effective strategies for the prevention of infections have been 
developed. 
The main focus of this book is, therefore, to present the most recent efforts in scientific 
research on the development of advanced antimicrobial materials and treatments, discussing the 
potential of nanotechnology in fighting many infective agents and preventing biofilm formation. 
The book is addressed to scientists and students in bioengineering, biology, chemistry and also to 
clinicians devoted to innovation and research. 
The Editors would like to thank the staff of the Materials Editorial Office for the constant help 
and support. 
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Abstract: The widespread use of contact lenses is associated with several complications, including
ocular biofilm-related infections. They are very difficult to manage with standard antimicrobial
therapies, because bacterial growth in a biofilm is associated with an increased antibiotic resistance.
The principal aim of this study was to evaluate the efficacy of antimicrobial peptides (AMPs) in
eradication of bacterial biofilms formed on commercially available contact lenses. AMPs were
synthesized according to Fmoc/tBu chemistry using the solid-phase method. Minimum inhibitory
concentration (MIC) and minimum biofilm eradication concentration (MBEC) of the compounds were
determined. Anti-biofilm activity of the antimicrobial peptides determined at different temperatures
(25 ◦C and 37 ◦C) were compared with the effectiveness of commercially available contact lens
solutions. All of the tested compounds exhibited stronger anti-biofilm properties as compared to
those of the tested lens solutions. The strongest activity of AMPs was noticed against Gram-positive
strains at a temperature of 25 ◦C. Conclusions: The results of our experiments encourage us toward
further studies on AMPs and their potential application in the prophylaxis of contact lens-related
eye infections.
Keywords: antimicrobial peptides; lipopeptides; biofilm; ocular infections; contact lenses
1. Introduction
Contact lenses (CL) are one of the most popular biomaterials and represent a suitable surface
for bacterial colonization in the eye, leading to ocular infection. Approximately 140 million people
worldwide wear CL for vision correction [1]. The widespread use of CL is associated with a risk of
complications, including CL-related bacterial infections [2]. The ability of different species of bacteria
to adhere to the surface of biomaterials resulting in biofilm formation plays an important role in
pathogenesis of CL-associated infections. Microbial cells inhabiting a three dimensional structure of
biofilm have been reported to be up to 1000 times more resistant to antibiotics than their planktonic
forms [3].
The surface of the eye is constantly exposed to numerous environmental factors, including
a frequent adhesion of microorganisms. Majority of the environmentally-introduced microorganisms
are constantly removed from the surface of the eye through the natural host defense mechanisms,
such as tears, corneal nerves, epithelial cells, keratocytes, interferons, and innate immunity cells.
The primary line of defense against ocular infection is provided by mechanical barriers, eyelids,
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and eyelashes. The blinking action of the eyelids removes most foreign particles and microorganisms
from the eye and renews the tear film. Tears are one of the crucial elements of the eye’s defense system.
They keep the eye lubricated and free from foreign bodies by flushing action. The tears’ film also
provides an effective antimicrobial system capable of reducing the number of bacteria in vivo.
The tear fluid is composed of water, electrolytes, lipids, mucins and proteins (immunoglobulins,
lysozyme, lactoferrin, lipocalin, and lacritin) [4,5]. A combination of lysozyme and lactoferrin has been
found to be highly effective in eradicating staphylococci [6].
The most common ocular infections associated with CL are bacterial conjunctivitis, contact
lens acute red eye (CLARE), contact lens peripheral ulcer (CLPU), infiltrative keratitis (IK), and
microbial keratitis (MK). Staphylococcus aureus, S. epidermidis, Streptococcus pneumonia, S. pyogenes,
Haemophilus influenzae, Enterococcus spp. Moraxella spp. Escherichia coli, Serratia marcescens,
Pseudomonas aeruginosa, and Proteus mirabilis are the most common etiological factors associated
with CL-related infections [1,7,8].
Handling CL, not complying with the hygienic procedures, replacement frequency and a poor
quality of material, inadequate care solutions, and CL case compliance are major factors of CL
contamination. There is also a strong correlation between CL extended wear and corneal infection and
inflammation [9]. Extended wear of CL promotes enhanced adhesion of bacteria and consequently the
development of corneal infection [10].
The current standard treatment of bacterial eye infections relies on conventional antibiotic therapy.
However, the widespread use of broad-spectrum systemic antibiotics in ocular infection therapies
resulted in an increase in resistance among the bacteria and induction of antibiotic-resistant strains.
A significant number of S. aureus and coagulase-negative staphylococci, as well as P. aeruginosa
associated with ocular infection, have been strongly antibiotic-resistant [11,12]. The standard therapy
is of limited effectiveness in abatement of biofilm infection.
Antimicrobial peptides (AMPs) have been found to exhibit activity against a wide range of
bacteria responsible for ocular infections. These naturally occurring antimicrobial agents have been
examined as therapeutic antibiotics. As a part of the innate immune system, AMPs can be applied to
prevent the formation of biofilm as well as to eradicate mature structures. The mechanism of action of
AMPs is based on the interaction with the cell membrane and carries a low risk of microbial resistance.
AMP may be an alternative to conventional antibiotic treatment in ocular infection.
The most significant naturally occurring AMPs in the eye are human cathelicidin LL-37, as well as
α- and β-defensins [4,5]. These compounds are secreted into tears by corneal and conjunctival epithelial
cells and demonstrate a broad spectrum of antimicrobial activity. In response to inflammatory agents,
neutrophils infiltrating the ocular surface supply tear fluid with additional LL-37 and α-defensins.
In vitro studies confirmed antimicrobial activity of human β-defensins against methicillin-resistant
S. aureus and P. aeruginosa in ocular infection [13]. The LL-37 is also produced by mast cells.
The peptide significantly prevents from S. epidermidis adhesion and biofilm formation on the biomedical
materials [5,13]. In vitro studies have shown that LL-37 is also effective in P. aeruginosa biofilm
eradication [14]. Another AMP of tear fluid is psoriasin (S100A7). It is produced by cornea, conjunctiva,
and lacrimal glands and has been demonstrated to be highly potent against E. coli [15].
Currently, several innovative strategies to optimize AMPs anti-biofilm activity are under
evaluation with the aim to using them as a new class of antibiotics in the treatment of ocular infection.
Direct topical AMPs application, production of AMP’s derivatives and peptidomimetics, construction
of specifically-targeted AMPs (STAMP), or immobilization of AMPs directly onto the surface of
biomaterials are some of the examples [16,17]. Several in vitro and in vivo studies have been performed
to investigate a group of AMPs as potential anti-biofilm agents for ocular infection therapies [17–21].
The principal aim of this work was to evaluate the group of antimicrobial peptides with regard to
their potential use for eradication of bacterial biofilms formed on CL.
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2. Results
2.1. Minimum Inhibitory Concentration of the AMPs
The AMPs under study exhibited antimicrobial activity towards all of the tested bacteria, but their
efficacy varied depending on the strain (Table 1). Pexiganan turned out to be the most effective
peptide against planktonic bacteria. Bacterial growth was inhibited after exposure to pexiganan
at concentrations of 1–8 μg/mL. Short synthetic lipopeptides also effectively inhibited the growth
of all tested strains (4–32 μg/mL). The remaining peptides showed a comparable activity towards
Gram-positive strains (8–32 μg/mL), while application of significantly higher concentrations of the
compounds was required to inhibit the growth of Gram-negative strains (128–512 μg/mL).
Table 1. Minimum inhibitory concentration of the AMPs in μg/mL (μM).
Peptide S. aureus S. epidermidis S. pyogenes S. pneumoniae E. coli P. aeruginosa
Pexiganan 8 2 4 ≤1 4 4
(2.2) (0.6) (1.1) (≤0.3) (1.1) (1.1)
Citropin 1.1 32 8 16 16 128 256
(17.4) (4.3) (8.7) (8.7) (69.5) (138.9)
Temporin A 8 4 4 8 256 512
(4.9) (2.5) (2.5) (4.9) (157.5) (315.1)
Palm-KK-NH2
8 4 16 8 8 16
(10.8) (5.4) (21.7) (10.8) (10.8) (21.7)
Palm-RR-NH2
8 4 16 4 16 32
(10.1) (5.0) (20.1) (5.0) (20.1) (40.3)
2.2. Anti-Biofilm Activity of Antimicrobial Peptides at Different Temperatures
The results of the tests with CL differed from those obtained for bacteria living in a planktonic
form (Tables 2 and 3). MBEC tests have shown that citropin 1.1, the weakest antimicrobial agent
against planktonic cells, was the most potent anti-biofilm agent. It was the only compound that
eliminated the living bacteria from the surface of CL at both temperatures. The MBEC values ranged
from 16–64 μg/mL for Gram-positive strains. Biofilms formed by E. coli were eradicated after exposure
to citropin 1.1 at concentrations of 128–256 μg/mL. P. aeruginosa was eliminated from the lens surface
after application of citropin 1.1 at concentration of 512 μg/mL. Additionally, temporin A eliminated
the bacteria at that concentration. The remaining peptides were inactive towards P. aeruginosa cultured
on CL. Promising results were obtained with lipopeptide Pal-KK-NH2. The compound eradicated
biofilms formed by Gram-positive bacteria at concentrations of 32–64 μg/mL below 25 ◦C and at
32–512 μg/mL at 37 ◦C. E. coli was eliminated by exposure to the compound at concentration of
256 μg/mL at both temperatures. The remaining compounds exhibited a moderate anti-biofilm activity.
Surprisingly enough, pexiganan, the most potent antimicrobial agent in the MIC test, showed a rather
feeble anti-biofilm activity. With certain strains and compounds the activity varied depending on
the temperature. In many cases the MBEC values obtained for AMPs were 2–4 times lower at 25 ◦C
than at 37 ◦C.
3
Materials 2016, 9, 873
Table 2. Minimum biofilm eradication concentration (reduction of resazurin ≤10% ± 0.5%) at 37 ◦C
in μg/mL (μM).
Peptide S. aureus S. epidermidis S. pyogenes S. pneumoniae E. coli P. aeruginosa
Pexiganan >512 128 256 64 >512 >512
(>141.5) (35.4) (70.8) (17.7) (>141.5) (>141.5)
Citropin 1.1 64 16 32 32 256 512
(34.7) (8.7) (17.4) (17.4) (138.9) (277.8)
Temporin A 512 128 128 128 512 512
(315.1) (78.8) (78.8) (78.8) (315.1) (315.1)
Palm-KK-NH2
64 32 512 64 256 >512
(86.6) (43.3) (693.0) (86.6) (346.5) (>693.0)
Palm-RR-NH2
256 32 >512 32 512 >512
(322.1) (40.3) (>644.1) (40.3) (644.1) (>644.1)
Table 3. Minimum biofilm eradication concentration (reduction of resazurin ≤10% ± 0.5%) at 25 ◦C
(μg/mL (μM)).
Peptide S. aureus S. epidermidis S. pyogenes S. pneumoniae E. coli P. aeruginosa
Pexiganan 256 16 128 64 512 >512
(70.8) (4.4) (35.4) (17.7) (141.5) (>141.5)
Citropin 1.1 32 16 32 64 128 512
(17.4) (8.7) (17.4) (34.7) (69.5) (277.8)
Temporin A 128 64 256 128 128 512
(78.8) (39.4) (157.5) (78.8) (78.8) (315.1)
Palm-KK-NH2
32 32 32 64 256 >512
(43.3) (43.3) (43.3) (86.6) (346.5) (>693.0)
Palm-RR-NH2
128 64 128 64 256 >512
(161.0) (80.5) (161.0) (80.5) (322.1) (>644.1)
2.3. Efficacy of the Contact Lens Solutions against Biofilms
The commercial contact lens solutions were more effective after a single application at 37 ◦C
(Table 4). This was observed for three out of four tested solutions against S. pyogenes and E. coli, and for
one solution in case of P. aeruginosa. The CL solutions were active at both temperatures against biofilms
formed on the lens surface by S. aureus, S. epidermidis, and S. pneumoniae. They were ineffective against
E. coli and S. pyogenes cultured on lenses at 25 ◦C. The most difficult to eliminate from the surface of
lenses was P. aeruginosa. It could not be eradicated after exposure to all solutions at 25 ◦C and to three
out of four solutions at 37 ◦C.
Table 4. Efficacy of the contact lens solutions against biofilm at different temperatures (37 ◦C/ 25 ◦C).
Lens Solution S. aureus S. epidermidis S. pyogenes S. pneumoniae E. coli P. aeruginosa
A +/+ +/+ −/− +/+ +/− −/−
B +/+ +/+ +/− +/+ +/+ +/−
C +/+ +/+ +/− +/+ +/− −/−
D +/+ +/+ +/− +/+ +/− −/−
“+” active; reduction of resazurin ≤10% ± 0.5%, “−“ inactive; reduction of resazurin ≥10% ± 0.5%.
3. Discussion
Biomaterials associated infections constitute a major barrier to the long-term use of medical
devices and remain a serious therapeutic problem [17,22,23]. Bacterial growth in a form of biofilm
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is associated with an increased antibiotic resistance as compared to the growth under planktonic
conditions [24].
CL represent an ideal surface for bacterial colonization in the eye. CL-related infections are
relatively rare, but can pose severe vision-threatening complications. Standard treatment for most
bacterial ocular infection is primarily empiric with broad-spectrum antibiotics. Unfortunately,
the inadequate use of antibiotics leads to the development of resistant strains [25–27].
An alternative approach to the therapeutic problem of biofilm-associated infection would be the
development of a new generation of AMP-based drugs [28,29]. In this study we confirmed antibacterial
activity of the AMPs against common strains responsible for ocular infections.
In the MIC test the most potent antimicrobial agent was pexiganan, an analogue of the naturally
occurring magainin 2. Its strong antimicrobial activity has been reported by numerous studies [30–32].
The results clearly show the high effectiveness and broad-spectrum activity of pexiganan [33]. Potential
therapeutic applications of the peptide and further development of its analogues are under way [34–36].
Although the compound has shown a broad spectrum of antimicrobial activity against planktonic cells
of various bacterial strains, pexiganan turned out to be a weak anti-biofilm agent against structures
formed on CL. This supports the finding that bacteria organized in a biofilm can exhibit a reduced
susceptibility to AMPs. In our previous study reference bacterial strains susceptible to conventional
antibiotics in their planktonic form were highly resistant once cultured as biofilms on polystyrene
surfaces [32,37].
Both tested short lipopeptides also exhibited a high antimicrobial activity against all of the
tested strains in the MIC test. Previous studies on Palm-KK-NH2 showed its strong activity against
clinical strains of Gram-positive cocci including those resistant to antibiotics [38]. Pal-KK-NH2
demonstrated its ability to prevent a vascular graft biofilm formation in the rat model of staphylococcal
infections. Moreover, efficiency of the lipopeptide was enhanced upon combination with standard
drugs (e.g., vancomycin) [39]. Pal-KK-NH2 was also effective against a majority of strains in the biofilm
form, while Pal-RR-NH2 showed a slightly lower activity. In our previous study the compounds were
effective against biofilms formed by clinical isolates of S. aureus cultured on polystyrene [40].
Two amphibian peptides, citropin 1.1, naturally produced by Litoria citropa [41], and temporin
A, primarily isolated from Rana temporaria [42], were highly effective against planktonic cultures of
Gram-positive bacteria [43–46]. In the previous studies, temporin A also exhibited a strong activity
against Gram-positive bacteria, including vancomycin-resistant strains [47]. Effectiveness of the
compound was confirmed in animal models of infection caused by S. epidermidis [48] and S. aureus [49].
Research conducted by Simonetti et al. confirmed that temporin A was effective in MRSA-infected
chronic wounds in mice [50]. Citropin 1.1 was also extensively studied. Most recently, it was found to
be a potent anti-biofilm agent against S. aureus strains collected from patients with atopic dermatitis [51].
Moreover, the previous studies confirmed that the peptide demonstrates a synergy with rifampicin
and minocycline against S. aureus biofilm [52]. In another study, citropin 1.1 showed a high efficiency
in prevention of catheter-related infections caused by S. aureus [52]. Our results have shown that both
compounds eliminated P. aeruginosa from CL, in contrary to the remaining peptides and applied CL
solutions. Citropin 1.1 was the most effective compound in the study against biofilms formed by all of
the tested strains.
The obtained results indicate that AMPs possess a potential for the development as a therapeutic
and prophylactic agents against biofilm-related infections, especially those associated with
Gram-positive pathogens.
In recent years a variety of peptides were investigated for their potential in the prevention of eye
infections. For instance, Nos–Barbera et al. demonstrated positive effects of a cecropin-melittin hybrid
peptide topically applied in a pseudomonas keratitis model in rabbits [18]. Willcox et al. developed
antimicrobial cationic peptide coatings by covalent immobilization of melimine onto CL. Melimine
is a hybrid of the active regions of two antimicrobial peptides: protamine (from salmon sperm) and
melittin (from bee venom). Covalently-attached melimine significantly reduced clinical manifestations
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of CLARE in the P. aeruginosa guinea pig model [17]. In vivo melimine coatings demonstrated
a significant reduction of CLPU incidence in the rabbit model [19]. The broad-spectrum antimicrobial
activity of melimine was also confirmed in a human clinical trial, where melimine-coated lenses turned
out to be safe for use during wear and retained a high antimicrobial activity after wear [20]. Other
studies have shown that the melimine coating was heat-stable, non-toxic to mammalian cells in vitro,
and did not alter the physical dimensions of CL [17,19,21].
In this study, we investigated peptides according to their potential application as CL solutions
additives. All peptides eliminated Gram-positive bacteria from the surface of lenses, while only
temporin A and citropin 1.1 showed some activity against Gram-negative bacteria. All of the tested CL
solutions were ineffective against S. pyogenes and P. aeruginosa when cultured once at 25 ◦C. Three out
of four applied solutions were also inactive towards E. coli. Similarly to previous studies, we have
now confirmed that the efficacy of CL disinfecting solutions are dependent on the type of the bacterial
strain [53–55]. The results of our study indicate that P. aeruginosa was the most resistant strain to the
antimicrobial action of all of the tested fluids, a finding consistent with those of other studies [56,57].
Our research indicates that the susceptibility to antimicrobials of bacteria cultured on the lens
surfaces is dependent on the temperature. For some strains and the tested AMPs, the anti-biofilm
activity was stronger at 25 ◦C, while the tested lens solutions exhibited stronger activity at 37 ◦C.
As room temperature is commonly recommended for the storage of CL, the use of commercial CL
solutions appears to be rather inadequate for the prevention of ocular infections in CL users.
A harmony of proper hygiene and care habits of CL can effectively prevent contamination with
pathogenic microorganisms [58]. Handling of CL, insufficient hand washing practice, and failure
of some preservative systems are major sources of contamination implicated in the development
of CL-associated infections [59–61]. According to the report of Turner et al., 44% of CL users do
not wash their hands before handling, significantly increasing the risk of introducing pathogenic
microorganisms into the eye [62]. The CL storage case and solutions may also be potential reservoirs
for microorganisms responsible for ocular infections [5]. For example, studies exploring bacterial
bioburden in a CL care system confirmed that storage case contamination is much more common
than associated CL contamination [63–65]. The presence of pathogens in a storage case and in CL
solutions significantly increase the risk of their transfer to the lens surface and, ultimately, onto the
surface of the eye.
Our data reveal that AMPs might be promising antibacterial additives to CL solutions. However
there are certain limitations and issues which need to be considered. The long-time stability of
compounds in a water solution needs to be examined, but first of all the evaluation of toxicity towards
human eye cells needs to be carried out. In the previous study tested amphibian peptides turned out
to be safe towards HaCaT cells at their microbiologically-active concentrations. In the same assay
lipopeptide Pal-KK-NH2 exhibited high toxicity towards human keratinocytes [66]. Considering
the potential toxicity and the results of the present study, the most interesting candidates for further
examination are citropin 1.1 and temporin A. Encouraging results for other AMPs have been previously
reported. Mannis et al. evaluated a synthetic cecropin analogue (Shiva-11) as an antibacterial agent in
CL solutions. They demonstrated that it was effective against P. aeruginosa, S. epidermidis and S. aureus
in a buffered saline containing a CL [67]. In an extensive study of the Shiva-11, Gunshefski et al.
revealed that the peptide has a wide range of antimicrobial activity in vitro against human clinical
ocular pathogens [68].
Sousa et al. examined the effectiveness of a cecropin analogue (D5C) against P. aeruginosa and
compared it with the antimicrobial effect of commercial CL solutions. The investigators demonstrated
that D5C substantially enhanced antimicrobial activity of the disinfecting solutions [69].
The results obtained in this study are consistent with those previously reported. AMPs show
a broad-range antimicrobial activity and are potent anti-biofilm agents. Based on our results and
the literature data, we came to the conclusion that AMPs show a considerable potential for the
development of therapeutic and prophylactic antimicrobials against CL related infections. Further
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research is needed to establish the safety of ophthalmic application of the tested AMPs, as well as to
optimize the composition of CL solutions, to ensure stability of the applied AMPs. Effective products,
in combination with education on hygiene recommendations, will contribute to minimizing the risk of
eye infections.
4. Materials and Methods
4.1. Bacterial Strains and Culture Conditions
All selected strains were obtained from the Polish Collection of Microorganisms (Polish Academy
of Science, Wroclaw, Poland). Four Gram-positive and three Gram-negative strains linked with
CL-related infections lenses were tested (Table 5). The microorganisms were cultured in a Mueller
Hinton Broth II (MHB, Biocorp, Warsaw, Poland) overnight, at 37 ◦C.
Table 5. Reference bacterial strains.
Bacterial Group Species Number
Gram-positive
Staphylococcus aureus ATCC 25923
Staphylococcus epidermidis ATCC 14990
Streptococcus pneumoniae ATCC 49619
Streptococcus pyogenes PCM 465
Gram-negative Escherichia coli ATCC 25922
Pseudomonas aeruginosa ATCC 9027
4.2. Antimicrobial Peptides
All of the peptides were synthesized in the Department of Inorganic Chemistry (Medical




Lipopeptides: Palm-KK-NH2 and Palm-RR-NH2 (Palm–hexadecanoic acid residue)
4.3. Contact Lenses and Contact Lens Solutions
The CL and CL solutions used are commercially available. One-day CL (1-Day Acuvue Moist)
containing Etafilcon A were obtained from Johnson and Johnson Vision Care (Jacksonsville, FL, USA).
Four popular CL solutions were also tested (Table 6).
Table 6. Contact lens solutions and their contents.
Lens Solution Components
A Polyhexanide 0.0001%, Hydrolock (dexpanthenol and sorbitol), sodium phosphate,tromethamine, Poloxamer 407, disodium edetate.
B
Citrate, Tetronic 1304, aminomethylpropanol, sodium chloride, boric acid, sorbitol,
disodium edetate, Polyquad (Polyquaternium) 0.001%, Aldox (myristamidopropyl
dimethylamine) 0.0005%.
C Hydroxyphosphate Alkyl, Boric Acid 0.03%, Disodium Edetate, Poloxamine 1%,Sodium Borate, Sodium Chloride, Polyaminopropyl Biguanide 0.0001%.
D Boric Acid, disodium edetate, sodium borate, sodium chloride, DYMED (polyaminopropylbiguanide) 0.0001%, HYDRANATE (hydroxyalkylphosphonate) 0.03%, Poloxamine 1%.
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4.4. Peptide Synthesis
All of the peptides and lipopeptides were synthesized manually on polystyrene resin (Orpegen,
Heidelberg, Germany) modified by a Rink Amide linker [70]. 9-Fluorenylmethoxycarbonyl
(Fmoc) groups were used for protection of the α-amino groups of amino acids. Deprotection
of the groups was carried out for 20 min using a 20% piperidine (Merck, Darmstadt, Germany)
solution in N,N-dimethylformamide (DMF) (Honeywell, Seelze, Germany). Then the resin was
washed in DMF and dichloromethane (DCM) (Chempur, Piekary Slaskie, Poland). To check the
completion of the deprotection and acylation process, a chloranil test was performed. All amino
acids (Orpegen, Heidelberg, Germany) were coupled using a DMF/DCM (1:1 v/v) mixture in the
presence of coupling agents, 1-hydroxybenzotriazole (HOBt) (Orpegen, Heidelberg, Germany) and
N,N-diisopropylocarbodiimide (DIC) (Merck, Darmstadt, Germany). The progress of each acylation
was controlled by a chloranil test. The peptides were cleaved from the resin with a mixture of
trifluoroacetic acid (TFA) (Merck, Darmstadt, Germany), water, triisopropylsilane (TIS) (Merck,
Darmstadt, Germany), and phenol (Sigma Aldrich, Steinheim, Germany) as scavengers in the
ratio 92.5:2.5:2.5:2.5 v/v. Once the sequences were obtained, the peptides were precipitated with
cold diethyl ether (Chempur, Piekary Slaskie, Poland) and lyophilized. The crude products were
purified and analyzed by reversed-phase high-performance liquid chromatography (RP-HPLC) in
an acetonitrile-water (Sigma Aldrich, Steinheim, Germany) gradient containing 0.1% TFA. The identity
of the peptides was confirmed by matrix-assisted laser desorption/ionization time of flight mass
spectrometry (MALDI-TOF) and the counter-ion was determined by ion chromatography [71,72].
MS and HPLC analysis are included in Supplementary Materials.
4.5. Antimicrobial Activity Test Protocol
Peptide susceptibility tests on the reference bacterial strains were performed with the following
procedures recommended by the Clinical and Laboratory Standard Institute (CLSI). The activity
of five peptides was tested on the Mueller Hinton Broth II (Biocorp, Warsaw, Poland) using broth
microdilution method on polystyrene 96-well plates (Kartell, Noviglio, Italy). Bacterial inoculum
of ca. 5 × 105 CFU/mL was added to each well and exposed to solutions of peptides at increasing
concentrations (range 1–512 μg/mL). The plates were incubated overnight at 37 ◦C. MIC was assumed
as the lowest concentration at which bacterial growth was no longer visible. All experiments were
performed in triplicate.
4.6. Biofilm Assay
Biofilms of strains related with ocular infections were cultured on CL placed in polystyrene
24-well plates (Orange Scientific, Braine-l’Alleud, Belgium). Biomaterials were incubated at 37 ◦C in
bacterial suspension in the Mueller Hinton Broth II (Biocorp, Warsaw, Poland) at initial inoculums
of ca. 5 × 105 CFU/mL. After 24 h of incubation all of the CL were rinsed three times with a sterile
phosphate buffer (AppliChem, Darmstadt, Germany). The lenses were then transferred into new wells
with fresh MHB II. One-day biofilms were exposed to a pre-determined range of peptides concentration.
Plates with antimicrobial agents were incubated again for 24 h at 37 ◦C (optimal for bacterial growth)
or 25 ◦C (room temperature-standard storage temperature for CL). Anti-biofilm activity of selected
peptides was visualized using a cell-viability reagent, Resazurin (Sigma Aldrich, St. Louis, MO, USA).
Upon contact with living cells the dye is metabolized by bacterial dehydrogenases resulting in the
reduction of the blue resazurin to a pink resorufin. Positive controls contained CL immersed in bacterial
suspensions without antimicrobials, while CL in a sterile culture medium served as negative controls.
The minimum biofilm eradication concentration (MBEC) was read after a one-hour incubation with
Resazurin (final concentration per sample = 0.005%) MBEC was determined as the lowest concentration
at which the reduction of resazurin was lower or equal (10% ± 0.5%) as compared to positive (100%)
and negative (0%) controls. All experiments were performed in triplicate.
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4.7. Antimicrobial Activity of the Contact Lens Solutions
Effectiveness of the CL solutions against biofilms formed on CL was tested using the
previously-described procedure, with the difference that in the place of peptides, different undiluted
CL solutions were applied. Tested solutions were considered as active when they demonstrated the
ability to reduce the number of living bacteria on the surface of CL by at least 90% (reduction of
resazurin to lower or equal to (10% ± 0.5%) as compared to positive (100%) and negative (0%) controls).
All experiments were performed in triplicate.
Supplementary Materials: MS and HPLC analysis are available online at www.mdpi.com/1996-1944/9/11/873/s1.
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Abstract: Multidrug-resistant organisms are increasingly implicated in acute and chronic wound
infections, thus compromising the chance of therapeutic options. The resistance to conventional
antibiotics demonstrated by some bacterial strains has encouraged new approaches for the prevention
of infections in wounds and burns, among them the use of silver compounds and nanocrystalline
silver. Recently, silver wound dressings have become widely accepted in wound healing centers and
are commercially available. In this work, novel antibacterial wound dressings have been developed
through a silver deposition technology based on the photochemical synthesis of silver nanoparticles.
The devices obtained are completely natural and the silver coatings are characterized by an excellent
adhesion without the use of any binder. The silver-treated cotton gauzes were characterized through
scanning electron microscopy (SEM) and thermo-gravimetric analysis (TGA) in order to verify
the distribution and the dimension of the silver particles on the cotton fibers. The effectiveness
of the silver-treated gauzes in reducing the bacterial growth and biofilm proliferation has been
demonstrated through agar diffusion tests, bacterial enumeration test, biofilm quantification tests,
fluorescence and SEM microscopy. Moreover, potential cytotoxicity of the silver coating was evaluated
through 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide colorimetric assay (MTT) and
the extract method on fibroblasts and keratinocytes. Inductively coupled plasma mass spectrometry
(ICP-MS) was performed in order to determine the silver release in different media and to relate the
results to the biological characterization. All the results obtained were compared with plain gauzes
as a negative control, as well as gauzes treated with a higher silver percentage as a positive control.
Keywords: silver dressing; biofilm; antibacterial; wound infection
1. Introduction
Wound healing can be delayed by a number of factors, such as wound colonization by
microorganisms and infections. Many microorganisms in a wound produce factors detrimental
to healing, such as toxins and enzymes [1]. In burn wounds, bacterial infections can frequently occur
because of the accumulation of dead tissues, compromised immune system and blood supply [2,3].
In chronic wounds, bacteria persist in an adhesive matrix biofilm more resistant to antimicrobial
therapy [4,5]. Multidrug-resistant organisms are increasingly implicated in both acute and chronic
wound infections, thus compromising the chance of therapeutic options [6].
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To prevent infection or critical colonization of wounds, the choices are locally or systemically
delivered antibiotics, or dressings containing topical antimicrobial agents [7,8]. The intrinsic resistance
of bacterial cell within biofilm to conventional antimicrobials has encouraged new approaches
for the treatment of biofilm-associated infections; among them, the use of silver preparations
represents an interesting route towards new antimicrobials. Indeed, unlike antibiotics, silver interferes
with multiple components of bacterial cell structure and functions, making it less affected by
specific micro-environmental variations [9–11]. Moreover, in the form of nanoparticles, silver offers
many advantages in wound care and nanoparticles can also overcome existing drug resistance
mechanisms [12].
The anti-inflammatory effect of nanocrystalline silver offers exciting new applications [13].
In addition to the use of silver sulfadiazine as a topical cream, more contemporary studies have
explored the use of silver-impregnated dressings to manage infections [7]. Silver plays an important
role in the management of burn wounds by reducing the microbial growth within a wound dressing
and wound bed. The antimicrobial properties of silver-impregnated wound dressings against
Gram-positive and Gram-negative bacteria have been demonstrated in several in vivo studies [14–16].
Burn wounds treated with silver nanoparticles demonstrated better cosmetic appearance and
scarless healing [17]. In contrast to topical silver agents, wound dressings containing silver as an
antimicrobial agent have been recently introduced in various designs by the wound care industry [14].
An important advantage of using silver nanoparticles in wound dressings is the continuous release of
silver ions and possibility of coating the device on both the outer and inner sides, thus enhancing the
antimicrobial efficacy [12].
In this work, silver-treated wound dressings have been developed for the prevention of bacterial
infections in wounds and skin injuries. Traditional cotton gauzes were deposited with silver
nanoparticles on both sides by adopting a deposition technology based on the in situ photo-reduction
of silver nitrate. The efficacy of the adopted technology in providing a homogeneous coating of the
cotton fibers has been verified through scanning electron microscopy (SEM) and thermo-gravimetric
analysis (TGA). The antibacterial effectiveness of the silver-treated gauzes was tested in comparison
with positive and negative controls. The inhibition to bacterial growth and proliferation induced by the
presence of silver nanoparticles was verified through agar diffusion tests and bacterial enumeration on
Staphylococcus aureus. The efficacy in inhibiting the bacterial biofilm formation and proliferation on the
silver treated wound dressing was also demonstrated by biofilm quantification tests, fluorescence and
scanning electron microscopy. The biocompatibility of the silver coating was verified through MTT
assay on fibroblasts and keratinocytes and the results were related to ICP-MS analysis for evaluation
of silver release in different media.
2. Experimental Section
2.1. Deposition of Silver Nanoparticles on Cotton Gauzes
Sterile cotton gauzes (10 ˆ 10 cm, count 12/8) purchased by a local pharmacy were selected as
textile substrates because of their wide use as traditional dressings in the management of wounds
and burns. Coatings of silver nanoparticles were deposited on the gauzes through the in situ
photo-reduction of silver nitrate [18] by adopting a technology described for different natural and
synthetic materials [19–22]. In general, the technology involves three definite steps, namely the
preparation of the impregnating silver solution, the deposition of the silver solution onto the surface of
the material, and the UV exposure (365 nm) of the wet substrate. The process parameters such as the
composition of the silver solution, the deposition method and the UV exposure time are defined as
functions of the specific nature and application of the materials. In the specific case of cotton gauze
for wound dressing application, the substrates were dip coated in an alcoholic silver solution for
1 min and then immediately exposed to ultraviolet irradiation (365 nm, 500 W, distance 20 cm) in
order to induce the photo-chemical deposition of silver nanoparticles on the surface of the cotton
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fibers. Particularly, in this study an impregnating silver solution containing 0.5 w/v % of silver nitrate
dissolved in methanol was adopted for the production of the experimental samples. Methanol was
adopted as both reducing agent and solvent, even if deionized water can also be added to reduce the
costs of the treatment. Moreover, samples treated with 4 w/v % Ag were also produced and adopted
as positive control, whilst plain gauzes were used as negative control. After the silver treatment,
the samples were carefully washed in deionized water and dried in an oven at 60 ˝C for 2 h.
2.2. SEM Analysis on Silver Coated Gauzes
The morphological characterization was performed by a field emission scanning electron
microscope (FE-SEM), mod.
ř
igma Zeiss (Jena, Germany). The samples were firstly coated with a
2 nm palladium layer by an electron beam evaporator to avoid charging and examined at a 2–15 kV
acceleration voltage, 30 μm aperture, in top-view. To map the actual surface of the samples, the in-lens
detector was used, revealing the secondary electrons generated in the upper range of the interaction
bulb and therefore containing direct information on the sample surface morphology.
2.3. Thermo-Gravimetric Analysis TGA
The amount of silver deposited on the cotton substrates was calculated through
thermo-gravimetric analysis TGA (Mettler, Columbus, OH, USA). Untreated and silver treated samples
were heated from room temperature to 1000 ˝C in nitrogen flow and with a heating rate of 10 ˝C/min.
The percentage of silver deposited on the gauze was calculated as the difference between the solid
residues obtained from the treated and the untreated samples. Each type of sample was tested in
triplicate and the results were expressed as mean values ˘ standard deviation.
2.4. Qualitative and Quantitative Evaluation of the Antibacterial Capability
The efficacy of the silver-treated samples in reducing the bacterial viability and proliferation was
evaluated by agar diffusion tests and bacterial enumeration on S. aureus SA1 mucoid in comparison
with the untreated sample.
The agar diffusion tests were conducted according to Standard ‘SNV 195920-1992’. The procedure
consisted in incubating the samples for 24 h at 37 ˝C in contact with bacteria on nutrient agar plates
and then in evaluating the presence of an area of inhibited bacteria growth around the samples.
The antibacterial capability of the sample was defined as a function of the width of the inhibition area,
according to the levels provided by the Standard. Thus, if the width of the bacterial inhibition area
is greater than 1 mm, a “good” antibacterial activity can be associated with the sample; on the other
hand, if the sample is fully covered by bacteria, its antibacterial activity is labelled as “insufficient”.
The bacterial enumeration was performed through the serial dilution method. Samples of
untreated and silver treated cotton gauzes were incubated overnight at 37 ˝C in nutrient agar inoculated
with 100 μL of S. aureus suspension (inoculating cell density 0.94 ˆ 106 CFU/mL). After incubation,
the samples were removed from the broth, and serial dilutions were performed in sterile phosphate
buffered saline. From each dilution, 100 μL of the solution were extracted and plated in triplicate
on nutrient agar plates. After incubation at 37 ˝C for 24 h, the bacterial colonies grown on the agar
plates were counted and the average number of colonies was calculated for each sample. The samples
were tested in triplicate. In order to evaluate the effect of the silver coating on the bacteria viability,
the results were expressed as average percentages of bacterial proliferation calculated with respect to
the initial concentration of the bacterial suspension.
2.5. Quantification of Bacterial Biofilm on Cotton Gauzes
Samples of untreated and silver treated cotton gauzes (1 cm2) were placed in a 24-well microtiter
and incubated overnight at 37 ˝C with 2 mL nutrient broth inoculated with S. aureus (inoculating cell
density 0.94 ˆ 106 CFU/mL). The samples were washed three times with phosphate-buffered saline to
remove the non-adherent bacteria from the surface and then transferred to a sterile falcon containing
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2 mL phosphate buffered saline. Then, the samples were vortexed for 2 min to detach the adherent
bacteria and incubated at 37 ˝C for 4 h. For quantification of total number of bacteria, in triplicate,
aliquots of suspension were analyzed with a spectrophotometer (Visible spectrophotometer V-1200,
VWR, Radnor, PA, USA) and the optical density (OD600 nm) was reported as bacterial proliferation
expressed in colony-forming unit (CFU/mL) (1 OD600 = 1.5 ˆ 108 CFU/mL) [23].
Moreover, in order to evaluate the bacterial viability and to assess the bactericidal effect of the
silver treated samples, the plate count method was also adopted. The aliquots of suspension were
diluted in phosphate buffered saline through serial dilutions and then 100 μL of each dilution were
spread on nutrient agar plates. The plates were incubated at 37 ˝C for 24 h and bacterial colonies
grown on the agar plates were counted. The average number of colonies and the log reduction were
calculated for each sample, with respect to the untreated sample.
2.6. Fluorescence Microscopy on Adherent Bacteria
Another set of samples was incubated overnight at 37 ˝C in a 24-well microtiter, in the same
experimental conditions described in the previous section. After incubation, the samples were removed
from the multi-wells, washed three times with phosphate buffered saline and transferred to other
sterile wells for further SEM analysis. The wells used for gauzes incubation were washed with
phosphate-buffered saline (PBS) to remove any non-adherent bacteria and then analyzed. The biofilm
maturated on both gauzes and multi-wells surface was stained using green-fluorescent nucleic acid
stain (SYTO9, Molecular Probes, Eugene, OR, USA). After 15 min dark incubation, bacteria were
analyzed through a Zeiss inverted microscope (Axio Vert. A1 FL-LED, Oberkochen, Germany).
2.7. SEM Analysis of the Bacterial Adhesion on Cotton Gauzes
Samples of untreated and silver-coated cotton gauzes (2 ˆ 2 cm, average weight 15 mg) were UV
sterilized for 15 min on each side and incubated overnight at 37 ˝C in 3 mL of nutrient agar inoculated
with 100 μL of Staphylococcus aureus suspension (inoculating cell density 0.94 ˆ 106 CFU/mL).
After incubation, the samples were washed with phosphate buffered saline in order to remove the
non-adherent cells, whilst the adherent bacteria were fixed by using 2.5% glutaraldehyde and 2%
paraformaldehyde in cacodylate buffer 0.1 M for one hour. After fixation, the samples were washed
three times with cacodylate buffer for 10 min and then dehydrated in serially increasing concentrations
of ethanol (25%, 50%, 75% and 100%). Each wash lasted for fifteen minutes. The samples were stored
at ´20 ˝C and conditioned at room temperature before SEM analysis.
2.8. Cytotoxicity Test
Mouse embryonic fibroblasts 3T3 and human keratinocytes HaCaT were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum
(FBS) and antibiotics (1% UI/mL Streptomycin-Penicillin). Cell viability was analyzed through
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide colorimetric assay (MTT) and the extract
method, by adopting the only DMEM as positive control and the cells incubated without samples
as negative control. The cells were plated at 1 ˆ 105 cells/mL in 24-well plates and incubated for
24 h in a humidified incubator with 5% CO2 at 37 ˝C. For extract preparation, 0.2 g of untreated and
silver treated samples were immersed in 10 mL of phosphate buffer saline and incubated at 37 ˝C
for 24 h. The extracts were sterilized by using 0.22 μm filters and pH close to 7.4 was measured.
Then, the extracts were added to 24-wells plates with DMEM.
After incubation for 24 h, the culture medium containing the extracts was removed and 0.5 mg/mL
of MTT of DMEM was added to each well and the plates were incubated in a CO2 incubator for 2 h.
After incubation, the intracellular formazan crystals were solubilized with 1 mL of isoprapanol ad
centrifuged at 13,000 g for 5 min. The absorbance was determined at 550 nm using a spectrophotometer
(VWR V1200). The cell viability percentage was calculated in comparison to the control group obtained
without any extract. All the assays were performed in triplicate.
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2.9. ICP-MS Analysis
Silver release from silver-treated cotton gauzes was calculated through inductively coupled
plasma mass spectrometry ICP-MS (iCAP Q, Thermo Scientific, Waltham, MA, USA) in static conditions.
Silver treated and untreated samples (0.03 g) were immersed, in triplicate, in deionized water,
in phosphate-buffered saline (PBS) and in Dulbecco’s Modified Eagle’s Medium (DMEM) (5 mL) and
incubated 24 h at 37 ˝C. Different media have been adopted in this characterization in order to evaluate
possible interactions of the silver coating with chemical compounds, such as salts and amino acids,
in comparison with deionized water. After the incubation time, an aliquot portion (25 μL) of the different
media was diluted with nitric acid 1% (v/v). The samples were analysed, using silver solutions with known
concentration as standards (Sigma Aldrich, St. Louis, MO, USA, Silver Standard for ICP, 1000 mg/L).
3. Results
3.1. Deposition of Silver Nanoparticles on Cotton Gauzes
The silver deposition technology based on in situ photo-reduction reaction has been adopted in
this work to treat the experimental sample with 0.5 wt/v % silver solution and the control sample with
4 wt/v % silver solution.
3.2. SEM Analysis on Silver Coated Gauzes
The silver treated gauzes and the plain gauze were analyzed by scanning electron microscopy
SEM in order to verify the distribution of the silver particles on the cotton fibers, the differences
between the silver treated samples as function of the silver concentration tested and the dimension of
the silver nanoparticles. The results of the SEM analysis are reported in Figure 1, where an excellent





Figure 1. SEM analysis of distribution and dimension of the silver nanoparticles on the cotton fibres:
(a) neat cotton fibers; (b) cotton fibers treated with 0.5 wt/v % silver; (c) cotton fibers treated with
4 wt/v % silver; (d) cotton fibers treated with 0.5 wt/v % silver at higher magnifications (ˆ11740) for
the evaluation of the dimension of the nanoparticles.
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SEM analysis at higher magnification (ˆ11740) on the sample treated with 0.5% Ag is reported in
Figure 1d, where silver particles with dimensions ranging between about 100 and 300 nm can be observed.
3.3. Thermo-Gravimetric Analysis TGA
Thermo-gravimetric analysis TGA was performed in order to quantify the amount of silver
deposited on the cotton gauzes as the difference between the solid residues of the silver treated
sample and the untreated sample. The samples were tested in triplicate and the percentages of silver
deposited resulted 0.29 ˘ 0.02 wt % and 2.18 ˘ 0.04 wt % for the sample treated with 0.5 wt/v % and
4 wt/v % respectively.
3.4. Qualitative and Quantitative Evaluation of the Antibacterial Capability
The antibacterial capability of the silver treated samples was tested on S. aureus SA1 mucoid
through agar diffusion tests and bacterial enumeration. The results obtained by the agar diffusion tests
are reported in Figure 2a–c for the untreated sample (Figure 2a), for the sample treated with 0.5 wt/v %
Ag (Figure 2b) and for the sample treated with 4 wt/v % Ag (Figure 2c). As clearly visible by comparing
the width of the bacterial inhibition growth areas induced by the silver treated samples, no significant
difference in the antibacterial properties can be observed between the different concentrations of silver.
These data were confirmed by the results obtained by the bacterial enumeration reported in Figure 3,
where the percentages of bacterial proliferation calculated corresponded to 31% and 28% for sample
treated with 0.5 wt/v % Ag and 4 wt/v % Ag respectively. The untreated sample resulted in a bacterial
proliferation of 172%.
 
Figure 2. Agar diffusion tests on S. aureus: (a) untreated sample; (b) sample treated with 0.5 wt/v %
silver; (c) sample treated with 4 wt/v % silver. The presence of the inhibition zone to bacterial growth
is clearly visible around both the silver-treated samples.
 
Figure 3. Bacterial proliferation expressed as percentage induced by the silver treated samples in
comparison with the plain cotton gauze.
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3.5. Quantification of Bacterial Biofilm on Cotton Gauzes
The bacterial biofilm was quantified through both optical density measurements and the serial
dilution method. The first technique allows the estimation of total number of bacteria, while the second
one is related to live cells only. The results of spectrophotometric analysis are reported in Figure 4
as bacteria proliferation, indicating a 1 log reduction in bacteria adhered to the surface of the silver
treated cotton gauzes. The results obtained by the serial dilutions method are reported in Table 1.
In comparison with the untreated sample, >3 log reduction was obtained by experimental sample
(0.5 wt/v %), and even higher by the control sample (4 wt/v %).
 
Figure 4. Quantification of bacterial biofilm on cotton gauzes through optical density measurements.
Table 1. Quantification of bacterial biofilm on cotton gauzes through serial dilution method.
Sample CFU/mL Log Reduction
Untreated 1.62 ˆ 106 –
0.5% Ag 5.27 ˆ 102 3.49
4% Ag 5.00 ˆ 10 4.51
3.6. Fluorescence Microscopy on Adherent Bacteria
The results obtained by fluorescence microscopy on bacteria adhered on the multi-well surfaces
are reported in Figure 5a–d for control (Figure 5a), untreated sample (Figure 5b), sample treated with
0.5% Ag (Figure 5c) and sample treated with 4% Ag (Figure 5d). Control sample refers to bacteria
adhered on the tissue culture plate without any cotton sample.
 
Figure 5. (a) Fluorescence microscopy on bacteria adhered on the multi-well plates (magnification ˆ40)
after incubation with no sample; (b) untreated sample; (c) sample treated with 0.5 wt/v % silver;
(d) sample treated with 4 wt/v % silver.
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3.7. SEM Analysis of the Bacterial Adhesion on Cotton Gauzes
The efficacy of the silver coating in inhibiting the adhesion and the proliferation of bacterial
biofilm on the cotton gauzes was analyzed through scanning electron microscopy. The SEM pictures
reported in Figure 6a–c indicate the evident reduction in the adhesion of the bacterial cells to the fibers
induced by the presence of silver. Indeed, a high number of S. aureus colonies can be observed on the
neat cotton fibers (Figure 6a), whilst few isolated bacterial cells are visible on both the silver-treated
samples (Figure 6b,c, arrows).
 
Figure 6. SEM analysis on bacterial cells adhered and proliferated on the cotton gauzes: (a) untreated
gauze; (b) gauze treated with 0.5 wt/v % silver; (c) gauze treated with 4 wt/v % silver.
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3.8. Cytotoxicity Test
Potential cytotoxicity associated to the presence of silver coating has been investigated by
MTT assay through the extract method on murine fibroblasts 3T3 and human keratinocytes HaCaT.
The results obtained are reported in Figure 7 as cell viability percentage, compared to cells cultured
without any extract. The percentage of cell proliferation results were 103%, 105% and 21% in the
presence of the extracts from untreated sample and sample treated with 0.5 wt/v % Ag and 4 wt/v %
Ag respectively.
Figure 7. MTT assay for cytotoxicity evaluation.
3.9. ICP-MS Analysis
The release of silver in different media was calculated through ICP-MS analyses in static
conditions, aiming to evaluate the stability of the silver coating and its possible interaction with
biological fluids in terms of adhesion and cytotoxicity. The gauzes treated with 0.5 wt/v % released
0.409 ˘ 0.015, 0.449 ˘ 0.056 and 0.425 ˘ 0.055 ppm respectively in deionized water, in PBS and
in DMEM. On the other hand, the gauzes treated with 4 wt/v % of silver released 4.505 ˘ 0.071,
4.160 ˘ 0.099 and 4.954 ˘ 0.014 ppm in the same media (Figure 8).
 
Figure 8. ICP-MS analysis performed in water, PBS and DMEM.
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4. Discussion
The aim of this work was the development of silver-treated cotton gauzes and their evaluation for
potential application as antibacterial dressings in wound management.
As defined in the literature, an ideal wound dressing should maintain a moist environment and
oxygen permeation, should absorb excess exudates and prevent bacterial contaminations, and should
be non-adherent to the wound and easily removable [24,25]. The devices developed in this work are
intended to provide absorption due to the presence of cotton, and to prevent infections due to the
presence of silver. However, they can also be proposed as an inherent part of a more complex device,
where emollients and hydrogels can be added for improved hydration and comfort. Some wound
dressings including hydrocolloids and/or other substances, have also been proposed for providing
bioburden control, fast wound healing, ease of use and cost-effectiveness [26–28]. Moreover, today
silver-containing dressings are widespread in the management of burn injury and acute and chronic
wounds [28–30]. In addition to antimicrobial activity, silver dressings may modulate or reduce
wound pain [31], and also an active role in wound healing has been associated to the presence of
silver [32,33]. When compared to many wound dressings mainly based on nanocrystalline silver
and silver compounds, the silver-modified gauzes presented in this work are characterized by some
distinctive features related to both the nature of the materials and the production process adopted.
Indeed, most of the wound dressings available today are obtained by synthetic materials, such as
polyethylene, and are obtained through more complex production processes often involving the use of
binders [34–38].
The main groups of silver dressings available on the market are dressings with sustained levels
of silver release such as Acticoat, dressings with lower levels of silver release such as Actisorb
and Aquacel, dressings with high concentration of silver at wound surface such as Contreet Foam,
and dressings that release silver compounds rather than silver ions such as Urgotul [34].
In addition to the mechanism for silver release, these products are also different in terms of
nature and composition. For example, Aquacel Ag is a hydrofiber-based wound dressing made of
soft non-woven sodium carboxymethyl cellulose fibers integrated with ionic silver, while Urgotol
Silver, developed from a lipido-colloid technology, is a non-adhesive and non-occlusive dressing
made of polyester textile mesh impregnated with hydrocolloid particles and vaseline, where silver is
incorporated as silver sulphate [39,40].
On the contrary, these devices are completely natural and, although the silver particles lack
chemical bonds to link with natural fibers [37], an excellent adhesion of the coating to the substrate has
been obtained without the use of any binder [19–22]. No complex evaporation system or expensive
equipment are necessary in this silver deposition process, thus addressing an important aspect related
to the scaling-up of the technology.
This paper mainly involves microbiology and cytotoxicity aspects related to the specific
application of the material, aiming in particular to verify the efficacy of the silver treated wound
dressings in preventing infection in skin injuries in terms of bacteria biofilm adhesion and proliferation.
Thus, in the first part of the work, the silver coating was characterized through TGA and SEM
analyses in order to verify the presence and distribution of the silver particles on the substrate;
the second part is mainly dedicated to the biological investigation, in terms of antibacterial capability
and biocompatibility. For the specific application of the textile materials object of this research work,
the experimental samples were obtained by depositing cotton gauzes with 0.5 wt/v % silver solution
and the results were discussed in comparison with untreated gauze and gauze treated with 4 wt/v %
of silver as control samples. The presence of silver on the substrates was verified through TGA analysis
and resulted different between the treated samples, as expected. Interestingly, the other results obtained
by the different characterizations demonstrated that no significant differences occurred between the
samples treated with 0.5 wt/v % Ag and 4 wt/v % Ag. SEM analysis (Figure 1a–d) demonstrated that
0.5 wt/v % of silver ensured a homogeneous distribution of silver nanoparticles on the cotton fibers.
In order to verify and quantify the antibacterial capability of the samples, qualitative and quantitative
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tests, namely agar diffusion (Figure 2a–c) and bacterial enumeration tests (Figure 3), were performed
on S. aureus, as a representative microorganism responsible for skin and wound infections. As is visible
in Figure 2, both the silver concentrations exhibited inhibition areas to bacterial growth larger than
1 mm, and the bacterial enumeration tests also demonstrated an impressive reduction of the bacterial
proliferation associated to samples treated with both 0.5 and 4 wt/v % silver (Figure 3). The effect
of the silver coating in preventing bacteria biofilm adhesion and proliferation was also evaluated
through different experiments aiming to analyze and quantify the bacterial adhesion on the cotton
fibers. Textile materials can be a fertile ground for bacteria growth, and the wound site represents a
particularly good environment for bacteria adhesion and proliferation [41]. The results obtained by
bacterial biofilm enumeration tests demonstrated a high reduction of viability and proliferation of
bacteria adhered to the surface of the device (Figure 4, Table 1), thus confirming the bacteriostatic and
bactericidal effect of the silver coating. Indeed, the optical density measurements related to the total
amount of bacteria demonstrated 1 log reduction between untreated and silver treated samples, while
the evaluation of bacteria viability through the serial dilutions method indicated log reduction >3,
thus confirming the bactericidal effect of deposited silver [42,43]. Moreover, fluorescence microscopy
performed on bacteria stained on the multi-well plate after incubation with and without the samples
(Figure 5) indicated that the number of bacteria was significantly reduced in presence of the silver
coatings (Figure 5c,d), in comparison with the untreated sample (Figure 5b) and control (Figure 5a).
As expected, a high concentration of bacteria organized in clusters of colonies was observed in control
sample, i.e., in case of only medium inoculated with bacteria. On the other hand, compared to
control, the untreated sample (Figure 5b) resulted in a lower concentration of bacteria adhered on the
multi-well plate, because of the partial adhesion of bacteria also on the gauze surface. At this purpose,
SEM analysis was also performed on bacteria biofilm grown on the textile substrates (Figure 6a–c),
confirming the effectiveness of the silver coatings in reducing the bacteria adhesion and proliferation
on the gauze. Indeed, while a few isolated bacterial cells can be observed on the silver-treated samples
(Figure 6b,c), a large number of bacterial colonies aggregated in bacterial communities can be observed
on the untreated sample, indicating an initial step of biofilm growth (Figure 6a). The presence of
silver coating successfully inhibited the bacteria growth, and significant differences were not observed
between the silver concentrations tested. All the results indicated that the silver coating obtained by
0.5 wt/v % Ag solution was as effective as 4 wt/v % Ag against S. aureus, and that it successfully
inhibited the bacterial colonization and biofilm formation on the dressing. In the graph reported
in Figure 7, no significant differences can be observed in percentage of cell proliferation between
untreated and 0.5 wt/v % Ag-treated samples. These data confirmed no cytotoxic effect of silver
treated textile substrates and no skin irritation or hypoallergenicity effects through in vivo testing
on selected patients [44–47]. Although the cell viability was reduced by the samples treated with
4 wt/v % silver, the highest values of silver release produced results that were still lower than the limit
of cytotoxicity reported in the literature [48–50]. On the other hand, the presence of the silver coating
on the cotton gauze treated with 0.5 wt/v % did not affect the cell viability. ICP-MS analysis performed
in different media demonstrated the strong adhesion of the coating to the cotton substrate, thus also
confirming that very low amounts of silver are released by the experimental samples even in simulated
physiological conditions. The experiments were carried out in deionized water as control, in PBS in
order to reproduce physiological conditions, and in DMEM in order to relate the data to cytotoxicity
tests (Figure 8). As expected, samples treated with 4 wt/v % Ag released values of silver higher than
samples treated with 0.5 wt/v %, and the results were consistent with the biological characterization.
Moreover, the presence of a biological environment did not affect the silver release, thus confirming
the stability of the coating and the perfect adhesion to the textile substrate.
5. Conclusions
The aim of this work was the development of effective and low-cost silver dressings for the
prevention of bacterial infections in wound, burns and skin injuries. Conventional cotton gauzes
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extensively used in wound care for their absorbent properties and economic features were deposited
with silver nanoparticles through the in situ photo-reduction of silver nitrate. A low content of silver
(0.5 wt/v %) was adopted and tested in comparison with a higher silver percentage (4 wt/v %) and
an untreated sample. TGA and SEM analysis demonstrated the presence of nanoparticles and their
good distribution on the treated samples. The microbiological characterizations demonstrated that
the gauze treated with 0.5 wt/v % of silver was as effective as that treated with 4 wt/v % of silver
against bacteria in terms of viability and biofilm adhesion and growth. Due to the good antimicrobial
properties and biocompatibility demonstrated, the textile materials developed can be considered a
promising alternative to conventional wound dressings, with clear advantages in terms of prevention
of infections and costs.
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Abstract: In the current work, a new antibacterial bandage was proposed where diamond-like
carbon with silver nanoparticle (DLC:Ag)-coated synthetic silk tissue was used as a building block.
The DLC:Ag structure, the dimensions of nanoparticles, the silver concentration and the silver ion
release were studied systematically employing scanning electron microscopy, energy dispersive
X-ray spectroscopy and atomic absorption spectroscopy, respectively. Antimicrobial properties
were investigated using microbiological tests (disk diffusion method and spread-plate technique).
The DLC:Ag layer was stabilized on the surface of the bandage using a thin layer of medical grade
gelatin and cellulose. Four different strains of Staphylococcus aureus extracted from humans’ and
animals’ infected wounds were used. It is demonstrated that the efficiency of the Ag+ ion release
to the aqueous media can be increased by further RF oxygen plasma etching of the nanocomposite.
It was obtained that the best antibacterial properties were demonstrated by the plasma-processed
DLC:Ag layer having a 3.12 at % Ag surface concentration with the dominating linear dimensions of
nanoparticles being 23.7 nm. An extra protective layer made from cellulose and gelatin with agar
contributed to the accumulation and efficient release of silver ions to the aqueous media, increasing
bandage antimicrobial efficiency up to 50% as compared to the single DLC:Ag layer on textile.
Keywords: nanocomposite; silver; bandage; antimicrobial; S. aureus
PACS: 81.07.-b; AGRICOLASCC: L832
1. Introduction
Quite often, due to bad care of a wound (or a weak immune system), pathogenic microorganisms
cause wound inflammation. Bacteria, like methicillin-resistant Staphylococcus aureus (MRSA), can cause
severe infections with bad prognosis and consequences [1–3]. On the other hand, small wounds after
injuries can be healed using simple cotton bandages, which usually do not protect the damaged tissues
from bacteria and secondary infection.
It is known that bacterial adhesion is the first step in colonization of wounded skin and the
formation of a biofilm [4]. Therefore, it is very important to have the antibacterial surface directly
on the bandage to avoid the formation of these bacteria films, preventing bacteria multiplication
inside the bandage [5]. Bacterial infections are usually treated with antibiotics; however, a good effect
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is not obtained in every case, and this is because many bacteria are immunized to antibiotics after
being subjected to the treatment [6]. Moreover, antimicrobial resistance is directly associated with
over-usage of antibiotics; thus, alternative methods for treatment are necessary. One of the most
important pathogenic bacteria associated with different types of infections, including skin and soft
tissues, is S. aureus [7]. Infections caused by this species sometimes are very hard to treat because of its
multiple-resistance. Due to this reason, S. aureus is reputed as one of the most intractable pathogenic
bacteria in the history of antibiotic chemotherapy [8].
The closure of wounds and fistulas using silver sutures was shown to be very successful in
preventing infections [9]. Silver can be applied in different forms, namely as a metal, as a compound
or as a free dissolved ion. The famous Hippocrates first described silver’s antimicrobial properties
in 400 BC [10]. The ancient users of silver had no idea what form of silver worked best, but they
just observed the positive effects of silver and silver salts. They also realized that silver worked
best when some moisture was present. Now, it is proven that the silver ions (Ag+) are responsible
for the antimicrobial activity [11]. It is known that silver is an antiseptic metal and can act against
bacteria in different ways due to Ag cation release in aqueous media. Ag+ can destruct the cell
membranes, destroy the respiratory enzyme system or can block DNA replication. This variability of
antibacterial mechanisms of Ag hinders bacterial resistance formation [12]. The possible antibacterial
action mechanisms of silver nanoparticles (Ag NPs) are explained in the following way. Ag+ ions are
supposed to bind to sulfhydryl groups, which lead to protein denaturation by reducing disulfide bonds;
Ag+ can complex with electron donor groups containing sulfur, oxygen or nitrogen that are normally
present as thiols or phosphates on amino acids and nucleic acids [13]. Ag NPs react with sulfur-rich
proteins in the bacteria cell membrane and the interior of the cell or with phosphorous-containing
compounds, such as DNA. Accordingly, the morphological changes in the bacteria cell membrane
and the possible damage of DNA caused by the reaction with Ag NPs disturb the respiratory chain
or cell division processes, leading to cell death [14]. The antibacterial activity of a zero-valent silver
phase strictly depends on the surface development of the solid, since silver atoms/ions required to
accomplish the antibacterial activity are released only from the surface. Consequently, when this
solid phase is in a powdered form, the resulting antibacterial activity can be significantly increased,
and an ultrafine silver powder may result in several orders of magnitude more activity than the
corresponding bulk solid [15]. The Ag NPs are known to oxidize to Ag ions when they interact with
water molecules. Ag nanoparticles could provide sustained release of sufficient Ag ion compared to Ag
salts and bulk metallic forms due to higher active surface to volume ratios [16]. Finally, the nanosized
silver antibacterial activity is enhanced for two main reasons: the fraction of surface silver atoms
increases with decreasing particle size, and a greater fraction of surface silver atoms is weakly bonded
to the particle surface, which can be easily released to the surrounding medium. It is agreed that
the Ag NP nanocomposite antimicrobial activity is basically related to its ability to release Ag+ over
time [15].
The amount of biotechnological products containing silver nanoparticles in their composition
is increasing every day. For example, they are being used in the impregnation of wound dressings,
medical devices, dental materials, fabrics, among others, besides the combination with antibiotics
for the observation of a synergistic antibacterial effect [13]. Because of the increased attention to
antibacterial nanocomposites in the last few decades, there is significant interest in studying Ag ion
release from Ag NPs to optimize the nanocomposite performance and to reduce the negative effects on
human cells and the environment [17]. Ag nanoparticles have to be placed in media or on a surface,
which could have direct contact with skin tissues [18]. As an example, synthetic silk can be rinsed
in colloidal silver solution and, later on, dried out. However, in such a case, due to rinsing, less Ag
nanoparticles remain, and finally, the surface is polluted with the remainder of the chemicals used in
the process [19]. Therefore, this technology is not suitable for bandages. Antibacterial surfaces can
be produced, as well as a coating, where Ag-containing coatings can be envisaged as a pure Ag layer,
or Ag nanoparticles embedded in a matrix [12].
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In this case, diamond-like carbon (DLC) can be considered as a candidate, as it is known as a
versatile coating material that finds a variety of biomedical applications, including endoprosthesis and
dental implants. It provides mechanical robustness and cell-compatibility at the same time. To broaden
this range of beneficial properties even more, trials were reported when silver or silver nanoparticles
were embedded in order to add antibacterial properties [4,20].
Considering the final product, it should be mentioned that now, some bandages with silver-coated
textile are available on the market [21–23], where a thin silver layer is used that may release silver ions
if moisture is present. Some manufacturers offer hydrogel-based wound dressings [24,25], where the
hydrogel material is saturated with silver ions. In addition, hydrogel contains water and crosslinked
molecules, the structure of which ensures moisture absorption [26].
In the current work, DLC:Ag nanocomposite films were deposited on textile (synthetic silk) as a
part of a smart bandage prototype demonstrating antibacterial properties. The antibacterial properties
of such nanocomposites were systematically tested against S. aureus emphasizing conditions of DC
magnetron sputtering and, further, plasma processing steps. DLC:Ag properties were characterized
employing scanning electron microscopy (SEM) with energy dispersive X-ray spectroscopy (EDS) and
atomic absorption spectroscopy (AAS). Further development of the smart bandage by integrating new
functionalities is in progress and will be published in the forthcoming publications.
2. Results
2.1. Structure and Composition of DLC:Ag Layers Deposited on Textile and Crystalline Silicon
From the EDS measurements, it was obtained that the chemical content of Ag in as-deposited
DLC:Ag films varies from 0.46–6.43 at % (Table 1).
Table 1. Averaged DLC:Ag chemical composition obtained with EDS.
Sample No. Carbon (at %) Silver (at %) Oxygen (at %)
1 67.54 ˘ 1.33 1 0.46 ˘ 0.02 32.01 ˘ 1.33
2 61.55 ˘ 0.58 3.12 ˘ 0.11 31.16 ˘ 4.65
3 48.92 ˘ 3.65 6.43 ˘ 0.65 44.65 ˘ 4.27
1 Uncertainty is one standard deviation.
SEM measurements revealed that the lowest Ag content films do not have visible Ag nanoparticles
on the surface (Sample 1). A few particles were visible only on the surface of the silk substrates
(see Figure 1a) that were not present prior to deposition. The middle and highest investigated Ag
concentration samples (Samples 2 and 3) had a number of silver clusters on the surface (Figure 1b,c).
SEM micrographs and NP analysis are depicted in Figure 1.
Figure 1. SEM micrographs of DLC:Ag films of different Ag content on different substrates: (a) lowest
Ag content film (Sample 1; scale bar: 4 μm) on silk; the inset depicts the silk structure (scale bar: 100 μm);
(b,c) summarize the information about the medium and highest Ag concentration film (Samples 2 and 3,
respectively; scale bar: 1 μm) on silicon substrates; insets depict the particle size distribution number of
analyzed particles (N) and the average particle diameters (dav) of the corresponding SEM micrographs.
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2.2. Antimicrobial Activity of Virgin and RF O2 Plasma Processed DLC:Ag Films
Three as-deposited and O2 plasma-processed DLC:Ag thin films containing different amounts of
Ag 0.5–6.0 at % deposited on synthetic silk were investigated employing the disk diffusion method.
Figure 2 demonstrates the results of antimicrobial activity for Samples 1–3.
 
Figure 2. Testing of antimicrobial properties with the S. aureus LTSaM01 strain bacteria (disk diffusion
method) of virgin Samples 1 (a); 2 (b) and 3 (c); as well as after 20-s plasma processing
((d–f) respectively). The clear zone in (d–f) indicates areas where no bacteria multiplication is observed.
One can see that the virgin DLC:Ag-coated sample does not show an expressed bacteria inhibition
area for the S. aureus LTSaM01 strain (the same results were found for all investigated strains around
the samples in the Petri dishes), while the O2 plasma-processed sample demonstrates up to a 2.5-mm
inhibition zone.
The inhibition zones’ dimensions measured with four different strains after different processing
duration with O2 plasma for three different Ag concentration samples on silk are depicted in Figure 3.
 
Figure 3. Antimicrobial effect (linear dimensions of the clear zone) for three different Ag concentration
DLC:Ag films deposited on silicon and processed with O2 plasma for different durations (5–30 s)
(Samples 1–3) were tested with four different S. aureus bacteria strains, (a) LTSaDA01; (b) LTSaM01;
(c) LTSa635 and (d) LTSa603, the employing disk diffusion method. Measurement uncertainty: 0.5 mm.
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From Figure 3, one can see that after 5 s of O2 plasma etching, Sample 1 showed no antimicrobial
effect with all investigated bacteria strains. Sample 2 had only a weak effect for all bacteria strains,
i.e., the inhibition zone was ď0.5 mm (see Figure 3). Sample 3 with 6.43 at % of silver has shown even
better results with the shortest plasma processing duration, i.e., the inhibition zone was 1 mm, except
bacteria LTSaM01 (see Figure 3b), where a clear zone of 0.5 mm was obtained. After 15 s of etching
in O2 plasma, Sample 1 had a visible antimicrobial effect for all bacteria strains; the inhibition zone
was 0.5 mm. Samples 2 and 3 demonstrated a larger inhibition zone: 1.5 mm; except strain LTSa603
(see Figure 3d), where the inhibition zone was 1 mm. The best results in terms of inhibition zone
were observed for the samples etched for 20 s and 25 s. As can be seen from Figure 2d–f and Figure 3,
plasma etching strongly increased the inhibition effect for all four S. aureus strains for all investigated
samples with different Ag content nanocomposite DLC:Ag films.
The antimicrobial effect of differently plasma-processed DLC:Ag nanocomposite films on the
investigated strains could be related to the surface morphology changes and opening of the Ag NPs’
surface from the DLC matrix (see Figure 4). The chemical composition of the films after different
O2 plasma processing, providing the characteristic weak and strong antimicrobial effects on the
investigated bacteria strains, is depicted in Figure 5.
 
Figure 4. SEM micrographs of DLC:Ag (Sample 2) after different durations of O2 processing: (a) 5 s;
(b) 20 s. Scale bar: 1 μm.
 
Figure 5. Chemical composition of DLC:Ag films (Samples 1–3) after 5 s (a) and 20 s (b) of O2
plasma processing.
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From Figure 5, one can see that after O2 plasma processing, the surface concentration of carbon
decreases and the amount of silver increases. Analysis of the composition of the films has shown
a relatively high concentration of oxygen in the films as deposited and exposed to oxygen plasma.
Unfortunately, these measurements were done after a long exposure of the samples in atmosphere,
and potential changes of oxygen concentration in the films were hindered by the surface adsorption
processes. Therefore, these values probably could be considered only to identify possible trends of
variations but not the absolute (relative) concentration of oxygen.
2.3. Antimicrobial Activity of Bandage Prototype
Based on the best antimicrobial activity results, the 20 s plasma-processed DLC:Ag nanocomposite
film containing 3.12 at % Ag was selected for further investigation as a building block of the bandage
prototype. Synthetic silk substrate was used as a DLC:Ag substrate. A protective layer from cellulose
sheet (0.01 mm) gelatin (0.1–0.15 mm) worked as a silver ion accumulation matrix and prevented
the bandage from sticking to the wound’s soft tissues. The antimicrobial properties of the prepared
prototype were tested using the spread plate technique.
ASS experiments were used to follow the silver ion extraction process from the prototype
containing the DLC:Ag nanocomposite layer. Figure 6 depicts silver ion concentration changes
for different soaking durations of Sample 2 in purified water.
 
Figure 6. Silver ion concentration in purified water after soaking of synthetic silk coated with DLC:Ag
(Sample 2 (3.12 at % Ag)) for different time durations obtained with AAS.
It was obtained that the silver ion concentration increases sharply during the first 300 min and
saturates approximately after 900 min. A double logarithm function (y = a ˆ ln(´b ˆ ln(x))) can be
used to approximate the experimental curve, and a high correlation coefficient R2 = 0.96 was obtained
for the constants a = 4.36 and b = ´0.32.
Antimicrobial testing results of the smart bandage without and with the protective layer obtained
using the spread-plate technique with four bacteria strains are summarized in Figure 7.
It was found that the exponential law (equation: y = y0 + A ˆ exp(R0 ˆ x) could be used to describe
the time dependencies of CFU versus time, and Table 2 summarizes the values of the coefficients used
in the approximations.
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Figure 7. Time dependencies of bacteria colony forming units (CFU) versus time using the spread-plate
technique for the bandage prototype (PL) and the reference sample (No PL) measured with four types
of S. aureus bacteria strains: (a) LTSaDA01; (b) LTSaM01; (c) LTSa635 and (d) LTSa603.
Table 2. Coefficients of exponential dependencies used in the approximations of CFU versus time for





LTSaDA01 (a) LTSaM01 (b) LTSa635 (c) LTSa603 (d)
Value S.E. 1 Value S.E. Value S.E. Value S.E.
PL
y0 55.37 36.36 54.13 34.42 30.77 35.16 56.566 33.60
A 921.2 74.29 922.4 68.84 943.4 61.89 922.87 69.53
R0 ´0.0430 0.00826 ´0.0407 0.00717 ´0.0305 0.00463 ´0.0445 0.00803
R2 0.956 0.962 0.971 0.961
No PL
y0 ´83.45 110.3 ´75.39 97.95 ´101.1 130.6 ´77.21 95.29
A 1184.3 134.41 1157.7 121.45 1208.68 149.92 1170.6 117.74
R0 ´0.0149 0.00408 ´0.0154 0.0039 ´0.0132 0.00397 ´0.0153 0.00371
R2 0.919 0.930 0.908 0.936
1 Standard Error.
Tests with bacteria LTSaDA01, LTSaM01 and LTSa603 revealed that after 20 min, DLC:Ag-coated
synthetic silk without PL killed 10%–15% of S. aureus bacteria, when the same material with PL
killed 63%–65%. Tests with LTSa635 (MRSA) for the same duration of time have shown efficiencies
of 9% and 55%, respectively. Results of the longest soaking duration for 320 min revealed that the
bandage without PL had the same antimicrobial effect as compared to the bandage plated with PL,
i.e., after bandages, in both cases, 99% of all bacteria were killed, and only a few CFU were observed.
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3. Discussion
As was presented above, DC-reactive magnetron sputtering appears as an efficient way to produce
nanocomposite DLC:Ag coatings. Simple variation of the Ar/C2H2 flux ratio enables the deposition
of films with variable content of silver nanoparticle filler embedded in DLC matrix. The typical
structure of the DLC:Ag films deposited under similar conditions can be found in [27]. Similar results
were reported, as well, by [28], where DC-reactive unbalanced magnetron sputtering of Ag target in
acetylene atmosphere allowed producing DLC:Ag nanocomposite thin films with a variable content of
silver. During the experiments, the thickness of the film deposited on crystalline silicon and textile
was approximately 40 nm, and according to Figure 1b,c, the average size of silver nanoparticles varied
within a range 2–63 nm. In the case of lower silver concentration, low dimension silver nanoparticles
prevailed. The average diameters of silver nanoclusters in DLC:Ag nanocomposite films were 23.7 nm
and 28.8 nm for Samples 2 and 3, respectively. The larger silver content in the coatings matrix correlated
with larger silver cluster diameter. This is in good agreement with our previous experiments, where we
have performed deposition of DLC:Ag nanocomposites on silica substrates [29,30].
Antimicrobial results demonstrated that as-deposited DLC:Ag samples with low silver
concentration (Samples 1–3) had no or only very weak antimicrobial effect (see Figure 2). As we
have defined, additional O2 plasma etching appears as an efficient tool in enhancing the antibacterial
effect of the DLC:Ag nanocomposite surface. According to the results presented in Figure 5, O2 plasma
processing reduces the carbon surface concentration and provides the developed nanocomposite
surface (Figure 4), which seems close to the results obtained in [31], where O2 etching of organic
materials provided nanotextured surfaces. It should be noted that plasma etching for 20 s reduced
carbon content by 13.9% on average. During this process, a thin layer of carbon from the DLC:Ag
surface was removed to expose more silver nanoparticles, which were embedded and covered by
the DLC matrix [32]. On the other hand, due to O2 plasma bombardment, coalescence of silver
particles [33] and partial oxidation of silver nanoparticles take place. From this point of view, Sample
2 appears to be more efficient as compared to Sample 3 in terms of antimicrobial properties due to
the smaller size of the nanoparticles. The dominating mechanisms could be elucidated after more
comprehensive analysis of the behavior of DLC:Ag, and these experiments are in progress. After
the oxygen plasma etching procedure, the average silver content increased by 0.5 at % after 20 s.
The reduction of Ag in DLC:Ag films in the case of the highest silver concentration (Sample 3) could
be explained by volume expansion and strain-induced cracking of oxidized Ag NPs due to oxygen
ion bombardment [34,35]. Probably, a high concentration of silver, as well as an increase of the size
of the nanoparticles in the case of Sample 3 (as compared to the other two samples) contribute to the
efficiency of the mentioned mechanism. According to [36], the improvement of antimicrobial properties
correlates with the increased hydrophobicity and, according to our findings, with the increased surface
concentration of silver, as well.
As one can see, the etching time affected structural surface changes (Figure 4). Comparing
samples etched for 5 s and as-deposited samples, only minor surface changes were observed, but the
samples exposed to O2 plasma for the longer time had many small dimples instead of a smooth surface.
According to [36], this surface process is defined by the reaction of carbon materials, like DLC films
with oxygen plasma, where plasma produces a destruction of the graphite rings. This results in an
increase of single carbon chains where the concentration of aliphatic carbons atoms is pre-dominant
in O2 plasma-treated DLC films. Oxygen plasma treatment makes the DLC surface more desorbed,
rougher and superhydrophilic [36]. Finally, the superhydrophilic surface ensured maximum silver ion
diffusion from the samples to wet agar media. On the other hand, we have found that the prolonged
plasma exposure (above 25 s) resulted in the decrease of antibacterial activity for all investigated strains
and investigated silver concentrations (see Figure 3). This effect could be attributed to the ion beam
irradiation-induced increase of silver nanoparticles (ripening process) that we have observed early in
the case of reactive ion etching of DLC:Ag nanocomposites [33]. One can expect that the larger particles
have a smaller surface area, which is responsible for silver ion release into media. The nanoparticle
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size effect on the antimicrobial properties was reported as well in [37,38], where the authors declare
better antibacterial properties of small dimensions of AgNPs.
According to our findings, the optimal time for RF oxygen plasma etching was 20–25 s
(see Figure 3). For such plasma exposure, all of the coatings with different silver content revealed the
best antimicrobial properties, i.e., they had the developed surface and optimum dimensions of the
silver nanoparticles.
For such kinds of samples (Sample 2 as a typical example was taken (silver content after 20 s;
etching was 3.41 at %)), AAS analysis revealed efficient silver ion migration into aqueous media
(Figure 6). We found out that saturation of silver ion concentration in purified water takes place,
and after 24 h, at a 35 ˝C temperature, it reaches 4 ppm. It should be noted that according to [38],
the antibacterial activity against S. aureus starts at about 1 ppm. These results correlate well with the
microbiological testing (spread-plate technique; Figure 7) data where larger silver concentrations killed
more bacteria, as well.
Experimental data (Figure 7) revealed that the bandage without PL (soaking duration of 20 min)
demonstrated a lower antimicrobial effect as compared to the bandage where PL was applied. One
can assume that our chosen aqueous media (PL) can accumulate silver ions inside. After 24 h of
exposure of the bandage, the PL has accumulated silver ions and during the test acted as an efficient
source of silver ions. Moreover, the agar-gelatin layer at 35 ˝C can dissolve easily, and silver ions
can spread rapidly to all aqueous media, providing a very good antimicrobial effect. In all studied
cases, PL technology improved the antibacterial properties of the bandage, and it was more than
approximately 50% effective during the same time interval. The action speed was the main advantage
of the prototype, i.e., PL can be used as silver ion accumulation media for fast ion release in aqueous
media, enabling to kill instantly more than 50% of all of the bacteria population. It should be noted
that in wound healing, this is a very important factor, as the bacteria need to be killed in a short period
of time to prevent efficient growth of the bacteria population [39–41]; e.g., in [16], it was shown that
bacterial adhesion involved reversible bacterial association in the first 1–2 h after post-implantation,
followed by stronger bacterial adhesion, approximately 2–3 h later. After 24 h, certain bacteria formed
a biofilm, which was resistant to host defense and systemic antibiotic treatment.
In addition to the efficient antimicrobial properties, our bandage with PL having a gel-like
structure with the synthetic silk skeleton ensures good mechanical properties, as well. The cellulose
sheet as the membrane can sustain small particles and debris inside the bandage close to the DLC:Ag
surface, avoiding wound contamination. The gelatin and agar layer has very good water absorption
abilities, as was demonstrated in [42]. Furthermore, according to [14], approximately 39% more
silver is released into alkaline sweat (pH 8.0) as compared to acidic sweat (pH 5.5). In infected
wound, pH usually moves to a neutral or slightly alkali pH value; in that case, our technology also
has an advantage: silver ions should migrate faster, from nanoparticles inside the DLC matrix, and
the antimicrobial effect could be even stronger comparing to the tests in saline solution (0.9%) [14].
The higher release rate of Ag ion concentration into the surrounding medium and the longer it is
sustained, the more thorough the antimicrobial effect will be [43].
It should be noted as well that cytotoxicity is one of the main problems with using nanotechnology
in medical devices like bandages. Embedded cells like nanoparticles can cause adverse side
effects to the organism. In our bandage prototype, only the PL structure was used, to avoid this
problem, but further tests are needed to investigate toxicity. In the prototype bandage, the silver
ion concentration, according to the AAS data, could reach 4 ppm or 4 μg/mL. According to [13],
the minimum inhibitory concentrations of all bacteria tested were in a concentration range of AgNPs
(between 3.37 and 13.5 μg/mL) in which there was no observed significant cytotoxic activity compared
to the control [13].
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4. Materials and Methods
4.1. Deposition, Characterization and O2 Plasma Processing of DLC:Ag Films
DLC:Ag coatings with different Ag content were deposited on textile (twill weaved synthetic
silk, with a weft density of 110 cm´1 and a warp density of 100 cm´1) by DC-reactive unbalanced
magnetron sputtering of Ag target in acetylene atmosphere. Ag content was controlled varying feed
stock gas flow rates and changing magnetron power, as well as bias voltage. Crystalline silicon wafer
substrates were used as well for the comparative control of the deposition process. The deposition
conditions are summarized in Table 3. Further details on the deposition and properties of DLC:Ag
coatings with variable silver concentration can be found in our early papers [33,44,45].












1 520 70 21.1 553–625 0.07–0.12
2 235 70 21.1 568–741 0.07–0.22
3 200 80 7.8 625–656 0.10–0.11
The thickness of the deposited DLC:Ag coatings was approximately 40 nm (as measured by
scanning electron microscope (SEM)). The AgNPs’ particle size distribution and chemical composition
were obtained employing SEM FEI Quanta 200 FEG with an energy dispersive X-ray spectrometer
(EDS), Bruker Quantax. NPs’ diameters and the chemical composition of the films were studied
for the DLC:Ag samples deposited on Si substrates. EDS measurements were performed at a5-keV
accelerating voltage in order to minimize the excitation of the Si Kα peak. NP size analysis was
preformed employing ImageJ (NIH) software and custom MATLAB (MathWorks) code. More
detailed information about the applied NP analysis procedures can be found elsewhere [33,46].
Measurements of as-deposited nanocomposite thin film were performed at 3–5 different points,
and average normalized surface concentrations (excluding silicon) can be found in Table 1.
After the deposition, the samples were additionally etched by radio frequency (RF; 13.56 MHz)
oxygen plasma (99.9%) in 133 Pa pressure and 0.3 W/cm² power for 5–30 s. Morphology and
antimicrobial properties of the as-deposited and O2 plasma-etched DLC:Ag films on silicon and
silk were investigated.
4.2. Microbiological Testing of Virgin and O2 Plasma-Processed DLC:Ag Films
For testing of the bactericidal activity of DLC:Ag films on multiplying bacteria, four
clinically-important strains causing skin and wound infections of S. aureus previously isolated at
Lithuanian University of Health Sciences were selected. Two strains were isolated from sick humans
(LTSaDA01 and LTSaM01), as well as two strains were isolated from diseased pet animals: a dog
(LTSa603) and a cat (LTSa635). The strain LTSa635 was methicillin-resistant. The antimicrobial
properties of the DLC:Ag layer, as well as bandage prototype including the DLC:Ag layer were tested
using the disk diffusion method (see Figure 8a) and the spread-plate technique [47] (see Figure 8b).
The bacterial suspension density of 1 McFarland unit in saline solution (0.9%) was prepared and
inoculated onto Mueller Hinton agar (Thermo Scientific, Leicestershire, UK) in 94 mm-diameter Petri
dishes. In the disk diffusion method, synthetic silk samples (virgin and etched) of a 6 mm ˆ 6 mm
(˘1 mm) size with DLC:Ag coatings (Samples 1–3) were glued onto the agar surface using a small
drop of water. The samples were incubated for 24 h at 35 ˝C. The dimensions of inhibition zones
were measured from four sides of the sample, and the average value of the clear zone was calculated.
To check the temporal stability of the coatings, experiments with all three different silver concentration
DLC:Ag samples on synthetic silk were repeated for 4 times during a one-month period: at first day
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and thereafter at the 1st, 2nd and 3rd week after the deposition. Experimental results were fitted
employing OriginPro (OriginLab, Northampton, MA, USA).
(a) (b) 
Figure 8. Antimicrobial testing techniques. (a) Schematics of the disk diffusion method used for
microbiological testing (Ag+ diffusion of silver ions from the DLC:Ag surface into agar): (1) sample
coated with DLC:Ag nanocomposite; (2) bacteria colonies; (3) agar (bacteria nutrition media); (4) Petri
dish; (b) Schematics of the spread plate technique: (1) bandage prototype soaked in a test tube with
bacteria saline solution for different time durations; (2) the bacterial solution with Ag+ ions (0.1 mL)
was transported into a Petri dish; (3) inoculation of bacteria onto the agar surface; (4) calculation of
colony forming units (CFU).
4.3. Construction of the Bandage Prototype
DLC:Ag coating on synthetic silk indicated the best antimicrobial properties and was used as a
part of the smart bandage. The coating was exposed to UV irradiation for disinfection. As a protective
layer (PL), cellulose fibers (medium, C6288 Sigma, Sigma Aldrich, St. Louis, MO, USA), gelatin (53028
FLUKA, Sigma Aldrich) and agar (A1296 SIGMA, Sigma Aldrich) were used. A thin cellulose sheet,
acting as a membrane, was manufactured from microfiber cellulose and gelatin as a gluing material.
It was rolled into a 0.01 mm-thick sheet. The cellulose sheet was glued using gelatin and pressed using
a metal roller on DLC:Ag-coated synthetic silk. A hot suspension from gelatin and agar (90%/10%,
respectively) was prepared and placed on top as a second layer using a spin coater at low speed
(120 rpm). The structure of the smart bandage is presented in Figure 9. In such way, the prepared
bandage prototype was used in the antibacterial tests after 24 h.
 
Figure 9. Principle structure of the proposed bandage: (1) synthetic silk substrate; (2) thin
nanocomposite DLC:Ag films etched for 20 s in O2 plasma; (3) protective layer made from the thin
cellulose sheet (membrane) and the gelatin layer.
4.4. Antimicrobial Testing of the Bandage Prototype
Bactericidal activity evaluation tests of the bandage prototype were carried out using the same
four strains of S. aureus as described Section 4.2. The spread-plate technique [47] was applied to confirm
the bandage’s ability to kill bacteria on the surface and in the liquid media around it. The protective
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layer-covered rectangular-shaped bandage of 100 mm2 in area was soaked for 20, 40, 60, 80, 120, 160,
320 min in a thermostat at 35 ˝C in a 1-mL volume of bacteria in saline solution of 0.1 McFarland
units. To check the efficiency of the protective layer, an identical experiment was carried out with
the bandage including just the nanocomposite layer (Sample 2 etched for 20 s). After incubation,
the withdrawn solution was diluted 1:1000 times, and thereafter, 100 μL of bacteria suspension were
inoculated onto a Petri dish containing Mueller Hinton. After 24 h, colony forming units (CFU) were
counted. For statistical reliability, this experiment was repeated 3 times.
4.5. Antimicrobial Testing of the Bandage Prototype
Atomic absorption spectroscopy (AAS) was used to identify Ag+ migration from the bandage
(synthetic silk with Ag nanoparticles) to ultrapure water. The disk-shaped 10-cm2 bandage was soaked
in the test tube with 10 mL of thermostated water at 35 ˝C for time intervals from 20 min to 48 h.
Later on, water was filtrated from large (0.1 mm) particles, and AAS measurements were performed.
A Perkin Elmer Model 403 spectrometer was employed.
5. Conclusions
Diamond-like carbon-based silver nanocomposite layers deposited by DC-reactive magnetron
sputtering on textile appeared as an effective source of Ag+ ions and demonstrated expressed
antibacterial properties against four tested strains of Staphylococcus aureus bacteria.
The efficiency of the Ag+ ion release to the aqueous media can be increased by further RF oxygen
plasma etching of the nanocomposite. It was obtained that the best antibacterial properties were
demonstrated by the plasma-processed DLC:Ag layer having a 3.12 at % Ag surface concentration
with the dominating linear dimensions of nanoparticles being 23.7 nm.
An extra protective layer made from cellulose and gelatin with agar contributed to the
accumulation and efficient release of silver ions to the aqueous media, increasing the bandage
antimicrobial efficiency up to 50% as compared to the single DLC:Ag layer on textile.
The proposed bandage prototype (having a silver ion concentration in the protective layer below
the toxic level for organism cells) was able to kill more than 99.9% of all strains of bacteria after 320 min,
including methicillin-resistant Staphylococcus aureus.
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The following abbreviations are used in this manuscript
DLC diamond-like carbon
DLC:Ag diamond-like carbon with silver nanoparticles
RF radio frequency
MRSA methicillin-resistant Staphylococcus aureus
S. aureus Staphylococcus aureus
Ag+ silver ions
DNA deoxyribonucleic acid
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SEM scanning electron microscopy
EDS energy dispersive X-ray spectroscopy
AAS atomic absorption spectroscopy
N number of analyzed particles




y0 coefficient of extrapolation
A coefficient of extrapolation
R0 coefficient of extrapolation
S.E. standard error
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Abstract: Recently, numerous compounds have been studied in order to develop antibacterial
agents, which can prevent colonized wounds from infection, and assist the wound healing. For this
purpose, novel silver chloride nanoparticles stabilized with chitosan oligomer (CHI-AgCl NPs) were
synthesized to investigate the influence of antibacterial chitosan oligomer (CHI) exerted by the silver
chloride nanoparticles (AgCl NPs) on burn wound healing in a rat model. The CHI-AgCl NPs had
a spherical morphology with a mean diameter of 42 ˘ 15 nm. The burn wound healing of CHI-AgCl
NPs ointment was compared with untreated group, Vaseline ointment, and chitosan ointment group.
The burn wound treated with CHI-AgCl NPs ointment was completely healed by 14 treatment days,
and was similar to normal skin. Particularly, the regenerated collagen density became the highest in
the CHI-AgCl NPs ointment group. The CHI-AgCl NPs ointment is considered a suitable healing
agent for burn wounds, due to dual antibacterial activity of the AgCl NPs and CHI.
Keywords: Silver chloride nanoparticles; Chitosan oligomer; Burn wound healing; Antibacterial activity
1. Introduction
Antibacterial materials could be used in food packaging or handling, medical tools, hospitals
where people are more vulnerable to infections, possible areas like bathrooms where personal hygiene
is important, air and water filtration, etc. Among various materials known to be effective against
a variety of bacteria, silver (Ag) compounds (including elemental silver, silver oxide, silver halide, etc.)
are unique materials due to their powerful antibacterial activities against nearly 650 bacteria strains.
In addition, Ag compounds are well-known and have already been used in many biological and
medical fields, such as biosensors, wound healing materials, dental resin composites, and cancer
therapeutics [1,2].
Traumatic wounds including burn wound occur frequently in skin loss, and bacterial infections
often result from heavy contamination. There are many dressings and creams available to clinicians
for use in treating burn wounds. Numerous agents are valued for their antibacterial activity, which
can prevent colonized wounds from becoming infected, thereby assisting the wound to heal. Wound
infection is one of the main problems and serious consequence in severe burns or extensive skin
loss since bacteria produce leukocidin and tissue-destroying enzymes that further impair healing.
As a result, wound infections alter and delay normal the wound healing mechanism. One of the
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approaches for treating a wound infection is the use of wound dressings containing antibacterial
materials with a broad-spectrum of activity. Ag compounds have been widely found in wound
dressings in various forms, such as elemental Ag (Ag metal, and nanocrystalline Ag), inorganic
compounds (silver oxide, silver phosphate, silver chloride, silver sulfate, silver calcium-sodium
phosphate, silver zirconium compound, and silver sulfadiazine), and organic complexes (silver zinc
allantoinate, silver alginate, and silver carboxymethylcellulose) [3–5]. Recent evidence suggests that
the antibacterial mechanism is due to the release of Ag+ or Ag0. In addition, this antibacterial effect
accelerates wound healing [6,7]. The slow release of Ag ions is required for a continual bactericidal
concentration of Ag ions in the wound. Silver chloride (AgCl) is colorless and its low solubility product
ensures a long life and a slow release of silver ions for antibacterial property [8,9]. Indeed, there have
been some reports on using AgCl for antibacterial agent in wound dressing [10–12].
Chitosan, a β-1,4-linked polysaccharide of glucosamine (2-amino-2-deoxy-β-D-glucose) with
lesser amounts of N-acetylglucosamine, is a natural non-toxic biopolymer derived by deacetylation of
chitin [13]. Chitosan oligomer (chitooligosaccharide, CHI) is easy to prepare by the acidic or enzymatic
partial hydrolysis of chitosan. It has been reported that lower oligomers of chitosan are water-soluble
and biologically active, through their solubility and activities are dependent on average degree of
polymerization (DP) and the degree of deacetylation (DD) [14,15]. Chitosan and chitosan oligomer
have pronounced antibacterial effects because of the presence of amino groups [16,17]. Many studies
have also been carried out on the use of chitosan and its derivatives as a wound healing accelerator by
enhancing the functions of inflammatory cells, and there is good evidence that chitosan can beneficially
influence every separate stage of wound healing [18–22]. Chitosan and chitosan oligomer are currently
being explored as novel tools for wound and burn dressings, because of their immunostimulating,
hemostatic, antibacterial, nontoxic, biocompatible, and biodegradable properties [23].
In previous study [24], AgCl NPs stabilized with CHI were prepared by green synthesis. The effect
of the CHI, which was used as a resource of Cl ions and a stabilizing agent, on the formation reaction
of the AgCl NPs was investigated. It was confirmed that the Cl ions remained around ammonium
group in CHI molecule since the CHI was made by acidic hydrolysis using hydrochloric acid. Ag ions
readily reacted with the Cl ions during the formation of AgCl NPs. The synergistic effect of CHI-AgCl
NPs on the antibacterial activity was confirmed to be because it was prepared by the combination of
CHI and AgCl NPs, known antibacterial materials. However, further studies on accelerating effect of
the in vivo wound healing by antibacterial CHI-AgCl NPs have not been studied.
The present study was carried out to give an example of an effective burn wound healing agent
based on synergistic effect from using both AgCl and CHI. We synthesized CHI-AgCl NPs using
water-soluble chitosan oligomer by an environment-friendly method. Furthermore, the CHI-AgCl
NPs ointment was prepared to evaluate the healing effect for burn wound using rat model with the
expectation of applications in pharmaceutical and biomedical fields.
2. Materials and Methods
2.1. Preparation of CHI-AgCl NPs
Oligomeric chitosan (CHI, DD = 87%) was supplied by Hyosung Co. (Korea), and its composition
is as follows: dimer 2.31, trimer 12.53, tetramer 15.11, pentamer 13.59, hexamer 8.86, heptamer 6.46,
octamer 8.87, and nonamer or higher 32.27 mol %. Cl ions (Cl´) remained in CHI molecule because
CHI was made by acidic hydrolysis using chitosan in hydrochloric acid. CHI was used as a resource
of Cl ions and stabilizing agent for preparing AgCl NPs. Distilled water was used as solvent in all
the syntheses to provide benign environmental conditions in this system. In a typical preparation,
0.5 mL of 0.1 M AgNO3 solution was added to 60 mL of 5% (w/v) CHI solution. After complete
dissolution, the mixture was reacted in a three-necked glass-stopper flask fitted with a double-walled
spiral condenser to prevent evaporation and heated to 70 ˝C for 300 min. All solution components
were purged with nitrogen gas to eliminate oxygen. After the formation of CHI-AgCl NPs, the
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suspension was freeze-dried immediately at –85 ˝C to produce the powder CHI-AgCl NPs. A series of
experiments were performed to obtain transparent CHI-AgCl NPs by varying the order of reactants
and the reaction temperature.
2.2. Characterization of CHI-AgCl NPs
A UV-Vis spectrophotometer (Shimadzu, UV-2450, Tokyo, Japan) was used to record absorption
spectra in the suspension of CHI-AgCl NPs using a cell with path length of 1.0 cm. The morphology
of CHI-AgCl NPs was observed using a transmission electron microscope (TEM) (EM 912 OMEGA,
ZEISS, Jena, Germany). The samples for TEM observation were prepared by spotting a few microliters
of the suspension of synthesized CHI-AgCl NPs onto a holey carbon TEM grid followed by drying
before putting them into the TEM sample chamber.
2.3. Preparation of Ointments
Three ointments for in-vivo burn wound healing were prepared from Vaseline, CHI, and CHI-AgCl
NPs powder. The burn wound healing effect of CHI-AgCl NPs against CHI alone was examined,
and Vaseline was used as a base component of the ointment. The composition of each ointment for
burn wound healing is described in Table 1. The CHI and CHI-AgCl NPs powder were dissolved in
distilled water to obtain 10% (w/v) aqueous solutions at room temperature, which were used in the
water phase. Twelve grams of Vaseline, 12 g of stearyl alcohol and a 4 g of surfactant (Cremophor
RH40, HCO-40, SIGMA, Darmstadt, Germany) were heated at 75 ˝C and mixed with the water phase
solution (40 mL) at 75 ˝C to obtain an emulsion. Uniform ointments were obtained after slow cooling
of the emulsion.
Table 1. The composition of each ointment for in-vivo burn wound healing in the rats.
Ointment Composition Vaseline CHI CHI-AgCl NPs
Oil phase 12 g Vaseline, 12 g Stearyl alcohol, 4 g Cremophor RH40
Water phase (40 mL) – 4 g CHI 4 g CHI-AgCl NPs
Optical images
   
2.4. Burn Wound Model
The experiment was approved by the institutional committee for animal care in laboratory
research. For all experiments, four-week-old Sprague-Dawley rats were housed and bred at the
experimental animal center of Chungnam National University. The animals were provided with
a commercial diet and water ad libitum under temperature-, humidity-, and lighting-controlled
conditions (22 ˘ 2 ˝C, 55 ˘ 5%, and a 12:12-h light–dark cycle, respectively). Procedures involving
animals and their care were conducted in accordance with our institutional guidelines, which comply
with international laws and policies [25]. To induce burns with skin damage, a slightly modified
soldering iron with a flat contact area of 28.3 mm2 (AD = 6 mm) was made. Before creation of the burn
wound, rats were anaesthetized by Tiletamine plus Zolazepam, (30 mg/kg + 10 mg/kg) according
to body weight. Hair on the dorsal side of the rats was removed, and a burn wound was inflicted
by placing the circular iron disc (heated to 95 ˝C) over the dorsal side for 20 s. Second-degree burns
without cellular and tissue structure in the dermis were observed by sections stained with hematoxylin
and eosin (H&E). Animals were divided after 7 days of acclimation in the cage, and then assigned
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equally (n = 30) to one of the following groups: Group 1-untreated controls dressed with gauze; Group
2-treated with the Vaseline ointment with gauze; Group 3-treated with CHI ointment with gauze;
and group 4-treated with CHI-AgCl NPs ointment with gauze. Small amounts of ointment were
applied everyday for 21 days. The sample tissue was enucleated after treatment 1, 3, 7, 14, and 21 days
before sacrifice. The skin tissue for histopathological analysis was fixed in 10% buffered formalin,
subsequently dehydrated, and embedded in paraffin. The tissue paraffin was cut into 5 μm sections.
Fixed sections were then stained with H&E and Masson’s trichrome staining (MT).
2.5. Analysis of Blood Counts
The biochemical analysis of the whole blood was performed to confirm the healing process.
The blood sample was obtained from the abdominal aorta of animals before sacrifice. After being
placed in a serum tube containing the EDTA, and the tube was shaken with an orbital shaker. Complete
blood counts were measured using an automatic blood chemical analyzer (MS9-5, CARESIDE CO.
LTD, Seongnam, Korea).
3. Results and Discussion
3.1. Characterization of CHI-AgCl NPs
The formation of CHI-AgCl NPs was confirmed easily by both the color change from yellow to
yellowish brown with increasing reaction time and the strong surface plasmon resonance (SPR) peak
around 400 nm due to the formation of spherical AgCl NPs [12]. Figure 1a shows some typical UV-Vis
spectra of the suspension with CHI-AgCl NPs for the different reaction times. A strong SPR peak was
observed at around 400 nm, which is a characteristic of spherical faceted AgCl NPs. A red shift of
the absorption maximum was observed with increasing reaction time. The inset graph in Figure 1a
shows the change in absorbance at λ = 400 nm of the CHI-AgCl NPs suspension with the reaction
time for 300 min. To further investigate the morphology of CHI-AgCl NPs, the sample was analyzed
with a field emission scanning electron microscope. There is a roughly spherical CHI-AgCl NPs, as
seen in Figure 1b. The size of the roughly spherical CHI-AgCl NPs ranges between 30 and 50 nm, and
their average diameter is 42 ˘ 15 nm (inset image in Figure 1b). It was assumed that the formation
mechanism of AgCl NPs occurred in two steps. The mechanism on the formation of CHI-AgCl NPs
is illustrated in Figure 1c. Firstly, the Ag ions readily reacted with Cl ions, which remained around
the ammonium group of CHI after the acidic hydrolysis by hydrochloric acid (HCl). Secondly, small
AgCl NPs were stabilized with amino and hydroxyl groups in CHI and underwent growth to large
particles [26–30].
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Figure 1. (a) UV-Vis spectra of CHI-AgCl NPs dispersion with reaction time (the inset shows the
change in absorbance at 400 nm with reaction time); (b) TEM image and the corresponding particle
size distribution (inset) of the CHI-AgCl NPs; and (c) a proposed mechanism for the formation of
CHI-AgCl NPs.
3.2. A Clinical Pathology Study
A clinical pathology study was conducted during in-vivo burn wound treatment to determine the
effects of burn trauma on skin that was infected and dehydrated after sustaining injury. The survival
curves were found to be significantly different between the ointment-treated groups (Groups 2–4)
and untreated group (Group 1). The survival rates of the CHI-AgCl NPs ointment group were 90%,
but those of the untreated, Vaseline, and CHI groups were 80% at 21 days (n = 30). In all groups of
animals, most of the fatalities occurred between Day 1 and 6 because of the post-burning infection
(Figure 2a). In particular, the surviving rate was highest in the CHI-AgCl NPs ointment group in
comparison with other ointment treated groups (Groups 2 and 3), making it clear that the CHI-AgCl
NPs ointment had prevented the infection and improved the burn wound healing. The body weight
gain and components of blood were determined for the clinical pathology study during the burn
wound healing process. The body weight gain was compared in Figure 2b. On early treatment days
until Day 3, the body weight gain was decreased for all groups. There was no significant difference
in all groups during treatment days. White blood cells (WBC) are involved in defending the body
against both infectious disease and foreign material. Although the normal range of a white blood
cells was 6.60 to 12.6 m/mm3, the amount of WBC was somewhat increased in all of the untreated
and treated groups after sustaining injury [31]. It was still increased in the untreated group with
increasing treatment days, but those of the other treated groups were decreased. The variation of
WBC in CHI-AgCl NPs treated group (Group 4) was the lowest of all groups, which indicated that
the CHI-AgCl NPs ointment reduced the infection, resulting in accelerating the burn wound healing.
The amount of platelets was increased in the all groups during early-treatment days because the burn
wound was created, and was reduced thereafter with increasing treatment days (Figure 2c,d).
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Figure 2. The in-vivo clinical pathology study of untreated (), Vaseline ( ), CHI () and CHI-AgCl
NPs ointment (İ) on: survival curves (a); body weight gains (b); concentration of white blood cells
(WBC) (c); and concentration of platelet (PLT) (d).
3.3. Histological Analysis
The healing pattern of the burn wounds was studied to examine the histology for the untreated,
Vaseline, CHI, and CHI-AgCl NPs groups on Days 1, 3, 7, 14, and 21 using H&E staining method
(Figure 3). Generally, the injury initiates inflammatory phases for healing [32]. Therefore, it is difficult
to assess whether the inflammatory response is part of the normal healing process or an effect of
the material during the early stages of wound healing. For the untreated group, the epidermis is
completely destroyed and interrupted, and the tissue of the wound is filled by necrotic material,
bulla, and infiltrated inflammation until Day 21. Hyperkeratosis was also observed on Days 7 and
14. The Vaseline-treated group was shown to be similar to the untreated group. At 21 days, however,
the Vaseline-treated group exhibited less infiltrated inflammation than untreated group, but not bulla.
In the CHI ointment-treated group, the number of bulla was gradually decreased, and infiltrated
inflammation was not observed in comparison to the Vaseline-treated group. In contrast, the CHI-AgCl
NPs ointment-treated group was shown to have little infiltrated inflammation, and the underlying
area showed fibrosis with proliferation of fibroblasts that were placed in the granulation tissue, and
started to fill up the regenerated tissue from Day 14. After 21 days, the epidermis was filled with
mature granulation tissue like normal tissue, confirming the accelerated burn wound healing by the
improved antibacterial activity of the AgCl NPs stabilized with CHI.
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Figure 3. Evaluation of histopathology in the healing effect of ointments on burn induced skin damage
using the H&E staining. The photographs were taken at an original magnification of ˆ40.
3.4. Evaluation of Collagen Percentage
Collagen is the main structural protein component of connective tissue, and is mainly found in
skin. Therefore, it is desirable to observe the regenerated collagen in damaged skin during the healing
process. To observe the collagenous components, the wounds with or without treated ointment were
stained using a Masson’s trichrome staining method. Figure 4 shows representative photomicrographs
of wound healing on Days 3, 7 and 14. The collagenous components were stained in blue, and the
cytoplasm appeared in varying shades of red. It was precisely observed that the necrosis was filled in
the regenerated tissue in untreated group (Group 1), whereas the ointment-treatment (Groups 2–4)
influenced the regeneration of collagen for burn wound healing. For an accurate description, the
density of collagen at 14 days was determined using an image analyzer (Nikon, Japan), as shown in
Figure 5. The relative collagen density was increased significantly in the ointment-treated groups,
compared to that of the untreated group. Among them, the CHI-AgCl NPs-treated group (Group 4)
showed the highest collagen density, suggesting increased collagenase activity by the dual antibacterial
activity of the AgCl NPs stabilized with CHI. The data were represented as the mean ˘ standard
deviation (SD) of 10 independent experiments, and difference was significant at p < 0.05 compared
with the untreated, Vaseline, and CHI groups.
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Figure 4. Evaluation of histopathology in the healing effect of ointment on burn induced skin damage
using the Masson’s trichrome staining. The photographs were taken at an original magnification of ˆ40.
 
Figure 5. (a) The relative collagen density in burn induced skin damage at treatment Day 14.
Evaluation of histopathology in the healing effect of untreated (b); Vaseline (c); CHI (d); and CHI-AgCl
NPs (e) ointment using MT staining. The photographs were taken at an original magnification
of ˆ100. The data are mean ˘ SD of 10 independent experiments. * indicates data with a statistical
significance (p < 0.05) compared with the untreated and CHI-AgCl NPs ointment-treated groups.
49
Materials 2016, 9, 215
4. Conclusions
In view of the rapid progress of application of nanomaterials in bioengineering fields,
environmentally friendly methods should be required since the common methods generate toxic and
biological hazards. The CHI-AgCl NPs was successfully obtained by a simple and environmentally
benign method that used water and CHI as a biomaterial. The CHI is fundamental in the formation and
stabilization of well-dispersed AgCl NPs with a mean diameter of 42 ˘ 15 nm. The burn wound treated
with CHI-AgCl NPs ointment showed the highest percent of survival, and a reasonable number of
white blood cells because of the prevention of infection in wound healing. The collagenous components
were more regenerated in the CHI-AgCl NPs ointment group than the other treated groups. It was
demonstrated that the CHI-AgCl NPs were more effective as a wound-healing accelerator because
of improved antibacterial activity of CHI exerted by the AgCl NPs. Consequently, CHI-AgCl NPs
ointment is considered a promising material for burn wound healing.
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Abstract: In this work, biopolymer-based nanocomposites with antimicrobial properties were
prepared via melt-compounding. In particular, graphene nanoplatelets (GnPs) as fillers and an
antibiotic, i.e., ciprofloxacin (CFX), as biocide were incorporated in a commercial biodegradable
polymer blend of poly(lactic acid) (PLA) and a copolyester (BioFlex®). The prepared materials were
characterized by scanning electron microscopy (SEM), and rheological and mechanical measurements.
Moreover, the effect of GnPs on the antimicrobial properties and release kinetics of CFX was evaluated.
The results indicated that the incorporation of GnPs increased the stiffness of the biopolymeric matrix
and allowed for the tuning of the release of CFX without hindering the antimicrobial activity of the
obtained materials.
Keywords: nanocomposites; graphene nanoplatelets (GnPs); poly(lactic acid) (PLA); antimicrobial
activity; drug release; ciprofloxacin
1. Introduction
Biopolymers are an alternative to oil-based synthetic polymers since they are renewable and do
not contribute to environmental pollution being biodegradable, and they are currently used in several
applications [1–6]. Nevertheless, a broad use of biopolymers is often restricted by the necessity of
improving some functional properties such as mechanical and barrier properties. Therefore, intense
efforts have been made to improve their physical properties in order to enhance the commercial
potential of biopolymers such as poly(lactic acid) (PLA) [7–11].
An effective way to improve the properties of biopolymers is to incorporate nano-sized
reinforcements in the matrix [12–16]. Indeed, it is well known that nanocomposites, i.e., polymers filled
with particles having at least one dimension in the nanoscale range, show unique properties because
of the peculiar increase of the matrix-filler interface [17]. Various nano-sized fillers, such as layered
silicates, metal, polyhedral oligomeric silsesquioxane, carbon nanomaterials, and silica nanoparticles,
are being developed and extensively studied in the field of polymer nanocomposites. Among the above
materials, graphene, a flat monolayer of sp2´ bonded carbon atoms, is very promising due to its unique
characteristics such as high electronic conductivity, large specific surface area, and high mechanical
strength. Graphene combines a layered structure of clays with superior mechanical and thermal
properties of carbon nanotubes, which can provide excellent functional property enhancements.
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Recently, many studies have been conducted to provide biopolymers with antimicrobial properties
that might encourage their use in the field of active food packaging as well as in specific biomedical
applications [18–23].
Providing a polymeric device with antibacterial properties can be reached by different routes,
with or without the modification of the polymer structure. The incorporation of antimicrobials, or
other molecules, into a polymer matrix via melt-processing is a method that has been widely adopted
in the recent past since it has the advantage of using equipment commonly and already used to process
thermoplastic materials [2,3,24–31]. This method, moreover, ensures large production volumes and
solventless systems with obvious positive economic and environmental implications.
The effectiveness of the antimicrobial activity over time is mainly determined by the release rate
of the antimicrobial compounds. Release kinetics that are either too slow or too fast must be avoided
since the former means that microbial growth is not sufficiently inhibited and the latter means that
inhibition will not be sustained over time. The rate of release depends on different factors, i.e., the type
of polymeric matrix, the preparation method, the environmental conditions, the interactions between
the antimicrobial, and the matrix. In this regard, nanoparticles can potentially be used to control the
release of antimicrobial agents as reported in the scientific literature [17,32].
The aim of this work was to prepare and characterize biopolymer-based nanocomposites with
antimicrobial properties suitable for medical device packaging. In particular, graphene nanoplatelets
(GnPs) as fillers and ciprofloxacin (CFX) as biocide were incorporated via melt-compounding in a
commercial biodegradable polymer blend (BioFlex®) based on PLA. CFX is a wide-spectrum antibiotic
belonging to the fluoroquinolone family, active against both Gram-negative and Gram-positive strains.
Its spectrum of activity includes most strains of bacterial pathogens responsible for respiratory, urinary
tract, gastrointestinal, and abdominal infections.
The rheological, mechanical, and antimicrobial properties of the obtained nanocomposites were
evaluated. In particular, the influence of GnPs on the antimicrobial properties and release kinetics
was studied.
2. Materials and Methods
2.1. Materials
The polymer matrix used in this work was a sample of a biodegradable polymer blend of
proprietary composition (Bioflex), trade name Bio-Flex® F2110, supplied by FKUR (Willich, Germany).
It is based on PLA and a biodegradable copolyester and contains some additives.
Graphene nanoplatelets (GnPs), trade name xGnP®, Grade C, were supplied by XG Sciences
Inc., Lansing, MI, USA. Each particle consists of several sheet of graphene with an average thickness
of approximately 10–20 nm, average diameter between 1 and 2 μm, and a specific surface area of
about 750 m2/g.
Ciprofloxacin (CFX, chemical formula: C17H18FN3O3, Tm = 253–257 ˝C) was supplied by Sigma
Aldrich (St. Louis, MO, USA) and used as received without further purification. Its water solubility is
80 mg/L at 30 ˝C and 120 mg/L at 40 ˝C [33].
2.2. Preparation of Nanocomposites and the Incorporation of CFX
GnPs were added to Bioflex at 1 wt % and 5 wt % at the solid state, and the mixtures have then
melt-compounded in a batch mixer (Brabender PLE330, Duisburg, Germany) at 170 ˝C and a rotational
speed of 60 rpm for 5 min. For comparison, a pristine polymer-blend matrix was processed under the
same conditions. Before processing, Bioflex and GnPs were dried under vacuum at 90 ˝C for 4 h and
at 120 ˝C overnight, respectively.
The incorporation of CFX was achieved via melt-compounding using the same batch mixer
described above at the same processing conditions, i.e., 170 ˝C and a rotational speed of 60 rpm.
In detail, both the polymer and the GnPs were first fed to the mixer and compounded for 4 min.
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Thereafter, the CFX was added and the blend was processed for no longer than 1 min in order to avoid
eventual degradation phenomena of the additive. Both CFX and GnPs were added to the polymeric
matrix at 5% (w/w). For comparison, Bioflex, incorporating only CFX at 5% (w/w), was processed
under the same conditions. In Table 1, the composition of all the samples and their identification codes
are reported.
Films were prepared by compression-molding using a laboratory press (Carver, Wabash, IN,
USA). The material was preventively ground, placed in a mold between two Teflon sheets, and pressed
at 170 ˝C and 100 bar for about 2 min to obtain a 200-μm-thick film.








BIO 100 – –
BIO/GnP-1 99 1 –
BIO/GnP-5 95 5 –
BIO/CFX 95 – 5
BIO/GnP-5/CFX 90 5 5
2.3. Characterizations
The morphology of all the materials, including neat GnPs and neat CFX, was analyzed by scanning
electron microscopy (SEM; Quanta 200 ESEM, FEI, Hillsboro, OR, USA). In particular, both the GnPs
powder and the CFX powder were directly glued onto a sample holder, whereas the polymeric samples
were fractured under liquid nitrogen and then glued onto a sample holder. All the samples were
sputter-coated with a thin layer of gold to avoid electrostatic charging under the electron beam.
The rheological characterization was performed using a plate–plate rotational rheometer (HAAKE
MARS, Thermo Scientific, Waltham, MA, USA), operating at 170 ˝C on samples obtained by
compression-molding. The instrument has been set to operate in the frequency sweep mode in
the range 0.1–500 rad/s with a strain of 5%. Before testing, the samples were dried for 4 h under
vacuum at 90 ˝C.
Tensile mechanical measurements were carried out using a dynamometer (Instron model 3365,
High Wycombe, UK) on rectangular shaped specimens (10 ˆ 90 mm) cut off from films prepared by
compression-molding as described above. The grip distance was 30 mm, and the crosshead speed was
5 mm/min.
The antimicrobial activity of the materials was determined by the agar diffusion method
evaluating the presence of inhibition zones. In particular, Micrococcus luteus ATCC 10240 (ATCC,
Manassas, VA, USA) was used as a tester strain in order to study antimicrobial property of the
prepared materials. A bacterial suspension of ~109 colony forming units (CFU) was inoculated into
5 mL of lysogeny broth (LB)-soft agar to obtain a uniform bacterial overlay on LB-agar plates. Circular
samples (diameter 12 mm) containing CFX at 5% (w/w) were placed over a bacterial tester overlay.
Samples without CFX, i.e., BIO and BIO/GnP-5, were used as controls. Bacterial growth inhibition
halos were observed after overnight incubation at 37 ˝C.
A series of CFX solutions of distilled water containing 0.1–5 mg/L of CFX was used to obtain a
calibration curve correlating the absorbance peak intensity and the CFX concentration using a UV/vis
spectrophotometer (model UVPC 2401, Shimadzu Italia s.r.l., Milan, Italy). In the concentration range
here investigated, the calibration curve was found to be a line. The maximum absorbance peak of
CFX was detected at 276 nm. The release of CFX from the films was investigated by immersing a
pre-weighed sample in 10 mL of distilled water stored at 37 ˝C. At specific time intervals, for 6 weeks,
the absorbance peak intensity at 276 nm of the storage solutions was measured and converted to the
quantities of CFX released based on the calibration line previously calculated. After each measurement,
the samples were immersed in 10 mL of fresh distilled water and the cumulative release of CFX here
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reported was calculated by sequentially adding the CFX released after each step. Each measurement
was performed in triplicate.
3. Results and Discussion
3.1. Properties of Nanocomposites
SEM micrographs of the neat polymeric matrix, of the GnPs, and of the nanocomposite systems
are reported in Figure 1. The surface fracture of neat BIO (Figure 1a) exhibited the typical morphology
of polymer blends showing a poor interfacial adhesion, evidenced by the presence of voids due to
the detachment of the copolyester phase from the PLA matrix during the sample breaking. The SEM
micrograph of neat GnPs powder (Figure 1b) revealed irregular aggregates having different dimensions.
BIO/GnP-1 (Figure 1c) showed a fairly good dispersion of the GnPs and a good adhesion between the
matrix and the filler. As expected, upon increasing the filler concentration, the aggregates visible in the
fracture section increased, although a good adhesion was still evident (Figure 1d).
 
Figure 1. SEM micrographs of: (a) BIO; (b) neat GnP; (c) BIO/GnP-1; (d) BIO/GnP-5.
The influence of GnPs on the rheological behavior of the obtained systems was evaluated.
The complex viscosity values as a function of frequency are reported in Figure 2 for neat BIO and for
the related nanocomposites. The viscosity of the samples filled with GnPs was higher than that of
the neat matrix, and it increased with increasing the filler content. Moreover, both BIO/GnP-1 and
BIO/GnP-5 exhibited a more pronounced non-Newtonian behavior if compared with the unfilled
polymer. At high frequencies, the flow curves of the nanocomposite samples and of the unfilled matrix
were much closer among them, although the viscosity values of the nanocomposites remained higher
than that of the neat BIO. This rheological behavior is reported in the scientific literature as a typical
behavior shown by several nanocomposite systems including polymer/clay nanocomposites [34,35]
and polymer/GnPs nanocomposites [36,37]. It is generally attributed to a strong interaction between
the dispersed filler and the matrix that restricts the polymer chain movements.
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Figure 2. Complex viscosity as a function of frequency of neat BIO and related nanocomposites.
In Table 2, the elastic modulus (E), the tensile strength (TS), and the elongation at break (EB) of
neat BIO and of the nanocomposite systems are reported. The adding of GnPs provoked an increase of
the rigidity of the biodegradable matrix. In particular, the modulus increased on increasing the amount
of filler and BIO/GnP-5 showed a tensile modulus about 40% higher than that of neat BIO. Tensile
strength and elongation at break decreased in the presence of the nanoparticles. In detail, the decrease
of these properties was very slight for BIO/GnP-1, whereas adding the 5% of GnPs led to a higher
decrement, especially of the EB. The decrease of the tensile strength can be considered a consequence
of the reduction of the elongation at break that was likely due to the presence of some GnPs aggregates,
as shown by SEM micrographs. However, the reduction is quite low and does not compromise the use
of the material.
Table 2. Elastic modulus (E), tensile strength (TS), and elongation at break (EB) of neat BIO and
related nanocomposites.
Samples E (MPa) TS (MPa) EB (%)
BIO 140 ˘ 5.8 11.6 ˘ 0.5 165 ˘ 7.2
BIO/GnP-1 168 ˘ 6.2 11.1 ˘ 0.4 151 ˘ 6.1
BIO/GnP-5 195 ˘ 6.8 10.6 ˘ 0.6 135 ˘ 6.9
3.2. Properties of Antimicrobial Nanocomposites
Following the results described above regarding the effect of GnP amount on properties of
nanocomposites, CFX was incorporated in the nanocomposite system containing the 5% of GnPs. For
comparison, BIO, incorporating only the CFX, was prepared. In Figure 3, the SEM micrographs of neat
CFX, BIO/CFX, and BIO/GnP-5/CFX are reported. The micrograph of neat CFX powder (Figure 3a)
showed that CFX is visible under the form of irregular crystalline aggregates formed by needle-like
crystals. These aggregates were clearly visible in the cross section of the films containing CFX as shown
by SEM micrographs reported in Figure 3b,c. In particular, the CFX was well dispersed both in the
neat polymeric matrix (Figure 3b) and in the nanocomposite system (Figure 3c) in which both the
CFX and the GnPs were clearly visible. Moreover, in both cases, it is evident that the dimensions
of the CFX aggregates are smaller than the initial ones. This change in size can be attributed to the
melt-compounding that caused a disaggregation of the CFX clusters and the dispersion of the particles
into the matrix. Nevertheless, the adhesion level between CFX crystals and the polymer matrix is
quite poor.
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Figure 3. SEM micrographs of: (a) neat CFX; (b) BIO/CFX; (c) BIO/GnP-5/CFX.
The rheological behavior of the systems incorporating the antibiotic was evaluated and compared
with the respective systems without CFX. In Figure 4, the complex viscosity values as a function of
frequency of BIO/CFX and BIO/GnP-5/CFX were reported and compared with the flow curves of
BIO and BIO/GnP-5 shown above.
Figure 4. Complex viscosity as a function of frequency of systems incorporating CFX and of the
respective systems without antimicrobial additive.
The presence of CFX led to a slight rising of the flow curves both of the neat biopolymeric matrix
and of the nanocomposite system. Indeed, CFX acted as a micro-filler, causing the light increment of
the viscosity in the whole range of investigated frequencies.
In order to verify whether the CFX incorporation caused some modification of the mechanical
performance of the materials, tensile tests were performed. Table 3 reports the elastic modulus (E),
the tensile strength (TS), and the elongation at break (EB) of all the materials containing CFX. The results
showed that, for both systems, i.e., BIO/CFX and BIO/GnP-5/CFX, adding the antimicrobial additive
led to a slight increase of E and a decrease of EB. Indeed, CFX acted as a micro-filler, causing, at this
concentration, a slight increment of the rigidity and decrement of the ductility.
Table 3. Elastic modulus (E), tensile strength (TS), and elongation at break (EB) of BIO/CFX and
BIO/GnP-5/CFX.
Samples E (MPa) TS (MPa) EB (%)
BIO/CFX 150 ˘ 5.1 10.4 ˘ 0.5 130 ˘ 9.7
BIO/GnP-5/CFX 206 ˘ 7.1 10.2 ˘ 0.6 121 ˘ 9.9
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To verify that the incorporation of CFX conferred antimicrobial activity to the polymeric systems,
agar diffusion tests were performed. A Gram-positive bacterium, i.e., M. luteus, was used as tester strain
to evaluate the growth inhibition zone around the samples. Figure 5 reports the bacterial inhibition
halos observed around the systems incorporating the CFX and, for comparison, the respective systems
without antimicrobial.
 
Figure 5. Agar diffusion test performed on M. luteus overlay for the materials incorporating CFX and
for the respective systems without antimicrobial additive.
As expected, both the neat BIO and BIO-GnP-5 showed no antibacterial activity. On the contrary,
large bacterial growth inhibition halos were observed around both samples incorporating CFX after an
overnight incubation at 37 ˝C. More specifically, the presence of GnPs led to a reduction of the inhibition
zone, i.e., the inhibition halo diameter of BIO/CFX was about 42 mm, whereas BIO/GnP-5/CFX
exhibited an inhibition halo diameter of about 35 mm. This result can be explained considering that
the antimicrobial properties of the films are dependent on the release of CFX from themselves and that
the presence of the GnPs likely influenced the CFX release from the sample.
In order to verify this hypothesis, the release kinetics in distilled water at 37 ˝C was evaluated.
In Figure 6, cumulative CFX release as a function of the time from BIO/CFX and BIO/GnP-5/CFX
are reported. In particular, the release data were expressed as Mt/M8, where Mt is the cumulative
amount of drug released at time t, and M8 is the cumulative amount of drug released at infinite time
(which should be equal to the theoretical absolute amount of drug incorporated within the system at
time t = 0).
For both systems, the release of CFX was characterized by an initial burst phase followed by
a second phase, which is characterized by a slower release rate. However, according to results of
the agar diffusion test, BIO/GnP-5 released a lower amount of CFX during the entire six weeks of
immersion. This result can be explained considering that the incorporated GnPs into the polymer
matrix was able to create a tortuous pathway, thus slowing down the diffusion of drug molecules
through the polymeric matrix, as already reported in the scientific literature for other nanocomposite
systems [17,32].
In order to understand the release mechanism, the experimental data were fitted using the




where k is a kinetic constant related to the properties of the drug delivery system, and n is the
diffusion exponent that characterizes the release mechanism. In particular, when the value of n is ď0.5,
it indicates that the drug release follows the Fickian diffusion mechanism [38,39]. The power trend-lines
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fitting the experimental data (red dashed lines) are reported in Figure 6 together with the related
equations and the R2 values. It is worth noting that the power law model well fitted the experimental
release data since R2 values were very high, i.e., 0.9977 for both systems. The n values obtained by
the fitting were 0.3171 and 0.3547 for BIO/CFX and BIO/GnP-5/CFX, respectively. This implies that
the release of CFX from both systems followed a diffusion-controlled mechanism. The k value was
generally related to the release kinetics, i.e., a higher k value indicates a faster release. As expected,
the value of k was higher for the release from BIO/CFX in comparison with the k value obtained from
the release profile of BIO/GnP-5/CFX.
 
Figure 6. Cumulative CFX release from BIO/CFX and BIO/GnP-5/CFX. In the inset, only the first
hours of release are plotted in order to enhance their readability. The power trend-lines fitting the
experimental data (red dashed lines) are reported in the graph together with the respective equations
and the R2 values.
4. Conclusions
Biopolymer-based nanocomposites with antimicrobial properties filled with graphene
nanoplatelets (GnPs) were prepared via melt-compounding in a batch mixer. An antibiotic, i.e.,
ciprofloxacin (CFX), was chosen as biocide and incorporated together with GnPs in a commercial
biodegradable polymer-blend matrix.
The morphological analysis revealed that the GnPs were well dispersed in the biodegradable
matrix, although at the higher concentration some aggregates were visible. The nanocomposites
exhibited flow curves higher than that of the neat Bioflex, and the viscosity increased as the filler
content was increased. The adding of GnPs improved the stiffness of the matrix—in particular,
the elastic modulus increased with an increasing filler amount. The incorporation of GnPs affected the
release of CFX without hindering the antimicrobial activity of the obtained materials. In particular,
the presence of GnPs led to a slower release of CFX.
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Abstract: Orthopedic applications commonly require the administration of systemic antibiotics.
Gentamicin is one of the most commonly used aminoglycosides in the treatment and prophylaxis of
infections associated with orthopedic applications, but gentamicin has a short half-life. However,
silica nanoparticles (SiO2 NPs) can be used as elegant carriers for antibiotics to prolong their
release. Our goal is the preparation and characterization of SiO2-gentamicin nanohybrids for
their potential antimicrobial administration in orthopedic applications. In vitro gentamicin release
profile from the nanohybrids (gentamicin-conjugated SiO2 NPs) prepared by the base-catalyzed
precipitation exhibited fast release (21.4%) during the first 24 h and further extension with 43.9%
release during the five-day experiment. Antimicrobial studies of the SiO2-gentamicin nanohybrids
versus native SiO2 NPs and free gentamicin were performed against Bacillus subtilis (B. subtilis),
Pseudomonas fluorescens (P. fluorescens) and Escherichia coli (E. coli). SiO2-gentamicin nanohybrids were
most effective against B. subtilis. SiO2 NPs play no antimicrobial role. Parallel antimicrobial studies
for the filter-sterilized gentamicin were performed to assess the effect of ultraviolet (UV)-irradiation
on gentamicin. In summary, the initial fast gentamicin release fits the need for high concentration
of antibiotics after orthopedic surgical interventions. Moreover, the extended release justifies the
promising antimicrobial administration of the nanohybrids in bone applications.
Keywords: silica nanoparticles; gentamicin; in vitro release; antimicrobial effect; orthopedic applications
1. Introduction
Orthopedic applications such as bone implants and open fractures necessitate therapeutic and
prophylactic administration of antibiotics [1]. Microorganisms can attach onto the nails used for
stabilization of fractured-bones and may lead to systemic antibiotic resistant biofilms [2]. The
traditional systemic administration of antibiotics shows poor penetration to the infected tissues [3].
However, delivery systems that are able to locally release the antibiotics can maintain antibiotic
concentrations at the infected sites until healing is complete [4], reduce the frequency of drug
administration [5,6] and, consequently, enhance patient compliance [7]. Materials implemented
as carriers for antibiotics should have release kinetics that comply with the requirements to treat the
infection [8] and should be biodegradable to exclude further surgical intervention to remove them [3,9].
Gram-negative bacteria are increasingly associated with the risk of infections leading to
osteomyelitis, which has been more traditionally attributed to gram-positive bacteria, especially
Staphylococcus species. This increasing risk is due to the high number of administration of orthopedic
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implants. However, there are inadequate data regarding the involvement of gram-negative bacteria in
osteomyelitis [10]. Gentamicin is an aminoglycoside that is ideally used in treatment of osteomyelitis.
A potent broad-spectrum antibiotic that is effective against gram-positive and gram-negative
bacteria [11]. Controlled release of aminoglycosides is desirable, as their half-life is short and their
bioavailability is low, which is a challenge for the conventional treatment modalities [12].
In recent decades, much attention has been paid to silica nanoparticles (SiO2 NPs) as promising
carriers for controlled drug delivery [13,14]. Studies have been performed to investigate the role of
SiO2 xerogels as carriers to enable the controlled release of drugs. Aughenbaugh et al. [8] studied the
administration of SiO2 NPs prepared using different water/alkoxysilane molar ratios (4, 6 and 10) as
carriers for vancomycin and detected that the high molar ratio SiO2 gels possessed faster vancomycin
release than the low molar ratio ones. Shi et al. [15] examined the in vitro sustained release of
gentamicin from poly(lactide-co-glycolide)/mesoporous SiO2-hydroxyapatite composite material
(PLGA/HMS-HA). The release rate of gentamicin from HMS-HA particles was extended to one month
suggesting that PLGA/HMS-HA scaffolds are promising drug delivery materials for orthopedic
applications. Xue and Shi [6] suggested also that PLGA/mesoporous SiO2 hybrid structure is an ideal
drug release material for bone filling applications. Gentamicin exhibited a sharp initial burst for one
day followed by a slow release from the loaded SiO2 for three weeks. By the encapsulation with PLGA,
the release period can be extended to five weeks.
The aforementioned studies have only demonstrated the key role played by SiO2 NPs as carriers
for antibiotics especially in bone applications. Moreover, none of the previous studies have dealt
with the antimicrobial properties of the antibiotic-loaded SiO2 NPs that enable their administration
in different orthopedic applications. Accordingly, in the present paper, we report the antimicrobial
performance of the synthesized SiO2-gentamicin nanohybrids. To the best of our knowledge, only
a few studies have been implemented regarding the antimicrobial action of gentamicin-conjugated
SiO2 NPs. Corrêa et al. [16] detected that SiO2-encapsulated gentamicin prepared by precipitation
route and thus having a high amount of gentamicin on the surface of SiO2 NPs exhibited effective
antimicrobial action against Staphylococcus aureus (S. aureus). However, the previous work was not
coupled with mechanistic studies for the gentamicin release nor for the bacterial interactions with
the gentamicin-conjugated SiO2 NPs. Agnihotri and coworkers [13] examined the antimicrobial
action of aminoglycoside-conjugated SiO2 NPs and detected improved antimicrobial properties of the
conjugate against kanamycin-resistant E. coli. However, as in other prior studies, the aminoglycoside
release studies were not run concurrently with the antimicrobial studies. Therefore, the role of SiO2
NPs as prime antibiotic carriers that permit the extended release of antibiotics to be implemented in
orthopedic applications was not demonstrated. The present study aims to demonstrate the controlled
release of gentamicin from the SiO2-gentamicin nanohybrids through the in vitro release studies. The
present work makes an original contribution by performing the antimicrobial studies concurrently
with the in vitro release studies in order to estimate the amount of gentamicin released from the
SiO2-gentamicin nanohybrids. Consequently, appropriate concentrations of the nanohybrids that will
supply therapeutic levels of the gentamicin can be applied to avoid the possible sub-inhibitory released
concentrations of the antibiotic. Furthermore, our work is designed to shed light on the antimicrobial
actions facilitated by the SiO2-gentamicin nanohybrids in comparison with free gentamicin and native
SiO2 NPs to exclude any antimicrobial role that could be played by the SiO2 NPs and to demonstrate
that the antimicrobial effect can be attributed to the antibiotic.
In the present study, we examine the antimicrobial action of the tested materials against different
bacterial species and cover the lack of attention that the gram-negative bacteria have received regarding
their role in osteomyelitis. This lack of concern was addressed by performing antimicrobial studies
against different laboratory strains of E. coli and P. fluorescens as models of the gram-negative bacteria
that are reported in causing osteomyelitis. As our study does not focus on the clinical etiology of
osteomyelitis, nor are we looking to identify causative agents of this condition, we selected B. subtilis
as a model organism for gram-positive bacteria, as studies with S. aureus would require working in
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Biosafety level-II facilities. Moreover, as the present study primarily focuses on shedding insights
on differences between the antimicrobial sensitivities of gram-negative and gram-positive bacteria
in a setting where the antibiotic is delivered in the presence of the SiO2-gentamicin nanohybrids,
B. subtilis was chosen as a representative of gram-positive bacteria. Moreover, in this paper we
strive to complement previously published work by evaluating the effect of sterilization on the
loaded-gentamicin before the antimicrobial application through performing parallel antimicrobial
studies for the filter-sterilized gentamicin in comparison to the UV-irradiated gentamicin.
The conventional high processing temperatures of SiO2 NPs may affect the organic molecules,
but this can be overcome as sol-gel technology can be accomplished at room temperature [5].
Therefore, this work is targeted towards the preparation of the SiO2-gentamicin nanohybrids and
native SiO2 NPs at ambient temperature through a single step sol-gel procedure. The present
study focuses on the antimicrobial action of the SiO2-gentamicin nanohybrids against gram-positive
and gram-negative bacteria. The specific focus is on the elucidation of the possible use of the
SiO2-gentamicin nanohybrids in the treatment and prophylaxis of bone infections and orthopedic
applications. Moreover, Transmission electron microscopy (TEM) studies were performed to detect
the antibacterial mechanistic action of the SiO2-gentamicin nanohybrids on the microscopic level. The
interaction of the native SiO2 NPs and free gentamicin with the bacterial cells was also studied. The
main objective of this study is preparation of SiO2-gentamicin nanohybrids to demonstrate that the
released gentamicin has the extended antimicrobial action and could therefore be used efficiently for
targeting infectious microorganisms.
2. Results and Discussion
2.1. Characterization of the SiO2-Gentamicin Nanohybrids and Native SiO2 NPs
The SiO2-gentamicin nanohybrids prepared by the base-catalyzed precipitation route were
characterized by using different series of instrumental characteristic techniques to determine the
different properties of the SiO2-gentamicin nanohybrids and native SiO2 NPs. By X-ray diffraction
(XRD), the native SiO2 NPs and SiO2-gentamicin nanohybrids showed nearly the same XRD pattern of
the broad peak with Bragg angle at 2θ around 24˝ (Supplementary Figure S1), which indicates that
the SiO2 NPs used in the present study were amorphous in nature. This amorphous pattern has been
reported in previous studies [17].
The Fourier transform infrared (FTIR) spectra of the native SiO2 NPs, free gentamicin and
SiO2-gentamicin nanohybrids are depicted in Figure 1A,B. The native SiO2 NPs (Figure 1A) showed
Si–O–Si bending at 553, 790 and 955 cm´1. In addition, a sharp peak was detected at 1053 cm´1 for
the asymmetric Si–O–Si stretch and a broad band at 3381 cm´1 associated with the Si–OH stretching.
Similar spectrum was reported previously [18] for the well polymerized SiO2 network. The free
gentamicin (Figure 1A) showed a band at 606 cm´1 that is considered a major band for gentamicin [19].
Two more bands at 1524 and 1614 cm´1 were also detected. These bands can be ascribed to the N–H
vibrational bending of primary aromatic amines [20]. The spectrum of SiO2-gentamicin nanohybrids
(Figure 1B) showed peaks at 559, 793, and 957 and a broad peak at 3199 cm´1. This spectrum did
not impose significant shifts from the bands of the native SiO2 NPs, which can be attributed to the
amorphous nature of the SiO2 NPs. The intensity of the bands decreased after the conjugation. The
present measurements showed in addition a shoulder at 606 cm´1 and a band at 1529 cm´1 that are
obviously originating from the gentamicin. The current results indicate that gentamicin has been
loaded to the SiO2 NPs and causes no significant changes in the silica xerogel network.
The scanning electron microscopy (SEM) images provided important information for the native
SiO2 NPs and the SiO2-gentamicin nanohybrids as shown in Figure 2. The native SiO2 NPs (Figure 2A)
presented smooth spherical surfaces. However, the SiO2-gentamicin nanohybrids (Figure 2B) showed
surface roughness due to the conjugation of gentamicin to the SiO2 NPs and at the same time,
some nanohybrids are coalesced into larger agglomerates. Our results showed the loading of
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gentamicin to the SiO2 NPs. The detected roughness of the SiO2-gentamicin nanohybrids is important,
since surface roughness plays a major role in controlling the initial release of antibiotics, as rough
surfaces establish a larger area for antibiotic release [21]. Our results suggest that the initial antibiotic
release is mainly a surface phenomenon.
Figure 1. FTIR spectra of the: (A) native SiO2 NPs and free gentamicin sulfate; and (B) SiO2-
gentamicin nanohybrids.
Figure 2. SEM images of the: (A) native SiO2 NPs with the smooth spherical surfaces; and
(B) SiO2-gentamicin nanohybrids showing the surface roughness that is caused by the loaded gentamicin.
As depicted in Figure 3, the transmission electron microscopy (TEM) image of the native SiO2
NPs (Figure 3A) showed a homogenous spherical morphology and an average size of 327 ˘ 10 nm,
with a size range (Figure 3C) of 308 to 339 nm. The SiO2-gentamicin nanohybrids (Figure 3B) showed
network of conglomerated spherical SiO2 NPs of 332 ˘ 15 nm average size and a size distribution
(Figure 3D) of 292 to 354 nm. The slight increase in the size of SiO2-gentamicin nanohybrids over that
of the native SiO2 NPs can be related to the loading of the antibiotic to the SiO2 network.
The mass weight of the overnight dried SiO2 NPs and SiO2-gentamicin nanohybrids was measured
and their weight difference can be attributed to the loaded gentamicin sulfate that theoretically
comprises 12.7 wt % payload. The thermogravimetric analysis (TGA) results of the native SiO2 NPs
(not loaded with the antibiotic) and SiO2-gentamicin nanohybrids are shown in Figure 4. The data
demonstrate a total mass loss of 12.96% and 20.84% upon heating up to 500 ˝C in an argon atmosphere
for the native SiO2 NPs and SiO2-gentamicin nanohybrids, respectively. An initial weight loss of 6.94%
and 3.18% during heating of the native SiO2 NPs and SiO2-gentamicin nanohybrids up to 100 ˝C,
respectively, can be ascribed to the removal of the absorbed and residual water. Hence, the mass
loss of the native SiO2 after heating to 500 ˝C with the subtracted low-temperature moisture removal
is ~6%. The SiO2-gentamicin nanohybrids showed further weight loss of 4.4% at 215 ˝C that can
be considered as the start of aminoglycoside decomposition. A prior study [22] has recorded the
weight loss of amikacin sulfate at the range of 190 to 270 ˝C. Other work [23] demonstrated that rising
the temperature above 150 to 200 ˝C resulted in the loss of gentamicin. In the present study, the
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final weight loss of 13.25% in the range of 220 to 500 ˝C can be related to the removal of glycosidic
moieties [13]. The amount of gentamicin in the SiO2-gentamicin nanohybrids can be determined by
subtracting the mass loss of native SiO2 NPs from the mass loss of SiO2-gentamicin nanohybrids
after excluding the moisture weight loss in both samples and assuming that SiO2 absorbs equivalent
amount of water. Therefore, gentamicin sulfate, according to the TGA data, constitutes ~11.7 wt % of
the SiO2-gentamicin nanohybrids. This is very close to our calculated theoretical loaded gentamicin
sulfate (12.7 wt %) to the SiO2-gentamicin nanohybrids.
Figure 3. TEM images of the: (A) native SiO2 NPs showing a homogenous spherical morphology;
and (B) SiO2-gentamicin nanohybrids displaying the conjugated SiO2 network in conglomerates.
Size distributions of the: (C) native SiO2 NPs; and (D) SiO2-gentamicin nanohybrids. The size
distribution was determined by measuring the area of each single NP, using the ImageJ software
and calculating the average diameter of the measured 25 NPs.
Figure 4. TGA of the native SiO2 NPs and SiO2-gentamicin nanohybrids. The mass loss from 215 to
500 ˝C in the SiO2-gentamicin nanohybrids was ascribed to gentamicin decomposition.
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2.2. The in Vitro Release Profile of Gentamicin from the SiO2-Gentamicin Nanohybrids
Another objective of our study, after the detailed characterization of the prepared materials is to
detect the sustained gentamicin release from the SiO2-gentamicin nanohybrids. The in vitro release of
gentamicin is depicted in Figure 5. The SiO2-gentamicin nanohybrids (10 mg/mL) containing 11.7 wt %
gentamicin sulfate demonstrated a cumulative release of 250.5 ˘ 1.6, 356 ˘ 29.9, 386 ˘ 10.3, 435.3 ˘ 7.8
and 512.8 ˘ 0.7 μg/mL gentamicin in PBS solution after 24, 48, 72, 96 and 120 h, respectively. This
release profile constitutes a fractional release around 21.4%, 30.5%, 33%, 37.2% and 43.9% of the total
amount of the loaded-gentamicin sulfate, correspondingly, over the 5 days of the experiment.
Figure 5. The in vitro release of gentamicin from the SiO2-gentamicin nanohybrids (10 mg/mL) with
a drug concentration of 11.7 wt % in PBS at pH 7.4. The mean cumulative concentration of gentamicin
(μg/mL) (each data point is the mean of three measurements) was expressed as a function of immersion
time (h). The data were linearly fitted to the gentamicin standards. Error bars represent the standard
errors (n “ 3).
The relatively faster gentamicin release during the first 24 h (21.4%) when compared with the
slower sustained release during the successive days of the experiment is likely resulting from the
initial easily-released gentamicin that is attached to the surface of SiO2 NPs. Shi et al. [15] recorded
even higher initial bursts of gentamicin release (60%) from HMS-HA during the first hour. However,
slower release was detected within the following 11 h. They proposed that this initial burst release may
have also been due to the release of gentamicin molecules that were adsorbed either on the surface of
particles or by physical interaction with HMS-HA.
The subsequent decrease in the gentamicin release rate that is observed in our experiment
can be attributed to the chemical equilibrium between the gentamicin-silica chemical bonding
and the dissolution of water-soluble gentamicin in the aqueous medium [6]. In the same vein,
Kortesuo et al. [14] showed slower release of the loaded toremifene citrate and dexmedetomidine HCl
from the silica gel microspheres after their primary high release due to the depletion of the drugs from
the SiO2 surface.
At fitting our release data to various mathematical models, the data (Table 1) showed the best
pharmacokinetic fit to Korsmeyer–Peppas model (Figure 6A) with a release rate constant pkq “ 0.966,
n “ 0.416 (n ď 0.5 in case of Fickian diffusion) and a good linearity (R2 value) of 0.9769. This
fit suggests that gentamicin release from the SiO2-gentamicin nanohybrids is controlled by Fickian
diffusion [20,22]. Nevertheless, the release data fit fairly well to first-order model (Figure 6B) with
R2 value of 0.9655; this can explain the initial fast release of gentamicin during the first 24 h. Previous
studies have reported that fitting quality is likely better for the initial stage than for the terminal
one [24]. We conclude that, gentamicin release is fast at the initial stage, but without an unfavorable
initial burst release, followed by slower release during the successive days of the experiment. This
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release mechanism is due to the amount of gentamicin molecules adsorbed on the surface of the SiO2
NPs combined with the gentamicin diffusion from the SiO2-gentamicin nanohybrids.
Table 1. Calculated release rate constants (Ks) and correlation coefficients (R2) after fitting gentamicin
release profile, expressed by various mathematical models.
Mathematical Models Ks R2
Zero-order model 2.5167 0.9662
First-order model 1.1519 0.9655
Higuchi model 0.8583 0.9721
Korsmeyer–Peppas model 0.966 0. 9769
Figure 6. Pharmacokinetic fit of the release profile of gentamicin from the SiO2-gentamicin nanohybrids
to: (A) Korsmeyer–Peppas model; and (B) zero-order model. F is the drug release fraction at time t.
Our findings suggest that the SiO2 NPs can be proposed as elegant carriers for gentamicin sulfate
that permit the initial fast gentamicin release, which exceeds the minimal gentamicin therapeutic
concentration (1 to 4 μg/mL) against different sensitive bacteria [25]. The present findings thus fit the
initial need for high concentration of antibiotic after orthopedic surgery and avoid the sub-inhibitory
antibiotic concentrations that can provoke a problematic bacterial resistance. In addition, the reported
extended release of gentamicin is crucial factor for the efficient implementation of the SiO2-gentamicin
nanohybrids in versatile orthopedic applications.
2.3. Antimicrobial Activity of the SiO2-Gentamicin Nanohybrids, SiO2 NPs and Free Gentamicin
2.3.1. Agar Diffusion Assay
The final objective of our study is to identify the antimicrobial properties of the SiO2-gentamicin
nanohybrids that could permit their administration in different orthopedic applications. In order
to assess this antimicrobial activity, the zones of bacterial growth inhibition were measured for the
conjugated and native SiO2 NPs in comparison with that of free gentamicin (Figure 7; Supplementary
Figure S2). The native SiO2 NPs were not antimicrobial, as no zones of inhibition were produced
against any of the bacterial species that were tested. Our results indicate that the SiO2 NPs have
no antimicrobial effect when they are conjugated with antibiotics and act only as carriers for the
gentamicin. Therefore, the antimicrobial effect of the SiO2-gentamicin nanohybrids is exerted only by
the released gentamicin from the SiO2-gentamicin nanohybrids.
The agar diffusion results showed that the SiO2-gentamicin nanohybrids and free gentamicin
have a more marked antimicrobial effect against the gram-positive bacterium, B. subtilis, than on
the gram-negative bacteria, P. fluorescens and E. coli. It is evident that the outer membrane of
the gram-negative bacteria most probably acts as an extra barrier to the antimicrobial effects of
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the gentamicin. Gram-positive bacteria lack this outer membrane that may explain their greater
sensitivity [16].
Figure 7. Inhibition zone diameters (mm) of the SiO2-gentamicin nanohybrids and free gentamicin
(sterilized by UV-irradiation and filtration). Error bars represent the standard errors.
2.3.2. MIC (Minimum Inhibitory Concentration) of the SiO2-Gentamicin Nanohybrids, Native SiO2
NPs and Free Gentamicin
MIC of the tested twofold serially diluted SiO2-gentamicin nanohybrids, native SiO2 NPs and free
gentamicin were determined and are shown in Table 2. The native SiO2 NPs did not inhibit the bacterial
growth even at the highest concentration (1 mg/mL). These results confirm our negative agar diffusion
assay results for the native SiO2 NPs and demonstrate that the SiO2 NPs have no antimicrobial
effect. The MIC of the SiO2-gentamicin nanohybrids was 250 μg/mL (that released 6.26 μg/mL
gentamicin) against all the bacterial species. When comparing the same tested concentrations of
the free gentamicin with that of the SiO2-gentamicin nanohybrids, we found that free gentamicin
concentration of 0.98 μg/mL inhibited B. subtilis and 15.63 μg/mL was effective against P. fluorescens
and E. coli. MIC of the free gentamicin against P. fluorescens and E. coli is within the range of 3.91 to
15.63 μg/mL that is estimated to be 6.26 μg/mL, which is the amount of released gentamicin from
the 250 μg/mL SiO2-gentamicin nanohybrids that inhibited the P. fluorescens and E. coli. Comparing
the same concentrations of the tested SiO2-gentamicin nanohybrids with that of the free gentamicin is
important to prove that the high MIC of the SiO2-gentamicin nanohybrids (250 μg/mL) against the
bacterial species is governed by the amount of released gentamicin (6.26 μg/mL) and not from the
gentamicin itself.
Table 2. MIC of the SiO2-gentamicin nanohybrids, native SiO2 NPs and free gentamicin.
Tested Materials
MIC (μg/mL)
B. subtilis P. fluorescens E. coli
Native SiO2 NPs - - -
SiO2-gentamicin
nanohybrids 250 * 250 * 250 *
Free gentamicin 0.98 3.91 to 15.63 ¶ 3.91 to 15.63 ¶
Notes: (-) indicates that the tested material did not inhibit the bacterial growth. (*) represents that this
concentration of the SiO2-gentamicin nanohybrids released 6.26 μg/mL gentamicin that inhibited the bacterial
growth. (¶) indicates that the MIC of the free gentamicin is within this range (3.91 to 15.63) as the tested
concentrations were widely separated.
The agar diffusion assay and MIC results show that the antimicrobial efficacy of the
SiO2-gentamicin nanohybrids is less than that of the free gentamicin. This may be due to the
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aforementioned release profile of gentamicin from the SiO2-gentamicin nanohybrids. After 24 h,
the concentrations of 1 mg/mL and 250 μg/mL of the SiO2-gentamicin nanohybrids released 25.05
and 6.26 μg/mL gentamicin, respectively. The same concentrations of 1 mg/mL and 250 μg/mL of the
free gentamicin are solely gentamicin sulfate, which explains the more potent antimicrobial efficacy
of the free gentamicin than that of the SiO2-gentamicin nanohybrids. Our data demonstrate that the
sustained release of gentamicin from the SiO2-gentamicin nanohybrids fits their ideal antimicrobial
administration in different orthopedic applications. However, careful considerations should be taken
regarding the concentrations of the administered antibiotic-conjugated nanoparticles to avoid the
release of sub-inhibitory concentrations of the antibiotic. These sub-inhibitory concentrations may
result in the generation of antibiotic bacterial resistance that is elicited mainly from the miss-use
of the antibiotic-conjugated nanoparticles that would continuously supply low levels of antibiotic.
A previous study [23] has demonstrated a higher resistance of S. aureus to gentamicin-conjugated Au
NPs (MICs were 220 and 440 μg/mL) than to free gentamicin (MIC was 2 μg/mL) and concluded
that this resistance is not elicited from the low efficacy of gentamicin itself, but from the released
gentamicin that is interacting with the bacterial cells. Accordingly, we stress that it is important to
couple in vitro antibiotic release experiments with the antimicrobial assays to exclude any bacterial
resistance related to the low concentration of the released antibiotic from the carriers and not from
the antibiotic itself. According to our results, 10 mg/mL of the SiO2-gentamicin nanohybrids released
250.5 ˘ 1.6, 356 ˘ 29.9, 386 ˘ 10.3, 435.3 ˘ 7.8 and 512.8 ˘ 0.7 μg/mL gentamicin after 24, 48, 72, 96
and 120 h, respectively. In this case, the released gentamicin concentration exceeded the MIC of the free
gentamicin every 24 h; however, there was a high standard deviation value for the released gentamicin
after 48 h. It is therefore evident that attention should be taken in the formulation of these materials for
orthopedic applications. Notably, attention should be paid, on the one hand, to the concentrations of
the applied materials to avoid the release of sub-inhibitory concentrations of the antibiotic and on the
other hand, to avoid possible toxicity, which may result when the aim is to provide adequately high
levels of the released antibiotic. More importantly, the parallel study of the antimicrobial properties
of the filter-sterilized gentamicin showed non-significant increase in the diameters of the inhibition
zones (Figure 7) in comparison to that of the UV-sterilized free gentamicin. The recorded MIC was
exactly the same. These experiments show that UV-irradiation can be used as a convenient method for
sterilization of the antibiotic-loaded nanoparticles, especially if the size of the loaded nanoparticles
is larger than the pore size of the syringe filter (0.2 μm). Similarly, prior literature [26] described
that irradiation did not affect the release of gentamicin from the gentamicin-loaded collagen/PLGA
microparticle composite.
2.3.3. Bactericidal Mechanistic Action of the SiO2-Gentamicin Nanohybrids versus Free Gentamicin
In order to provide new insights on the antimicrobial properties of the SiO2-gentamicin
nanohybrids on the microscopic level, TEM studies were performed. The TEM micrographs of
the bacterial cells treated with the native SiO2 NPs, SiO2-gentamicin nanohybrids and free gentamicin,
as well as the untreated cells are depicted in Figure 8. The untreated B. subtilis (Figure 8A)
showed the typical thick cell wall of gram-positive bacteria, while the untreated P. fluorescens
(Figure 8B) demonstrated the thin cell wall of gram-negative bacteria. The cell wall thickness of
gram-positive bacterium B. subtilis is about 20–30 nm and formed by interwoven peptidoglycans
and secondary polymers. The gram-negative bacteria possess thin peptidoglycan layer with an outer
lipopolysaccharide membrane [27].
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Figure 8. TEM micrographs of the: (A) untreated B. subtilis and (B) P. fluorescens (control negative);
native SiO2 NPs-treated (C) B. subtilis and (D) P. fluorescens; and P. fluorescens interacted with
(E) SiO2-gentamicin nanohybrids and (F) free gentamicin. Black arrows indicate disorganization
of the bacterial cell membranes. White arrows show complete deterioration of the bacterial cells.
The native SiO2 NPs-treated bacterial cells (Figure 8C,D) showed no morphological changes and
the bacterial cells appeared intact and similar to the control untreated cells. These results confirm the
lack of any antimicrobial properties for the SiO2 NPs at the microscopic level and show that only the
gentamicin is responsible for the antimicrobial effect. The SiO2-gentamicin nanohybrids-treated
bacterial cells (Figure 8E) presented disorganization of the bacterial cell membranes. The free
gentamicin-treated bacterial cells (Figure 8F) were more affected than the bacterial cells treated with the
SiO2-gentamicin nanohybrids. The treatment with the free gentamicin showed complete deterioration
of the bacterial cell membranes resulting in the leakage of intracellular contents. The mechanism by
which the bactericidal action of the SiO2-gentamicin nanohybrids and free gentamicin is exerted can
be attributed to the aminoglycoside structure of gentamicin. The binding sites for aminoglycosides are
teichoic acids of the cell wall and phospholipids of the cell membrane of gram-positive bacteria [28].
Amongst Enterobacteriaceae members and Pseudomonas species, aminoglycosides can cross the cell
walls through porin channels and bind to the 30S subunit of ribosome, resulting in errors in protein
synthesis and bacterial death [29].
Finally, it should be noted that, our TEM results represent a third method to confirm the agar
diffusion assay and MIC outcomes as follows: (1) the SiO2 NPs act as carriers for the sustained release
of gentamicin and have no antimicrobial effect themselves; and (2) The SiO2-gentamicin nanohybrids
have a lower antimicrobial effect than the free gentamicin. This correlates with the sustained release
profile of gentamicin from the SiO2-gentamicin nanohybrids, which supports their potential to be used
in different orthopedic applications that require extended antibiotic release. However, it is to be noted
that this study has been only focused on model organisms, and not on bacteria isolated from bone
infections and associated with osteomyelitis. It would therefore be paramount to use such organisms in
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further studies to show more concrete evidence for the potential use of SiO2-gentamicin nanohybrids
for treatment and prophylaxis of osteomyelitis
3. Materials and Methods
3.1. Synthesis and Characterization of the SiO2-Gentamicin Nanohybrids and Native SiO2 NPs
The SiO2-gentamicin xerogels were prepared via the base-catalyzed precipitation route adopting
the method described by Corrêa et al. [16]. Briefly, 500 mg of gentamicin sulfate (Sigma-Aldrich,
Shanghai, China) was dissolved in 10 mL of tetraethyl orthosilicate (TEOS, Aldrich® chemistry,
Steinheim, Germany). Then, 20 mL of ammonium hydroxide (28%–30%, Sigma-Aldrich, St. Louis,
MO, USA) was added to the solution. The mixture was stirred for 20 min at room temperature until
precipitation. The resultant material was dried overnight at room temperature and then ground.
The native SiO2 NPs were prepared with the same aforementioned method but excluding the addition
of gentamicin sulfate.
Once the materials were prepared, several instrumental techniques were applied for the
characterization. The SiO2-gentamicin nanohybrids and native SiO2 powders were subjected to
X-ray diffraction measurements with an X’pert Powder Pro (PANalytical/PW3040/60, Almelo,
The Netherlands) operated at generator settings of 40 mA and 45 kV using Cu-Kα radiation and
a goniometer scanning (2θ) over 10˝–90˝. The FT-IR measurements were performed using a Nicolet
380 FT-IR (Thermo Electron Corporation, White Bear Lake, MN, USA) spectrometer in the attenuated
total reflection (ATR) mode, with a resolution of 2 cm´1 and a scan range of 4000–500 cm´1. The spectra
were averaged over 64 scans. The samples were analyzed using the absorbance mode. The SEM
analyses were accomplished by using a Hitachi SEM (S-4700, Tokyo, Japan) to detect the surface
morphology of the synthesized materials. For the SEM studies, the samples of the SiO2-gentamicin
nanohybrids were coated with a thin carbon film using a cool sputtering device (Leica EM SCD050,
Wetzlar, Germany). The TEM studies of the shape and size of the prepared materials were implemented
using a Tecnai G2 F20 TEM (FEI, Eindhoven, The Netherlands). The mass changes of the native SiO2
NPs and SiO2-gentamicin nanohybrids were weighted after overnight drying at room temperature to
determine the theoretical concentration of the loaded drug [6,15]. The TGA of the native and conjugated
SiO2 NPs was performed with a simultaneous thermal and spectral analysis using a STA449C Jupiter
(Netzsch Gerätebau GmbH, Selb, Germany) coupled with a Tensor-27 FTIR spectrometer (Bruker
Optics, Ettlingen, Germany). The analysis was conducted from 30 to 500 ˝C at a rate of 10 ˝C/min
following Sharma et al. [22], but in an argon atmosphere (flow rate of 20 mL/min). Aluminum crucibles
without lids were utilized in the experiment, with an empty crucible as a reference.
3.2. The in Vitro Release Studies of Gentamicin from the SiO2-Gentamicin Nanohybrids
Gentamicin sulfate absorbs neither ultraviolet nor visible light. Hence, indirect spectrophotometric
analysis was performed to detect the concentrations of the antibiotic using derivatization.
Phthaldialdehyde reagent (Sigma-Aldrich, St. Louis, MO, USA) acted as a derivatizing agent that
interacts with the amino groups of gentamicin sulfate to produce a chromophoric product [30].
The in vitro release studies were performed in phosphate-buffered saline solution (PBS, pH 7.4) at 37 ˝C.
The SiO2-gentamicin nanohybrids (20 mg) were placed in tubes containing 2 mL PBS (10 mg/mL).
The tubes were incubated at 37 ˝C and shaken at 150 rpm (Kühner incubator shaker, Lab-Therm,
Fennolab, Basel, Switzerland) for regular time intervals of 24, 48, 72, 96 and 120 h. After incubation,
the tubes were centrifuged at 5000 rpm (Centrifuge 5424, Eppendorf AG, Hamburg, Germany) for
5 min. Then, PBS medium was discarded and 2 mL of fresh PBS (pH 7.4) was added to remove all
the unattached gentamicin sulfate molecules [25]. Two milliliters of isopropyl alcohol (Sigma-Aldrich,
Steinheim, Germany) and another 2 mL of phthaldialdehyde reagent were added to the fresh PBS.
The gentamicin sulfate complex concentration was detected by an UV-vis spectrophotometer (Hitachi,
U-2000, Hachioji City, Tokyo, Japan) at 332 nm [30]. The gentamicin standards were prepared by
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dissolving appropriate amounts of gentamicin (10, 100 μg/mL and 1 mg/mL) in PBS. The release
rate of gentamicin from the SiO2-gentamicin nanohybrids was detected throughout 5 days. Statistical
analysis was conducted using the statistical package of Microsoft Excel 2013 (Office Professional Plus
2013, Impressa Systems, Santa Rosa, CA, USA). Each mean value was calculated from 3 consecutive
measurements. The standard deviations are represented by the ˘ values. Confidence interval of mean
values was detected as 95%.
Various mathematical models were applied to analyze the pharmacokinetic release profile of
the gentamicin from the SiO2-gentamicin nanohybrids. These models are: (1) zero-order model;
(2) first-order model; (3) Higuchi square root of time model; and (4) Korsmeyer-Peppas model as
shown by Equations (1)–(4), respectively:
F “ K˚t (1)
F “ 1 ´ e´k˚t (2)
F “ K˚t1{2 (3)
F “ K˚tn (4)
In the equations, F is the drug release fraction at time t (F “ %Qt
%Q8
in which %Qt is the drug-released
percentage at time t and %Q8 is the total drug-released percentage) and K˚ represents the release
rate constant. The exponent (0.5, 1 or n) is related to the diffusional processes that could describe
the different mechanisms of gentamicin release. The value of the exponent changes according to the
release mechanism. In case of Fickian diffusion n ď 0.5, for anomalous transport 0.5 ă n ă 1 and for
zero-order release n “ 1 [20,22]. Regression analysis was used to detect which model corresponds to
our in vitro release data.
3.3. Comparison of the Antimicrobial Action of the SiO2-Gentamicin Nanohybrids Versus Native SiO2 NPs
and Free Gentamicin
3.3.1. Agar Diffusion Assay
Antimicrobial susceptibility testing is most commonly performed using the agar diffusion method,
as recommended by the Clinical and Laboratory Standards Institute (CLSI) [31]. The sensitivity of
the bacteria to the tested materials was determined by measuring the inhibition zones produced by
diffusion of the antibacterial agents from the wells into the surrounding medium. The results were
interpreted according to the procedure presented by Winn et al. [32] and Quinn et al. [33].
Three different bacterial species from the culture collection of the Department of Biotechnology
and Chemical Technology, Aalto University were used as representatives of gram-positive and
gram-negative bacteria; namely, B. subtilis (TKK 10151), P. fluorescens and E. coli (VTT E-94564) that
were stored in ´80 ˝C. The bacterial species were sub-cultured on Nutrient agar (Lab M Limited®,
Heywood, UK). Colonies obtained from the agar plates after 24 h incubation were inoculated into
Mueller Hinton broth (Lab M Limited®). The bacterial concentrations were detected by measuring the
absorbance using an UV-vis spectrophotometer (Hitachi, U-2000, Tokyo, Japan) at 600 nm [34]. Since
the optical density measures the viable and dead bacteria in suspensions and as the traditional criterion
to differentiate viable from dead bacterial cells is the ability of viable cells to produce a colony [35],
our suspensions were obtained from 24-h cultured plates and the cultured broth was adjusted to match
0.5 McFarland standard. A volume of 100 μL of each bacterial suspension was spread on the Muller
Hinton agar plates and 20 μL of the different tested materials was dispensed in the wells of the plates.
Incubation of the plates was executed for 24 h at 28 ˝C for B. subtilis and P. fluorescens; and at 37 ˝C for
E. coli. The agar diffusion assays were performed in duplicate and the inhibition zone diameters (mm)
are the average of the measurements. Standard deviations of the inhibition zones (mm) are represented
by the ˘ values.
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Sterilization of the powder materials took place through UV-irradiation using an UV Chamber
(GS Gene Linker®, Bio-Rad, Hercules, CA, USA). Then, all the UV-irradiated samples were dispersed
in sterile de-ionized water in concentrations of 1 mg/mL for the microbiological tests. The agar
diffusion assays were performed at a starting concentration of 1 mg/mL of the tested materials to
screen for the antimicrobial action of the SiO2-gentamicin nanohybrids in comparison with the native
SiO2 NPs and the free gentamicin. Then, the concentrations of the tested materials were decreased to
detect the MIC in the broth microdilution assay. The tested materials were sonicated (power 234 W,
working frequency 47 kHz ˘ 6%, Bransonic®, 2210E-DTH, Derwood, MD, USA) for 30 min before the
antimicrobial applications to obtain homogenous solutions.
3.3.2. Broth Microdilution Assay
MIC is the minimal inhibitory concentration of antimicrobial agent that inhibits bacterial
growth [13]. The standard microdilution method was used to determine the MIC of the
SiO2-gentamicin nanohybrids, native SiO2 NPs and free gentamicin according to the CLSI [31].
The original concentrations of the tested bacterial suspensions were equivalent to 0.5 McFarland
standard. Within 15 min of the inoculum preparation, tenfold serial dilutions were performed in
Mueller Hinton broth to reach 1.5 to 3 ˆ 105 CFU/mL. For the tested materials, twofold serial dilutions
were performed from 1 mg/mL to 0.98 μg/mL. A volume of 100 μL of the different tested materials
was added from the concentrations of 1000, 250, 62.5, 15.63, 3.91 and 0.98 μg/mL into the wells of
the microdilution plate. Then, 10 μL of the bacterial suspensions were inoculated into the wells.
Mueller Hinton broth without any added antimicrobial material was used as a negative control and
only bacterial suspensions were used as a positive control. The results of MIC were read after 24 h
of incubation.
Parallel antimicrobial tests (Agar diffusion assay and MIC) were performed for the free gentamicin
sulfate sterilized by filtration through 25 mm syringe filter w/0.2 μm cellulose acetate membrane
(VWR International, Wallkill, NY, USA). These tests were done to detect the possible deteriorating
effect of the UV-irradiation on the loaded-gentamicin and whether it can be used as a sterilization
option for antibiotic-conjugated nanoparticles or not.
3.3.3. TEM Interaction Studies of the SiO2-Gentamicin Nanohybrids, Native SiO2 NPs and Free
Gentamicin with the Bacterial Cells
Microscopic interaction of the tested materials with the gram-positive bacterium, B. subtilis and
the gram-negative bacterium, P. fluorescens was investigated by TEM. The study included four groups.
The first group consisted of the native bacterial cells that acted as a control negative. The second,
third and fourth groups were the bacterial cells treated with the native SiO2 NPs, SiO2-gentamicin
nanohybrids and free gentamicin, respectively.
Bacterial cells from the 24 h-cultured agar plates were inoculated into Muller Hinton broth and
incubated at 28 ˝C for 24 h at 200 rpm in an incubator shaker (Lab-Therm, Fennolab, Kühner, Basel,
Switzerland). 10 μg/mL of the tested materials was added to the bacterial suspensions [36,37] and
re-incubation for a further 24 h was performed. The incubated bacterial suspensions with the tested
materials (5 mL) were centrifuged at 10,000 rpm for 5 min, washed and re-centrifuged [38]. The
samples were fixed by adding 0.5 mL of 2.5% gluteraldehyde at room temperature and collection of
cells was accomplished by centrifugation at 13,000 rpm for 3 min. The supernatant was discarded and
another 0.5 mL of 2.5% glutaraldehyde was added to the bacterial cells, after which the pellets were
kept at 4 ˝C overnight. Washing of glutaraldehyde was performed using sodium phosphate buffer.
Then, 1% osmium tetroxide was used as a second fixative for 1 h at room temperature. Washing of
osmium tetroxide was performed two times by sodium phosphate buffer. The dehydration process
was accomplished by increasing ethanol concentrations (50%, 70%, 96% and 100%) and finally by
acetone (100%). Infiltration of the samples was implemented in ascending series of Epon®:acetone
mix, starting with 30% for 3 h, followed by 70% and finally two changes of 100% epon, 3 h for each.
74
Materials 2016, 9, 170
Polymerization of the samples was performed in 60 ˝C oven for 14 h. After polymerization, the epon
blocks were cut into thin sections of 60 nm thicknesses using an ultramicrotome (Leica, EM Ultra Cut
UC6ei, Leica Mikrosysteme GmbH, Vienna, Austria). The sections were placed on grids (Formvar
carbon film on 300 mesh-Cu grids, Electron Microscopy Science, Hatfield, PA). The sections on the
grids were stained with 0.5% uranyl acetate, followed by 3% lead citrate for TEM micrographs.
4. Conclusions
We have demonstrated that the gentamicin of the SiO2-gentamicin nanohybrids represents
11.7 wt % payload that permits the fast gentamicin release of 21.4% during the first 24 h and extended
release of 43.9% over the five-day experiment. This fast release in the initial stage suggests that
SiO2 NPs are promising carriers for antibiotics and may have possibilities in the treatment and
prophylaxis of infections associated with orthopedic applications that require high initial concentration
of antibiotic for treatment followed by extended release. Coupling the antimicrobial tests of the
SiO2-gentamicin nanohybrids with the in vitro release experiments is essential to apply the nanohybrids
with concentrations that would ideally release the therapeutic levels of the antibiotic. This could avoid
the crucial problem of releasing sub-inhibitory concentrations of the antibiotic. The SiO2-gentamicin
nanohybrids are more potent against the gram-positive B. subtilis than the gram-negative P. fluorescens
and E. coli when tested as pure cultures on laboratory media. UV-irradiation is a convenient method
for sterilization of the nanoparticles loaded with gentamicin with no adverse effect on the antimicrobial
properties of the antibiotic.
This study strives to contribute to the research targeting the facile preparation of SiO2 NPs to be
used as antibiotic carriers that can permit the extended antibiotic release for efficient antimicrobial
administration in different orthopedic applications. The present data have shown the different
sensitivities of bacteria to the released antibiotic; however, it is evident that more detailed studies on a
wider range of bacteria, preferably isolated from patients with osteomyelitis and capable of biofilm
formation should be studied. In order to study the full potential of the developed materials, further
work on bacterial strains relevant for osteomyelitis, especially the gram-positive Staphylococcus species
is called for. Moreover, co-culture and bacterial interactions with bone and bone implants would also
be of interest. Furthermore, longer in vitro antibiotic release studies should be concurrently performed
for each specific clinical application of the SiO2-gentamcin nanohybrids. Our future research is
directed towards the in vitro and in vivo toxicological evaluations of the SiO2-gentamicin nanohybrids
to ascertain their more extensive application potential.
Supplementary Materials: The following are available online at www.mdpi.com/1996-1944/9/3/170/s1.
Figure S1: X-ray diffraction (XRD) patterns of the native SiO2 NPs and SiO2-gentamicin nanohybrids, Figure S2:
Antimicrobial activity of the: (A) native SiO2 NPs; and (B) SiO2-gentamicin nanohybrids versus free gentamicin
against: (1) B. subtilis; (2) P. fluorescens; and (3) E. coli.
Acknowledgments: Dina A. Mosselhy acknowledges the Centre for International Mobility (CIMO) for the funding
support (KM-14-9074) of the Finnish government scholarship pool and Aalto University School of Chemical
Technology. The authors acknowledge Teemu Myllymäki, Department of Applied Physics, Aalto University for
his aid in the FT-IR measurements. We would like to thank Juho Lotta, Department of Materials Science and
Engineering, Aalto University for his help in the SEM analyses. We thank Lauri Viitala Department of Chemistry,
Aalto University for his fruitful discussions in fitting the gentamicin release data to a suitable model. We are
grateful to the EM-Unit, Institute of Biotechnology, University of Helsinki for their assistance in processing the
bacteriological samples for TEM studies.
Author Contributions: Dina A. Mosselhy prepared the nanomaterials and performed the antimicrobial tests
under the supervision of Simo-Pekka Hannula and Katrina Nordström, respectively. Yanling Ge performed the
TEM characterization of the nanomaterials and the nanomaterials-bacterial interactions. Michael Gasik performed
the TGA and the statistical data analysis. Olli Natri participated in the design of the antimicrobial experiments.
Dina A. Mosselhy wrote the manuscript. All the authors discussed the results, revised and approved the final
version of the manuscript.
Conflicts of Interest: The authors declare no conflicts of interest.
75
Materials 2016, 9, 170
References
1. Falaize, S.; Radin, S.; Ducheyne, P. In Vitro Behavior of Silica-Based Xerogels Intended as Controlled Release
Carriers. J. Am. Ceram. Soc. 1999, 82, 969–976. [CrossRef]
2. Radin, S.; Ducheyne, P. Controlled Release of Vancomycin from Thin Sol-Gel Films on Titanium Alloy
Fracture Plate Material. Biomaterials 2007, 28, 1721–1729. [CrossRef] [PubMed]
3. Thein, E.; Tafin, U.F.; Betrisey, B.; Trampuz, A.; Borens, O. In Vitro Activity of Gentamicin-Loaded
Bioabsorbable Beads against Different Microorganisms. Materials 2013, 6, 3284–3293. [CrossRef]
4. Radin, S.; Ducheyne, P.; Kamplain, T.; Tan, B.H. Silica sol-gel for the controlled release of antibiotics. I.
Synthesis, characterization, and in vitro release. J. Biomed. Mater. Res. 2001, 57, 313–320. [CrossRef]
5. Barbé, C.; Bartlett, J.; Kong, L.; Finnie, K.; Lin, H.Q.; Larkin, M.; Calleja, S.; Bush, A.; Calleja, G. Silica Particles:
A Novel Drug-Delivery System. Adv. Mater. 2004, 16, 1959–1966. [CrossRef]
6. Xue, J.M.; Shi, M. PLGA/mesoporous Silica Hybrid Structure for Controlled Drug Release. J. Control. Release
2004, 98, 209–217. [CrossRef] [PubMed]
7. Gao, P.; Nie, X.; Zou, M.; Shi, Y.; Cheng, G. Recent Advances in Materials for Extended-Release Antibiotic
Delivery System. J. Antibiot. 2011, 64, 625–634. [CrossRef] [PubMed]
8. Aughenbaugh, W.; Radin, S.; Ducheyne, P. Silica Sol-Gel for the Controlled Release of Antibiotics. II.
The Effect of Synthesis Parameters on the In vitro Release Kinetics of Vancomycin. J. Biomed. Mater. Res. 2001,
57, 321–326. [CrossRef]
9. Radin, S.; El-Bassyouni, G.; Vresilovic, E.J.; Schepers, E.; Ducheyne, P. In Vivo Tissue Response to Resorbable
Silica Xerogels as Controlled-Release Materials. Biomaterials 2005, 26, 1043–1052. [CrossRef] [PubMed]
10. De Carvalho, V.C.; Rosalba, P.; de Oliveira, P.R.D.; Dal-Paz, K.; de Paula, A.P.; Félix, C.D.S.; Lima, A.L.L.M.
Gram-Negative Osteomyelitis: Clinical and Microbiological Profile. Braz. J. Infect. Dis. 2012, 16, 63–67.
[CrossRef]
11. Faber, C.; Stallmann, H.P.; Lyaruu, D.M.; Joosten, U.; von Eiff, C.; van Nieuw Amerongen, A.; Wuisman, P.I.J.M.
Comparable Efficacies of the Antimicrobial Peptide Human Lactoferrin 1–11 and Gentamicin in a Chronic
Methicillin-Resistant Staphylococcus aureus Osteomyelitis Model. Antimicrob. Agents Chemother. 2005, 49,
2438–2444. [CrossRef] [PubMed]
12. Abdelghany, S.M.; Quinn, D.J.; Ingram, R.J.; Gilmore, B.F.; Donnelly, R.F.; Taggart, C.C.; Scott, C.J.
Gentamicin-Loaded Nanoparticles Show Improved Antimicrobial Effects towards Pseudomonas aeruginosa
Infection. Int. J. Nanomed. 2012, 7, 4053–4063.
13. Agnihotri, S.; Pathak, R.; Jha, D.; Roy, I.; Gautam, H.K.; Sharma, A.K.; Kumar, P. Synthesis and Antimicrobial
Activity of Aminoglycoside-Conjugated Silica Nanoparticles Against Clinical and Resistant Bacteria.
New J. Chem. 2015, 39, 6746–6755. [CrossRef]
14. Kortesuo, P.; Ahola, M.; Kangas, M.; Kangasniemi, I.; Yli-Urpo, A.; Kiesvaara, J. In Vitro Evaluation of Sol-Gel
Processed Spray Dried Silica Gel Microspheres as Carrier in Controlled Drug Delivery. Int. J. Pharm. 2000,
200, 223–229. [CrossRef]
15. Shi, X.; Wang, Y.; Ren, L.; Zhao, N.; Gong, Y.; Wang, D.A. Novel Mesoporous Silica-Based Antibiotic Releasing
Scaffold for Bone Repair. Acta Biomater. 2009, 5, 1697–1707. [CrossRef] [PubMed]
16. Corrêa, G.G.; Morais, E.C.; Brambilla, R.; Bernardes, A.A.; Radtke, C.; Dezen, D.; Júnior, A.V.; Fronza, N.;
Dos Santos, J.H.Z. Effects of the Sol-Gel Route on the Structural Characteristics and Antibacterial Activity of
Silica-Encapsulated Gentamicin. Colloids Surf. B. Biointerfaces 2014, 116, 510–517. [CrossRef] [PubMed]
17. Lee, J.; Lee, Y.; Youn, J.K.; Na, H.B.; Yu, T.; Kim, H.; Lee, S.M.; Koo, Y.M.; Kwak, J.H.; Park, H.G.; et al.
Simple Synthesis of Functionalized Superparamagnetic Magnetite/silica Core/shell Nanoparticles and Their
Application as Magnetically Separable High-Performance Biocatalysts. Small 2008, 4, 143–152. [CrossRef]
[PubMed]
18. Radin, S.; Falaize, S.; Lee, M.H.; Ducheyne, P. In Vitro Bioactivity and Degradation Behavior of Silica Xerogels
Intended as Controlled Release Materials. Biomaterials 2002, 23, 3113–3122. [CrossRef]
19. Sarabia-Sainz, A.-I.; Montfort, G.R.C.; Lizardi-Mendoza, J.; Sánchez-Saavedra, M.D.P.; Candia-Plata, M.D.C.;
Guzman, R.Z.; Lucero-Acuña, A.; Vazquez-Moreno, L. Formulation and Characterization of
Gentamicin-Loaded Albumin Microspheres as a Potential Drug Carrier for the Treatment of E. coli K88
Infections. Int. J. Drug Deliv. 2012, 4, 209–218.
76
Materials 2016, 9, 170
20. Pandey, H.; Parashar, V.; Parashar, R.; Prakash, R.; Ramteke, P.W.; Pandey, A.C. Controlled Drug Release
Characteristics and Enhanced Antibacterial Effect of Graphene Nanosheets Containing Gentamicin Sulfate.
Nanoscale 2011, 3, 4104–4108. [CrossRef] [PubMed]
21. Van de Belt, H.; Neut, D.; Uges, D.R.A.; Schenk, W.; van Horn, J.R.; van der Mei, H.C.; Busscher, H.J. Surface
Roughness, Porosity and Wettability of Gentamicin-Loaded Bone Cements and Their Antibiotic Release.
Biomaterials 2000, 21, 1981–1987. [CrossRef]
22. Sharma, U.K.; Verma, A.; Prajapati, S.K.; Pandey, H.; Pandey, A.C. In Vitro, in Vivo and Pharmacokinetic
Assessment of Amikacin Sulphate Laden Polymeric Nanoparticles Meant for Controlled Ocular Drug
Delivery. Appl. Nanosci. 2014, 5, 143–155. [CrossRef]
23. Perni, S.; Prokopovich, P. Continuous Release of Gentamicin from Gold Nanocarriers. RSC Adv. 2014, 4,
51904–51910. [CrossRef] [PubMed]
24. Radin, S.; Chen, T.; Ducheyne, P. The Controlled Release of Drugs from Emulsified, Sol Gel Processed Silica
Microspheres. Biomaterials 2009, 30, 850–858. [CrossRef] [PubMed]
25. El-Ghannam, A.; Ahmed, K.; Omran, M. Nanoporous Delivery System to Treat Osteomyelitis and Regenerate
Bone: Gentamicin Release Kinetics and Bactericidal Effect. J. Biomed. Res. Part B Appl. Biomater. 2005, 73B,
227–284. [CrossRef] [PubMed]
26. Vetten, M.A.; Yah, C.S.; Singh, T.; Gulumian, M. Challenges Facing Sterilization and Depyrogenation of
Nanoparticles: Effects on Structural Stability and Biomedical Applications. Nanomed. Nanotech. Biol. Med.
2014, 10, 1391–1399. [CrossRef] [PubMed]
27. Beveridge, T.J.; Makin, S.A.; Kadurugamuwa, J.L.; Li, Z. Interactions between biofilms and the environment.
FEMS Microbiol. Rev. 1997, 20, 291–303. [CrossRef] [PubMed]
28. Chen, L.; Zhang, J. Bioconjugated Magnetic Nanoparticles for Rapid Capture of Gram-positive Bacteria.
J. Biosens. Bioelectron. 2012, S11, 1–5. [CrossRef]
29. Neu, C.H.; Gootz, T.D. Chapter 11: Antimicrobial chemotherapy. In Medical Microbiology, 4th ed.;
Baron, S., Ed.; University of Texas Medical Branch at Galveston: Galveston, TX, USA, 1996; pp. 1–10.
30. Phromsopha, T.; Baimark, Y. Chitosan Microparticles Prepared by the Water-in-Oil Emulsion Solvent
Diffusion Method for Drug Delivery. Biotechnology 2010, 9, 61–66. [CrossRef]
31. Clinical and Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for
Bacteria that Grow Aerobically, Approved standard—Ninth Edition; M07-A9; CLSI: Wayne, PA, USA, 2012;
Volume 32, pp. 1–68.
32. Winn, W.C., Jr.; Allen, S.; Janda, W.; Koneman, E.W.; Procop, G.; Schreckenberger, P.; Woods, G. Koneman’s
Color Atlas and Textbook of Diagnostic Microbiology, 6th ed.; Koneman, E.W., Ed.; Lippincott Williams & Wilkins:
Philadelphia, PA, USA, 2006.
33. Quinn, P.J.; Markey, B.K.; Leonard, F.C.; FitzPatrick, E.S.; Fanning, S.; Hartigan, P.J. Veterinary Microbiology
and Microbial Disease, 2nd ed.; Wiley-Blackwell: Chichester, UK, 2011.
34. Suresh, A.K. Co-Relating Metallic Nanoparticle Characteristics and Bacterial Toxicity; Springer International
Publishing AG: Cham, Switzerland, 2015.
35. Brown, O.R. Instrumented quantitation of live bacteria in the presence of dead cells. Appl. Microbiol. 1966,
14, 1054–1055. [PubMed]
36. Mosselhy, D.A.; Abd El-Aziz, M.; Hanna, M.; Ahmed, M.A.; Husien, M.M.; Feng, Q. Comparative Synthesis
and Antimicrobial Action of Silver nanoparticles and Silver Nitrate. J. Nanopart. Res. 2015, 17, 1–10.
[CrossRef]
37. Bao, H.; Yu, X.; Xu, C.; Li, X.; Li, Z.; Wei, D.; Liu, Y. New Toxicity Mechanism of Silver Nanoparticles:
Promoting Apoptosis and Inhibiting Proliferation. PLoS ONE 2015, 10, e0122535. [CrossRef] [PubMed]
38. Mirzajani, F.; Ghassempour, A.; Aliahmadi, A.; Esmaeili, M.A. Antibacterial effect of silver nanoparticles on
Staphylococcus aureus. Res. Microbiol. 2011, 162, 542–549. [CrossRef] [PubMed]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access





Non-Equilibrium Plasma Processing for the
Preparation of Antibacterial Surfaces
Eloisa Sardella 1,*, Fabio Palumbo 1, Giuseppe Camporeale 2,* and Pietro Favia 1,2
1 Istituto di Nanotecnologia, Consiglio Nazionale delle Ricerche, Via Orabona 4, 70126 Bari, Italy;
fabio.palumbo@cnr.it (F.P.); pietro.favia@uniba.it (P.F.)
2 Dipartimento di Chimica Università degli Studi di Bari “Aldo Moro”, Via Orabona 4, 70126 Bari, Italy
* Correspondence: eloisa.sardella@cnr.it (E.S.); giuseppe.camporeale1@uniba.it (G.C.);
Tel.: +39-0805-442110 (G.C.); +39-080-5442295 (E.S.)
Academic Editor: Mauro Pollini
Received: 29 April 2016; Accepted: 20 June 2016; Published: 25 June 2016
Abstract: Non-equilibrium plasmas offer several strategies for developing antibacterial surfaces that
are able to repel and/or to kill bacteria. Due to the variety of devices, implants, and materials in
general, as well as of bacteria and applications, plasma assisted antibacterial strategies need to be
tailored to each specific surface. Nano-composite coatings containing inorganic (metals and metal
oxides) or organic (drugs and biomolecules) compounds can be deposited in one step, and used
as drug delivery systems. On the other hand, functional coatings can be plasma-deposited and
used to bind antibacterial molecules, for synthesizing surfaces with long lasting antibacterial activity.
In addition, non-fouling coatings can be produced to inhibit the adhesion of bacteria and reduce
the formation of biofilm. This paper reviews plasma-based strategies aimed to reduce bacterial
attachment and proliferation on biomedical materials and devices, but also onto materials used in
other fields. Most of the activities described have been developed in the lab of the authors.
Keywords: antibacterial coatings; plasma processing; surface characterization
1. Introduction
1.1. Materials Related Infections and Common Antibacterial Approaches
Bacterial adhesion on biotic and abiotic surfaces is a widespread problem in many fields, and its
prevention has dictated considerable research efforts during the last decades. In healthcare, the function
of therapeutic and diagnostic devices can be compromised by nonspecific adsorption of proteins and
adhesion of cells onto device surfaces during long-term in vivo and ex vivo exposure to physiologic
fluids. A good example is the case of implanted prosthesis: upon implantation, a competition exists
between integration of the device into the surrounding tissue and adhesion of bacteria at the implant
surface. For successful implants, tissue integration should occur before appreciable bacterial adhesion,
thereby preventing colonization at the implant. However, host defenses are often unable to prevent
bacteria adhesion and colonization [1]. In this case, bacteria first adhere to the biomaterial interface,
then actively bind to the extra-cellular matrix (ECM) surrounding the implant, and form a protein
layer at its surface. In this process, bacteria progressively form a biofilm, i.e., a well-defined metabolic
state of bacteria life cycle where microbial cells, driven by a quorum sensing mechanism, lower their
growth rate and baseline metabolism and express mechanisms leading to cellular aggregation in
an amorphous polysaccharide matrix, also called slime. Biofilms allow bacteria to survive in harsh
environmental conditions [2]. Nosocomial infections like those related to the use of central venous
catheters, urinary catheters, prosthetic heart valves, and orthopedic devices are clearly associated
with biofilms adhering to biomaterial surfaces. Since bacteria in biofilms can evade host defenses and
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withstand antimicrobial systemic chemotherapy [3], the utility of antimicrobial coatings able to repel
and/or kill bacteria appears clear.
Bacterial contamination is also a serious concern in food packaging and in several fields of
industrial engineering. Antibacterial packaging materials are needed to control the microbial
contamination of solid/semi-solid food by inhibiting the growth of microorganisms at its surface, which
normally comes into direct contact with the packaging material. Controlling bacterial proliferation
means, in the food industry, prolonging the shelf life of food without altering its organoleptic properties.
It also prevents humans from being infected by food-borne diseases, mainly caused by microbiological
spoilage and contamination of food with pathogen microorganisms [4,5]. It is of paramount importance
that this target is achieved with materials well tolerated by the human metabolic system, with no use
of allergenic or potentially toxic compounds. Since active packaging could potentially be applied to
most foods, the audience interested in this technology is huge.
One of the most serious concerns in Industrial Engineering is the occurrence of biofouling and
biofilms on surfaces in contact with proteins and other biologic contaminants. Biofouling is defined as
the settlement and accumulation of floating organisms onto an inanimate substrate; marine biofouling
is also a concern for skull and propellers of vessels [6]. In industrial settings, biofouling can often
degenerate into bacterial biofilms, representing both a hygienic and an economic problem: they can
contaminate the conveyor belts in the production process, reduce heat transfer and operating efficiency
in heat exchange equipment, increase energy and water consumption, cause mechanical blockages and
accelerate corrosion of metal surfaces [7]. Marine biofouling is also a concern for skulls and propellers
of vessels.
Considering the high number of fields where surface bacterial contamination represents a severe
danger, and the size of the related business, it is easy to understand why in the last decades a huge
scientific and technological effort has been devoted to optimize and set up methods to prevent bacterial
adhesion and proliferation on material surfaces. Accordingly, research has focused on the development
of antibacterial surfaces and thin coatings that can be applied to different devices to confer resistance
to bacterial colonization without affecting other properties. For instance, the visual clarity of contact
lenses should not be affected by an antibacterial coating, and the flexibility of a vascular graft should
not be limited by a bioactive coating on its lumen. In general, such coatings should not establish
adverse effects on host bodies, cells and tissues. Moreover, given the variety of biomedical devices and
implants, as well as bacteria, a single successful approach is not feasible, so antibacterial strategies
need to be tailored to specific needs [8]. For contact lenses, for example, non-fouling coatings seem
appropriate, as they will resist both the attachment of bacteria and biofouling [9]; on the other
hand, for hip and knee prostheses, one wishes to deter bacteria for long periods of time, in order to
avoid late-stage infections, while encouraging a good integration of the implant with human tissue.
To achieve this target, a composite coating should be deposited at the implant surface, with the task of
releasing antibacterial compounds in sub-inhibiting concentrations, and maintaining environmental
drug concentrations higher than the Minimum Inhibiting Concentration (MIC) of the target organisms
for a long time. This result can be achieved embedding bioactive compounds in polymeric matrices
that limit their diffusion in the surrounding medium [10]. A fine level of control on the release kinetics
could be acquired with hydrogel coatings, for example, from poly(ethylene glycol) di-acrylate and
co-polymers; water absorption swells the polymer network and opens the way to the diffusion of the
active compound [11,12]. Another common strategy for drug delivery is based on the biodegradability
of the coatings: bioresorbable polymers, such as poly(lactic acid), can be degraded in newly formed
human tissues into molecules that can be easily metabolized by human cells. Concurrent release of the
active embedded compounds can take place while the coating is dissolved [13].
Drop casting/dip coating [1,14,15], Layer-by-Layer (LbL) deposition [16–19], sol-gel [20,21] and
electrochemical deposition [11,12,22–24] are probably the most common ways for coating the surface
of solid materials with a drug-delivering matrix providing a time-controlled release of bioactive
ingredients (Table 1). Some processes are instead based on the covalent attachment of carboxylic,
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amine or thiol groups normally present in antibacterial molecules to proper surface reactive chemical
groups exposed by functionalized polymeric coatings (see Table 1). Covalent immobilization has found
a wide application in all technological fields requiring the permanence of the active compound on the
topmost surface of the coatings, such as permanent bone prosthesis, industrial parts, nosocomial tools,
etc. On the other hand, since the active ingredients are not released, these bio-conjugated surfaces
cannot be effective through wide spatial ranges [25–27].
Table 1. Examples of bioactive surfaces with antibacterial properties.
Drug Delivery Systems
Technology Antibacterial Agent Bacterial Target Ref.
Drop Casting/Dip Coating Chlorexidin - [14]
Immunoglobulin G Escherichia coli [15]
Layer-by-Layer Defensin Micrococcus luteusE. coli [16]
PEGylated polylysine E. coli [18]
Triclosan Staphylococcus aureus [19]
Sol-gel Ag+/Zn2+ Staphylococcus mutans [28]
















-COOH/-F Melimine P. aeruginosaS. aureus [25]
-NH2 Algnic acid - [26]
-COCl Vancomycin S. aureus [30]
1.2. Plasma Technology
Plasma, the “fourth state of matter”, the most common state in nature, is ionized gas with
equal density of positive and negative particles [31]. Thermonuclear plasmas apart, less energetic
thermal (103–104 K) and cold (room temperature, RT) plasmas, populated by electrons, ions, atoms
and molecules in different states, are relevant for technological applications. From their start in
Microelectronics (Integrated Circuits, IC) and Photovoltaics (Solar Cells) in the 1970s, cold plasmas
permeate several other industrial fields today, including the biomedical ones. Ref. [32] offers a brief
Essay on the temporal evolution of plasmas in Science and Technology.
Cold (non-equilibrium) plasma discharges can be ignited at low (1–100 Pa, LP) or atmospheric
pressure (AP) by applying a proper electrical field (generally in kHz, MHz or MW) to a gas/vapor
mixture in properly configured plasma reactors/source. In a typical LP system, the “parallel plate”
plasma reactor, the discharges is ignited between two parallel electrodes a few cm apart, with substrates
positioned on one of the two. Many different configurations exist (electrodes, coils, movable substrates,
etc.) to optimize plasma processes on particular substrates (flat, porous, webs, inside of narrow tubes,
particles, etc.). AP systems include Dielectric Barrier Discharges (DBD) and AP plasma jets (APPJ).
In DBDs, a dielectric layer (e.g., alumina) onto one or both electrodes, allow homogeneous (glow)
rather than non-homogeneous (filamentary) discharges, and reduce the current (heating) through
the system. An inter-electrode gap of a few mm is typical of DBD systems. In APPJs, the plasma is
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generated in a small caliber dielectric tube (e.g., with a metal needle electrode connected to the HV
generator and a ground ring electrode wrapped around the tube), and then ejected on the substrate
by the flow of the feed. Plasma reactors and sources can be precisely designed and optimized for LP
and AP processes for processing small lab scale samples, or large scale high throughput industrial
products [33].
By properly varying plasma parameters such as LP/AP regime, nature of the feed, reactor
features and materials, frequency power and modulation of the electric field, and others, it is possible
to properly tune density and distribution of the active species (atoms, radicals, ions, and electrons)
generated by the fragmentation of the gas feed that interact with the exposed substrates. In this way,
surface composition and properties of material substrates can be tailored in many possible ways with
heterogeneous gas/solid reactions. Advantages of plasmas for materials processing include: the ability
to modify thin surface layers of conventional materials with no alteration of the bulk, limited use
of chemicals, dry technology with no use of solvents, easy integration in industrial processes, and
intrinsic sterility. Three kinds of surface modification plasma processes can be defined, in general,
as follows.
Dry etching: When defined species are generated in the plasma in the presence of certain materials
(e.g., oxygen atoms vs. polymers, etc.), ablation reactions can occur, which form volatile species
from the substrate (e.g., H2O and CO2 from polymers). By coupling cold (mostly LP) plasmas with
micro/nano lithographic techniques, etching processes can be performed very precisely (e.g., on Si and
other semiconductors), with lateral resolution of tens of nm and very high aspect ratio, to satisfy the
needs of extreme miniaturization and newer materials for IC fabrication [34].
Plasma Enhanced Chemical Vapor Deposition (PE-CVD): Radical species are generated in LP/AP
PE-CVD plasmas fed with proper chemicals to deposit coatings 1–103 nm thick. Depending on
the feed and on the experimental conditions, substrates can be decorated with coatings of many
possible chemical compositions, including silica-like, silicone-like, fluorocarbon, diamond-like and
others, for a wide range of properties (hardness, hydrophilic/phobic character, cytocompatibility,
resistance to corrosion, etc.) that can be imparted at the surface of substrates. Since the chemical
compound of the feed usually generates many possible fragments, building blocks of the coating,
also volatile compounds without the functional groups (e.g., double bonds) needed for conventional
polymerizations (e.g., methane), can originate PE-CVD coatings, whose stoichiometry can be varied in
continuo with the plasma parameters. When organic compounds are used, the terms monomer for the
feed and Plasma Polymerization for the technology are used.
Plasma Treatments: In these processes, materials are exposed to cold plasmas fed with reactive
(e.g., O2, N2, H2, NH3, H2O vapor, N2/H2, etc.) or inert (Ar, He, etc.) non-polymerizable gases.
Surface modifications imparted with Plasma Treatments are extremely shallow, a few nm, and
include removal of surface contaminants, surface oxidation, and surface grafting of polar groups
onto polymers to impart hydrophilic character, printability, affinity with other materials, anchor
groups for (bio)molecules, cytocompatibility and other properties.
Nowadays, Plasma Sciences and Technology impacts three different areas of Medicine and
Biology, namely:
‚ Plasma Medicine, i.e., the therapeutic use of cold AP air plasmas on living tissues for non-invasive
surgery, wound sterilization and healing, blood clotting, teeth bleaching, cancer treatments, and
other applications [35].
‚ Sterilization and decontamination of materials and devices [36].
‚ Surface modification of biomaterials, Tissue Engineering scaffolds, biosensors and medical
devices [37] aimed to optimize the response of biological entities (proteins, bacteria, cells, fluids,
and tissues) in contact with the modified material and drive, and, consequently, their behavior
in vitro and in vivo.
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This paper describes LP/AP non-equilibrium plasma-processes developed at the lab of the authors,
aimed to develop antibacterial surfaces, namely: non-fouling Poly(Ethylene Oxide) (PEO)-like coatings;
surface-immobilized antibacterial molecules; nano/bio-composite coatings releasing antibacterial
biomolecules; and nano-composite coatings releasing antibacterial metal ions.
2. Non-Fouling Plasma Deposited Coatings
All surfaces allow, in principle, for the adhesion of several different species. Bacterial colonization
of materials, in particular, is a surface-mediated process, that poses challenges to biomaterial scientists.
A promising alternative to a conventional systemic therapy against infections is represented by
engineered surfaces with tailored properties aimed at locally inhibiting bacterial adhesion and
proliferation on medical devices. Fouling is a main concern in the case of surfaces exposed to aqueous
environments where microorganisms can bind to a surface and form a conditioning layer, which
then provides an easily accessible platform for other undesired species to attach and proliferate [38].
Hydrophobic/superhydrophobic surfaces have been proposed as anti bacterial surfaces, and they
can be easily fabricated by means of PE-CVD [39]. Since the first conditioning layer of proteins
and biomolecules would adhere through their hydrophobic moieties with weaker (e.g., Van der
Waals) forces with respect to H-bonds and other forces acting through their hydrophilic (e.g., -COOH,
-NH2, -OH, etc.) moieties, weaker adhesion of biofilms and bacteria and cells would result at these
surfaces [40].
Hydrophilic polyethylene glycol (PEG) polymers, also referred to as polyethylene oxide (PEO),
have been shown to resist to protein and cell (including bacteria) attachment [41]. Such surfaces are
defined as “non-fouling” or “anti-fouling” [42–44]. This property is believed to correlate strongly
with the hydration layer at the PEO surface [45], attributed to the presence of hydrophilic ether
(CH2-CH2-O)n. functionalities. These groups create a water-solvated structure which forms a
liquid-like surface with highly mobile disordered molecular chains [46–48]. For protein adsorption to
occur, there must be a reduction in the dehydration entropic energy associated with the removal of
surface bound water [45]. Due to this effect, the tightly bound water molecules entrapped in the PEO
surface through hydrogen bonds form a physical and energetic barrier that cannot be displaced by
proteins and cells. The unique non-fouling properties of PEO-modified surfaces have encouraged the
development of several approaches (i.e., covalent immobilization, physical adsorption, self-assembled
monolayers and plasma deposition) to PEO-like thin films [44,49–58].
Kingshott et al. [59] showed that physisorbed PEO polymers do not provide long-lasting reduction
in bacterial adhesion, whereas PEO chains covalently attached to a substrate are effective. About these
findings Vasilev et al. [8] hypothesize that bacteria act as “mega-surfactants” with high interfacial
affinity for the material surface, displacing physisorbed polymer chains from the material surface,
whereas covalently surface-grafted polymer chains resist such displacement.
Compared to other methods, LP PE-CVD processes from monomers with CH2CH2O moieties
in their structure have been widely applied as a versatile tool to impart non-fouling properties with
PEO-like coatings on a large variety of substrates [44,49–51,53,55–58,60]. Three important features
have to be achieved for these coatings: good adhesion to substrates, stability in water media, and high
retention of the CH2CH2O functionalities of the monomer. This latter parameter is known as PEO
character, and can be evaluated by measuring the relative importance of the ether carbon component
C1 at ~286.5 eV of Binding Energy in the C1s X-ray Photoelectron Spectroscopy (XPS) spectrum of the
coating [49,50]. High PEO character is desirable in non-fouling surfaces for proteins and cells; coatings
with low PEO character, instead, promote protein and cell/bacteria adhesion and proliferation [53].
Pre-treatments in LP plasmas fed with Ar can be useful to improve the adhesion of the PE-CVD
coatings; the positive-ion bombardment associated to such pre-treatments cleans the substrates from
contaminations and generates nano-roughening at their surface.
We have set-up a robust LP PE-CVD process to deposit PEO-like coatings on metals, ceramics
and substrates such as polystyrene (PS), polyethylene terephthalate (PET) and glass, and studied
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how to deposit films with high PEO character [49,50,53]. PEO-like coatings were deposited from
a feed of di-ethylene glycol dimethyl ether (DEGDME) vapors and Ar at constant flow rate ratio
(0.40 sccm DEGDME, 5 sccm Ar) and pressure (400 mTorr). A stainless steel plasma reactor equipped
with two “parallel plate” asymmetric stainless steel electrodes was used; the small (Ø 8 cm) one
was connected to a radiofrequency (RF, 13.56 MHz) generator through a matching network while
the large (Ø 18 cm) electrode was connected to ground. Varying the RF power input from 5 to 15 W
allowed the deposition of coatings with different chemical compositions. A high degree of monomer
fragmentation was achieved in the plasma at 15 W, resulting in coatings with a PEO character of about
40% and advancing/receding water contact angles (WCA) of 71˝ ˘ 5˝ and 50˝ ˘ 5˝, respectively.
At 5 W, coatings with a PEO character as high as 80% and more hydrophilic behavior (WCAadv
56˝ ˘ 5˝, WCArec 37˝ ˘ 5˝) were obtained [53]. To confirm that the PEO character is correlated to
the fouling/non-fouling behavior of the coatings, PE-CVD coated quartz crystals were exposed to a
fibronectin (a cell adhesion protein) solution into a Quartz Crystal Microbalance (QCM-D) at 37 ˝C. The
coatings deposited at 5 W, with high PEO-character, proved to be very stable in water solution, well
adherent to substrates, with no leach of compounds and no protein adsorption from the solution. The
adhesion of fibronectin was observed, instead, on coatings with lower PEO-character. The non-fouling
activity of PEO-like coatings deposited at low power was confirmed by their low affinity with human
telomerase cancer cells (hTERT-BJ1), keratinocytes and murine fibroblasts; cells could neither spread
nor even adhere on PEO-like surfaces characterized by high PEO character [50,53].
Standing the proved non-fouling activity of PEO-like coatings plasma-deposited in mild LP
plasma conditions, only few applications have been reported in literature about their use to prevent
surface bacterial colonization [61–63]. The principles ruling the non-fouling properties of hydrophilic
surfaces towards proteins and eukaryotic cells should also be valid for bacteria; PEO-like coatings
LP plasma deposited from DEGDME should thus be able to inhibit protein and cell adhesion to solid
substrates, as well as bacterial fouling. LP PE-CVD has proven to be a robust, versatile tool to produce
this kind of surfaces and to adapt their characteristics to the application needs. Sardella et al. have
plasma-deposited micro-patterned surfaces alternating PEO-like domains with cell adhesive ones
derived from PE-CVD of acrylic acid. These coatings can drive cells to adhere only to specific regions
of the substrates, leaving the non-fouling ones clean [50,53]. By combining PE-CVD with colloidal
lithography, non-fouling PEO-like coatings could be generated on surfaces characterized by nanometric
reliefs, that quenched the cell-adhesive properties of the rough PET substrate underneath [49].
AP PE-CVD processes have also received great attention for the deposition of PEO-like
coatings [64]. Recently, the possibility to feed AP plasma processes with aerosols of liquids, of
solutions or suspensions (e.g., of biomolecules or of nanoparticles, NPs) has been explored, with very
interesting results. This approach allows the use of precursors with high boiling points that could not
be used in LP processes or with common bubbling systems. We have studied how to deposit PEO-like
films by means of aerosol-assisted AP plasma processes. A He aerosol of tetraethylene glycol dimethyl
ether (TEGDME) was used as feed. Two different He flow rates were used: a constant He flow to
generate the TEGDME/He aerosol with a constant flow of monomer, and a variable flow of He (carrier)
to transport the aerosol. The effects of several experimental conditions on the chemical composition
of the coatings were investigated, ranging from PEO-like non-fouling to cell-adhesive. Experiments
were carried out in a parallel plate electrode DBD reactor. Each electrode (50 ˆ 50 mm2; 4 mm gap)
was covered with a thin alumina plate. The effects of applied voltage, excitation frequency (both
influencing the power of plasma) and monomer dilution could be investigated on the PEO character
and on the deposition rate of the coatings. Indeed, the AP regime allowed higher deposition rates
compared to corresponding LP processes. The deposition rate could be improved by increasing the
applied voltage (but the PEO-character of the coating became lower); increasing the frequency led
both to a lower deposition rate and to a lower PEO-character. Increasing frequency and voltage, in
fact, increases the plasma power and, as in LP processes, leads to higher monomer fragmentation and
lower PEO-character. A significant reduction of intact ether moieties was also observed by increasing
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the flow of He carrier, which lowers the concentration of the aerosol and increases the monomer
fragmentation [65,66].
3. Bio-Conjugated Plasma Modified Surfaces
Covalent grafting of antibacterial compounds onto biomaterial surfaces has been the subject of
considerable research in the quest for antibacterial surfaces with long-lasting efficacy. Certain PE-CVD
coatings and plasma treated surfaces are well suited as adhesive interlayers for the covalent surface
immobilization of antimicrobial molecules for several reasons: ease of deposition; good adherence on
most materials; presence of reactive chemical groups for covalent bonding not available on the material
underneath. These processes, traditionally carried out in LP plasmas, usually include two main
steps, as shown in Figure 1: an initial phase aimed at enriching the topmost surface of the substrate
with functional groups (grafting oxygen- or nitrogen-containing reactive groups or depositing films
functionalized with the same groups); adsorption or binding (e.g., by covalent bonds) of the bioactive
molecule to the surface. Plasma-synthesized surfaces rich in amine, carboxylic, epoxy and aldehyde
groups have been used by many scientists for their compatibility with well-established chemical
reactions for immobilizing bioactive molecules such peptides, proteins, quaternary ammonium
compounds, antibiotics, etc. [8,64,67–71].
 
Figure 1. General scheme of a covalent immobilization on a functionalized plasma deposited coating.
Carboxyl-functionalized coatings deposited in LP plasmas have been exploited in our lab
for the covalent surface attachment of bovine lactoferrin (BLF) and lactoferricin B (LfcinB), one
of the sub-unities resulting from BLF digestion with pepsin. BLF and LfcinB are classified as
antimicrobial peptides (AMPs), i.e., small cationic polypeptides (<10 kDa; 3–50 amino acid residues)
produced by all organisms, from plants to insects to humans as a major part of their non-specific
defenses against infections. They have good activity against most bacteria, and excellent activity
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(MIC of 1–4 μg/mL) against multidrug resistant Pseudomonas aeruginosa or methicillin-resistant
Staphylococcus aureus [72]. The antimicrobial activity of BLF and LfcinB, immobilized on the -COOH
groups of a PE-CVD ethylene/acrylic acid (pdEthAA) film, was evaluated to control Pseudomonas
strains responsible for the spoilage of mozzarella cheese [68]. This procedure was already successfully
tested for the immobilization of other biomolecules or bio-structures, such as vesicles, heparin and
RDG cell-adhesive peptides [73–77]. Plasma deposition of pdEthAA films was carried out in a
RF plasma reactor equipped with two parallel internal and symmetric stainless steel electrodes.
The upper electrode is ground-shielded and connected to a RF (13.56 MHz) generator through a
matching network, whereas the lower, sample holding electrode is connected to the ground. Using
mild enough experimental conditions (i.e., 30 W) and a constant 3:1 flow ratio of ethylene and
acrylic acid vapors, COOH-functionalized coatings highly stable in water could be deposited in
polypropylene microtubes for bacterial culture. After PE-CVD, carboxylic groups were activated
with 1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) and incubated with BLF
or LficinB solutions to allow the covalent immobilization of both peptides in their active form, as
confirmed by the reduction of the growth rate of milk spoilage bacteria P. gessardii and P. fragi after
24 h of cultivation in the modified microtubes [68].
In another approach, glycidyl methacrylate (GMA) was plasma-deposited in an AP-DBD
to demonstrate that epoxy–containing interlayers can be effectively exploited for immobilizing
Dispersin B (DspB), a 42 KDa protein with anti-biofouling activity [69]. The DBD source, shown in
Figure 2, consisted of two high-voltage electrodes (1 mm gap) covered with alumina and a moving
ground electrode. Ar was used as carrier gas, passing through a bubbler containing GMA. The plasma
was ignited at 10 KHz in continuous and pulsed mode. When the discharge is pulsed, the off-time
deposition can proceed through conventional polymerization reactions, thus a higher retention of
functional groups in the coating can be achieved. In pulsed mode, the plasma-on time was fixed at
10 ms, while the off-time was in the range 10–80 ms. In the FTIR spectra reported in Figure 3 (top) it
can be observed that coatings deposited in pulsed mode display less broad bands in the absorption
regions of epoxy groups, indicating a higher retention of such groups from the monomer. Pulsing the
discharge also affects the surface morphology, as highlighted by the SEM images in Figure 4 (bottom).
It has been found that pulsed conditions, at the lowest duty cycle investigated (10 ms on, 80 ms off),
lead to the fast deposition of adherent and smooth layers with the highest epoxy surface density,
according to FTIR and XPS (18% of the total atomic carbon) data. PE-CVD GMA coatings were used to
bind DspB to stainless-steel at ambient temperature; the immobilization was controlled by means of
FTIR spectroscopy and then tested against biofilm forming S. epidermidis ATCC35984.
Figure 2. Schematic illustration of the AP-DBD source used for the PE-CVD from GMA, obtained
from [69], with permission from © 2015 John Wiley and Sons.
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Figure 3. (Top) FT-IR spectra of PE-CVD GMA films deposited at 50 W at different on/off time ratio:
(a) continuous; (b) 10 ms:10 ms; (c) 10 ms:40 ms; (d) 10 ms:80 ms; and (e) conventional GMA polymer.
(Bottom) SEM images of PE-CVD GMA films deposited at 50 W at different on/off time ratio. Adapted
from [69], with permission from © 2015 John Wiley and Sons.
The antibiofilm activity onto coated and uncoated stainless-steel substrates is reported in Table 2
as percent of reduction of the adherent bacterial population. With respect to steel substrates uncoated
or coated just with PE-CVD GMA, it can be seen that Dispersine-immobilized samples led to about
80% reduction of bacteria, indicating the efficacy of the immobilization of Dispersine in its active form
on the coating. Similar GMA coated surfaces were also used to bind Laccase, a hydrolase enzyme,
whose activity was confirmed in the degradation of a sulfamidic antibiotic [69].
Table 2. Anti-biofouling activity against S. epidermidis of modified stainless-steel surfaces compared to
uncoated ones. Adapted from ref. [69], with permission from © 2015 John Wiley and Sons.
Samples Reduction of Adherent Population [%]
Stainless steel 0
ppGMA layers 0
Dsp B immobilized at pH 8.5 84 ˘ 11
4. Plasma Deposited Composite Coatings Embedding Organic Antibacterial Agents
When the prevention of bacterial colonization is required for short time (days–weeks), or for an
entire body district and not only at the tissue/device interphase, bioactive coatings are demanded
to release antibacterial drug in the surrounding medium in time- or stimuli-controlled way. Organic
antibacterial compounds can be embedded in a composite coating by direct plasma deposition.
The antibacterial agent can be a biomolecule with known antimicrobial activity such as lysozyme or
nisin, or a synthetic drug like vancomicyn, or a commonly used quaternary ammonium salt. Essential
natural oils can also be utilized [78]. The matrix can be properly chosen in order to match specific
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surface characteristics of the final product, e.g., biocompatibility, swelling, water resistance and so on.
The drug release rate should also be controlled.
A recent approach to one-step PE-CVD of such nano/bio-composite coatings has been developed,
for which a drug solution/suspension is injected in form of aerosol into a DBD through an atomizer, as
shown in Figure 4 (bottom), while a polymerizable precursor is also fed. This approach is versatile, since
the nature of the matrix and of the coupled biomolecule and their relative amount can be properly tuned
to meet specific requirements. According to this approach, the precursor is fragmented in the discharge
and plasma polymerized to form the matrix, while the active agent is simultaneously embedded
within the growing film [79–81]. Damage to the biomolecule is limited by the milder fragmentation
conditions typical of AP with respect to LP discharges, and by a thin protective solvent shell around the
biomolecule, which can be effectively included in the coating without loss of structure and activity [80].
This concept has been proven with the optimization of Lysozyme (Lyz) containing antibacterial
nano/bio-composite coatings. Ethylene was chosen as the precursor to form a hydrocarbon matrix,
while Lyz was injected as a water solution aerosol [82].
Figure 4. Sketch of the antibacterial containing nano/bio-composite coating (top) and schematic
diagram of aerosol-assisted atmospheric-pressure DBD deposition system (bottom). Adapted from [82],
with permission from © 2015 John Wiley and Sons.
The DBD reactor, schematized in Figure 4, consists of two parallel silver electrodes covered with
0.63 mm thick alumina plates (8 ˆ 13 cm2; 5 mm gap). The feed is pumped through the discharge by an
aspirator placed on the opposite side of the flow injection. The electrode setup is confined in a sealed
Plexiglas® chamber [83]. A flow rate of 2–5 slm of He passes through the atomizer (mod. 3076, TSI) to
generate the Lyz water solution aerosol; 10 sccm ethylene were added to an auxiliary He inlet to keep
the total flow rate at 5 slm. Crystalline polished p-doped Silicon substrates were used. A sinusoidal
AC voltage was applied (6 KVpp, 4 KHz) at a power density of 0.25 W¨cm´2.
In Figure 5, the absorption FTIR spectra of films deposited at various atomizer He flow rates are
reported, along with the spectrum of pure lysozyme. All coatings exhibit hydrocarbon absorption
bands (3015–2777 cm´1, 1462 cm´1 and 1383 cm´1). The addition of the Lyz solution results in
the appearance of typical amide bands (C=O stretch at 1660 cm´1, and NH bending at 1537 cm´1),
consistent with the presence of protein or amino acid residues in the coating. The broad band at around
3350 cm´1 is due to the overlap of –OH and amidic –NHx. XPS analysis confirmed the presence of
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nitrogen in coatings prepared with the atomized Lyz solution. A deposition rate up to 75 nm/min was
achieved for the coating with the highest Lyz content.
Figure 5. FT-IR spectra of: casted Lyz (black line); films deposited at atomizer flow rate of 0–5 slm with
a 5 mg/mL Lyz solution (red curves); and at 5 slm atomizer flow rate with a 8 mg/mL Lyz solution
(grey line). Adapted from [82], with permission from © 2015 John Wiley and Sons.
Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight (MALDI-TOF, Micromass
M@LDITM—LR, Waters MS Technologies, Manchester, UK; equipped with a nitrogen UV laser 337 nm)
analysis was carried out to detect and identify lysozyme. The MALDI spectra of native Lyz and of
Lyz-embedded coatings were similar, only showing the mono- and bi-charged ions of lysozyme at
m/z 14,300 and 7150, respectively, indicating that the protein was still intact in the coating after the
deposition [82].
The ability of the coatings, uniformly deposited onto 2.4 ˆ 2.4 cm2 silicon shards, to release
lysozyme was tested in distilled water by Reverse Phase-HPLC. The chromatogram of the solution
obtained from the coatings was characterized by only one signal at the same elution time of native
Lyz. No protein fractions could be detected, confirming MALDI-TOF data about the absence of
main alterations of Lyz. On the other side, HPLC revealed that, for the coating deposited with
atomized 8 mg/mL Lyz solution, after 1 h of incubation a Lyz concentration of 28 μg/mL was found
in incubation water. Further immersion led to no more release, and the FT-IR analysis of the coating
revealed that all loaded Lyz was released. In order to slow down the release, samples were prepared
with a 50 nm hydrocarbon barrier layer on top of the nano/bio-composite coating, deposited in the
same experimental conditions, from a He 5 slm/C2H4 10 sccm feed (no Lyz aerosol). The added barrier
layer consistently reduced the release, as reported in Table 3. This strategy is clearly valuable for
designing thin systems with programmed release rate. The nano/bio-composite coating with a 50 nm
barrier layer could release Lyz for 7 days of immersion in water.
Table 3. Released Lysozyme from composite coatings deposited on 2.4 ˆ 2.4 cm silicon shards at an




15 Min 1 Day 7 Days
Without barrier coating 20 28 -
With barrier coating 2 15 18
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The bioactivity of released lysozyme was tested with an agar diffusion test against
Micrococcus lisodeikticus. When lysozyme diffused through the agar loaded with bacteria, agar turned
from opaque to transparent, attesting for the antibacterial activity of the protein. Lysis net halos
diameters are reported in Table 4. It can be observed that the solution released from the PE-CVD
Lyz coating induced a halo with a diameter of about 8 mm, quite close to that originated from a
30 μg/mL standard protein solution. As expected, no halos were found for extract solutions of Lyz-free
coatings. Such findings show the possibility to effectively include anti-microbial agents in PE-CVD
coatings. Since the bio-activity seems to be retained, important applications can be envisioned for the
dry manufacturing of drug carrier systems with programmed delivery.
Table 4. Agar diffusion activity test results for the Lyz-containing coating from a composite layer
prepared with a 8 mg/mL solution aerosol, at 5 slm of He. Based on [82].
Sample Inhibition Halo Diameter [mm]
C2H4/Lyzsol coating 8 ˘ 1
C2H4/H2O plasma deposited coating (control) 0
Lyz std solution (10 μg/mL) 0
Lyz std solution (30 μg/mL) 6 ˘ 1
Lyz std solution (300 μg/mL) 12 ˘ 1
Blank (negative control) 0
5. Plasma Deposited Composite Coatings Embedding Inorganic Antibacterial Agents
Certain metals are known to possess bactericidal properties, among them silver, titanium dioxide
(TiO2), zinc oxide (ZnO) and copper oxide (CuO) have enabled the development of a new generation
of biocides. Depending on the metal property, the biocide behavior of metals and metals oxides can
be triggered by different mechanisms including the involvement of metals as catalytic co-factors in
the generation of reactive oxygen species (ROS) [84]. In this mechanism, metals are involved both in
cell oxidative stress and in triggering pro-inflammatory signal cascades that promote programmed
cell death [85]. Another possible mechanism of action is based on the binding of the metals to atoms
(e.g., O, N, and S), of donor ligands through strong and selective interactions that inhibit vital biological
roles covered by the donors [86]. Metals and metal oxides can exert their function either in the cell
membrane or in the intracellular region [87,88]. Generally, the biocidal activity of such inorganic
antimicrobials has been found to be associated to the ionic form [89].
The antibacterial activity of silver and silver ions in proper concentrations, accompanied by low
toxicity to human cells, is well known since a long time ago [90]; in addition, bacterial resistance is
not developed. Silver has been incorporated into the surface of a variety of medical devices, such as
vascular, urinary and peritoneal catheters, vascular grafts, prosthetic heart valve sewing rings, surgical
sutures and fracture-fixation devices [91]. During the last years, nanotechnology has produced a new
route to take advantage of the antimicrobial behavior of metals by synthesizing highly active metal
nanoparticles (NP) [92].
Several surface modification approaches aimed at introducing inorganic antibacterial elements as
well as NPs have been described so far, and comprehensive reviews have been published [8,20,93]: a
scheme of the possible strategies for plasma-assisted approaches used to synthesize coatings containing
antibacterial inorganic elements is shown in Figure 6.
One of the plasma-assisted strategies, illustrated in Figure 6a–c, requires the plasma activation
of the material surface and further exposure of the material to a solution of metal compounds or
of NPs. The plasma process is used to improve the interaction between the metal (or NPs) and the
surface, or for the further modification of the adsorbed metal (i.e., chemical reduction, and production
of NPs). Leys et al. [94,95] described a three-step approach (Figure 6b) consisting of the AP PE-CVD
of a silicone-like thin film using an AP plasma jet, followed by the dipping-adsorption of silver
nano-particles (AgNPs), then by a final AP-PE-CVD of a silicone-like barrier layer that allowed the
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reduction and control of the release of Ag+ ions. Such coatings show antimicrobial activity against
P. auruginosa, S. aureus, and C. albicans. A similar strategy was performed also on nylon plasma-treated
with a DBD in atmospheric air [96].
 
Figure 6. Scheme of plasma assisted approaches. The first route is a hybrid multi-step approach
consisting of a PE-CVD coating containing carboxylic or amino groups that enhances (a) the adsorption
of Ag+ ions or (b) of AgNPs at the surface and/or inside the coating. The reduction of Ag+ ions with
NaBH4 (or trisodium citrate) or (c) through a plasma fed with H2 occurs. Finally, a PE-CVD barrier
coating allows the control of silver release. The second group of processes are single step approaches
totally based on plasma processes; (d) Electrolytic anodization is performed at high potential to
ignite a discharge at material/liquid interface to change the chemical state of the surface and embedd
antibacterial components (e.g., AgNO3) within its surface; (e) PE-CVD of a metal-containing volatile
precursor (e.g., zinc acetate or silver bisphosphine, or maleimide complex) can be used to deposit
metal-containing nanocomposite coatings; a plasma co-deposition of NPs and of an organic precursor
allow to obtain a nanocomposite coating both in case of (f) an AP Plasma Jet or of (g) a DBD fed with
an aereosol of a suspension of NPs; (h) A process based on plasma sputtering of a metal of interest
and PE-CVD from a precursor is aimed at obtaining a metal-containing nanocomposite coating; (i) A
contemporary sputtering of a polymer target and a metal one, or a deposition of the polymer of interest
by PE-CVD and a contemporary ion implantation can lead to a thin layer containing nanoclusters of
the metal of interest dispersed in an organic (or inorganic) matrix. Abbreviations: Mal: maleimide;
Ph: phosphine.
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Hydrogel-like plasma deposited coatings (Figure 6a) have been used to fix Ag+ ions from an
AgNO3 solution. The authors demonstrated control over the release of Ag+ by depositing a thin
(<20 nm) plasma-polymer overlayer [97]. Following this strategy, some research groups proposed the
PE-CVD of coatings from a proper organic precursor (i.e., acrylic acid or n-heptylamine) to absorb
Ag+ ions from an AgNO3 solution and to reduce them with NaBH4 to form AgNPs embedded in the
coating [98,99]. Such surfaces were found to be bioactive against E. coli and S. aureus.
Plasma-deposited PEO-like coatings exhibit hydrogel behavior in water [100]; for this reason,
they have been investigated by the authors to absorb Ag+ ions to be reduced to metal silver. PEO-like
coatings were plasma-deposited at LP [101] at 60 W power (high fragmentation conditions), 20 sccm
Ar, 0.25 sccm DEGDME, 50 mTorr for 15 min. XPS show high cross-linking of the coating, attested by
the low amount of -CH2CH2O- moieties (i.e., low PEO-character, grey peak in Figure 7), and by the
presence of -COOH groups. These coatings were chosen to uptake Ag+ ions through ionic bonds with
their ionized -COOH groups. Following the procedure of ref. [102], the samples were rinsed for 15 min
in solutions at pH 4 (HCl 10´4 M) and pH 8 (NaOH 10´6 M), then they were exposed for 15 h to a
1 mg/mL solution of AgNO3 to absorb Ag+ ions, and finally immersed in a water solution of trisodium
citrate (0.7 mg/mL) for 24 h for reducing Ag+ to Ag. As shown in Figure 7, the coatings conditioned at
pH 8 were able to embed a higher amount of silver, likely due to the interactions of Ag+ with the surface
carboxylate ions formed at higher extent than at pH 4. The concentration of silver detected is similar
to that reported by Kumar et al. [99] who showed an abatement of bacterial concentration higher
than 99.7% compared to untreated PET against E. coli and S. aureus. The advantage of such approach
consists in the possibility to control the loading of silver by controlling the chemical composition of the
deposited material and the pH; the disadvantage is that at least two steps are necessary to obtain such
coatings. To overcome this limit, one can incorporate AgNPs into a PE-CVD coating by a simultaneous
deposition of a metal (metal oxide) and a plasma organic or inorganic matrix (Figure 6d–i). There are at
least three approaches, uniquely based on plasma processing, to perform such depositions: (1) plasma
electrolytic oxidation (Figure 6d); (2) plasma deposition from a metal containing precursor (Figure 6e);
and (3) dual strategies (Figure 6f–i).
Figure 7. XPS spectra acquired on silver loaded PEO-like coatings after pre-conditioning of the coating
at: (a) pH 4; and (b) pH 8.
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A new surface modification approach involves the electrochemical conversion of metal surfaces
(i.e., Titanium) into more desirable chemistries and topographies by using anodizing or plasma
electrolytic oxidation processes (Figure 6d) [103,104]. This technique produces coatings characterized
by an excellent adhesion to substrates; however, it requires the use of a metal substrate. To overcome
this limit, hybrid processes where a plasma-assisted approach is coupled with another one are proposed.
The most frequent examples of hybrid plasma strategies are reported in Figure 6e, PE-CVD from a
precursor containing a complex of the metal of interest or organo-metal compound [105,106]; Figure 6f,g
AP plasma co-deposition of an organic coating and AgNPs or AgNPs precursors [107–109]; and
Figure 6h,i, simultaneous sputtering of a target coated with the antibacterial agent (i.e., Cu, Ag, TiO2)
and PE-CVD of an organic precursor or ion beam deposition [110,111].
Polymer-like coatings represent a potentially interesting approach to controlled drug release
of inorganic antimicrobial compounds. Plasma polymerization of an organic film while adding
an antibacterial agent by sputtering from a target is one of the most widely used and well
characterized approach in this field. Silicone-like/Ag [112], silicone-like/Cu, diamond-like/Ag,
ethylene-like/Ag [113] and PEO-like/Ag nanocomposite coatings have been produced in this way.
The formation of Ag clusters in different matrices is promoted by the high mobility of Ag atoms in the
growing coating, which leads to aggregation of Ag clusters [114], whose size is strongly dependent
on the Ag content [115]; often, the silver distribution is not uniform along the thickness of the
coatings [116].
To deposit Ag/PEO-like nanocomposite coatings we used a LP deposition system with parallel
asymmetrical plate electrodes. The smallest one (7 cm dia) covered with a 2 mm thick Ag lamina, is
connected through a matching network to a RF (13.56 MHz) power supply, the other one (25 cm dia),
sample holder, is grounded. The asymmetric configuration allows a strong positive ion-bombardment
on the silver electrode, at proper pressure, power and gas composition, that sputters Ag atoms from
the target. At the same time a PEO-like coating develops at the ground electrode, where the ion
bombardment is reduced, that incorporate Ag atoms and nanometric clusters. DEGDME vapors were
flown at 0.25 sccm in all experiments, mixed with a variable flow of Ar (10–20 sccm). The input power
was changed from 10 to 60 W at constant pressure (50 mTorr) to vary the amount of sputtered silver.
In these conditions, the deposition of a coating at the silver electrode, that would block the sputtering
of Ag atoms, is prevented. By adjusting the process parameters, the coatings could be tailored
(e.g., Ag content, dimensions distribution and morphology of Ag clusters) to different requirements
for specific applications, where they act as Ag reservoirs. Bacterial adhesion on such samples was
evaluated both in static and under flow conditions in order to investigate the combined effect of
flow and surface chemistry on the ica gene expression [117]. By a comparison between Ag/PEO-like
coatings and highly cross-linked PEO-like ones, but with no silver embedded, prepared in the same
conditions, only 30% of adherent bacteria on Ag/PEO-like coatings remained alive. It is known that
assessment of icaA DBC operon gene expression is crucial to the understanding of the pathogenesis of
S. epidermidis infections [118]. Higher expressions of icaA genes were observed for bacteria in contact
with Ag/PEO-like coatings with respect to those on the corresponding highly cross-linked PEO-like
ones with no silver.
In order to preserve the antibacterial efficiency while protecting eukaryotic cells from the
toxic effect of the excessive Ag+ release, a barrier layer was deposited on top of plasma deposited
Ag/PEO-like coatings [119] to limit the release of Ag+ ions in water media (Figure 8). Thickness and
chemical composition of the barrier significantly influence the release that may occur through small
cracks and pores, as well as by diffusion through the coating and the barrier together, slightly swollen
in water media [98,109]. The barrier layer can control and prolong the antibacterial effect.
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Figure 8. The scheme of silver ions generation and diffusion into a liquid medium during time starting
from soon after the plasma processes. In the scheme, the first layer acts as the reservation layer while
the outermost layer is used to control diffusion of silver through the coating. The generation of silver
ions pass through the oxidation of silver when is in the elemental state [119].
We have tested the Ag+ release in cell culture Dulbecco’s Modified Eagle Medium (DMEM) during
eukaryotic cell culture experiments, a very complex environment were the release could be altered
by protein adsorption and damage of the coating induced by adhering cells. After 24, 48 and 72 h
of culture, 500 μL of medium were digested in 2 mL of HNO3 (70%, Sigma Aldrich, St. Louis, MO,
USA) to oxidize the organic matter, then dissolved in 2% v/v HNO3 solution in water. The amount
of silver released was measured with ICP Atomic Spectroscopy. Ag/PEO-like coatings containing
5% of silver, as detected by XPS, were coated with 15 nm and 60 nm thick PEO-like barrier coatings
with 20% PEO-character. An abatement of the released silver resulted with the 60 nm barrier, at all
incubation times investigated, while no effect was observed with the 15 nm barrier. At 24 h the amount
of released silver from samples coated with 60 nm overlayers was 0.5 ˘ 0.02 ppm¨cm´2, after 72 h the
same coatings released 1.5 ˘ 0.2 ppm¨cm´2 while the release was up to 5 ˘ 0.5 ppm¨cm´2 without
the barrier. When at least 1 cm2 samples were used, independently on the barrier, the amount of
released silver was higher than the MIC of Ag+ ions (0.9–1.7 ppm) for most gram negative and positive
bacteria [120].
Ag/PEO-like coatings prepared by us containing from 1% [101] to 25% of silver [101,117], show
antibacterial effects against P. aeuruginosa, S. epidermis, and E. coli; coatings with 3% silver showed a
100% reduction of P. aeuruginosa adhesion, as reported in Figure 9.
Figure 9. Micrographs of P. aeuruginosa adhesion onto native PVC Endotracheal Tubes as well
(native) and coated by Ag/PEO-like coatings containing 3% of silver. The mosaic pattern seen on the
Ag/PEO-like micrograph is due to the wrinkling of the underlying PVC substrate, adapted from [101],
with permission of © 2005 John Wiley and Sons.
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To check the toxicity of Ag/PEO-like coatings for eukaryotic cells, in vitro cito-toxicity tests were
performed with SAOS2 cells grown on coatings loaded with 5% of silver, with and without barrier
layers. Coatings without the barrier resulted somewhat toxic, and could promote the adhesion of
only few round shaped cells, due to the high release of Ag+ but, maybe, also to the direct contact of
cells with Ag clusters protruding from the surface. On samples with a 60 nm thick barrier coating
(20% PEO character, the same of the matrix of the Ag/PEO material), instead, more cells could adhere
and spread, as shown in Figure 10, indicating a healthier environment for the cells due to the lowered
release of Ag+.
 
Figure 10. SAOS 2 Coomassie Blue stained cells on Ag/PEO-like (5% Ag) surfaces uncoated (a) and
coated (b) with a 60 nm thick barrier coating (PEO character 20%).
6. Conclusions and Perspectives
An overview on plasma-based technologies optimized for the deposition of antimicrobial coatings
has been given in this paper, where most of the surfaces described have been developed in our
laboratory. In particular, we believe to have shown the power and the flexibility of LP and AP
plasma-based techniques in engineering antibacterial coatings for the prevention of infections in
biomedical materials, with approaches that could probably also be exploited in other fields, such as
active food packaging, marine fouling and industrial food processing, where bacterial attachment and
contamination, and biofilm formation are of concern.
Plasma Technology, indeed, is nowadays expressing several newer approaches to surface
modification, decontamination/sterilization methods and medical therapies in several fields where it
was not considered before, where of bacteria proliferation always has to be controlled, e.g., in Medicine
for wound healing and cancer treatments [121], and in Agriculture for seed germination and food
decontamination [122].
Among several approaches presented, in particular, the aerosol-assisted AP plasma synthesis
of nano/bio-composite coatings with antibacterial molecules embedded in, and releasable from,
plasma-deposited nanometric coatings, possibly implemented by plasma-deposited diffusive layers
is considered, in perspective, among the most promising approaches to antibacterial surfaces and to
drug-release systems in general. We believe that this synthetic method will be strongly implemented,
in the near future, with the increased use of natural molecules, e.g., available from extracts and oils
from plants, flowers and fruits, for an ecologic approach to antibacterial material and surfaces.
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Abstract: Antimicrobial copper nanoparticles (CuNPs) were electrosynthetized and applied to the
controlled impregnation of industrial polyurethane foams used as padding in the textile production or
as filters for air conditioning systems. CuNP-modified materials were investigated and characterized
morphologically and spectroscopically, by means of Transmission Electron Microscopy (TEM), and
X-ray Photoelectron Spectroscopy (XPS). The release of copper ions in solution was studied by
Electro-Thermal Atomic Absorption Spectroscopy (ETAAS). Finally, the antimicrobial activity of
freshly prepared, as well as aged samples—stored for two months—was demonstrated towards
different target microorganisms.
Keywords: copper nanoparticle; polyurethane foam; ETAAS; XPS; nanoantimicrobials
1. Introduction
Application of nanotechnology in the textile industry is practiced with two main purposes.
The first one aims at the improvement of the textile performance: fibers modified by nanopowders,
or carbon nanotubes (CNTs), generally possess higher mechanical resistance in respect with
untreated ones [1]. The second purpose deals with the development of multifunctional textiles, i.e.,
antimicrobial [2], anti-stain [3], water repellent [4,5], anti-static [6–8], and self-cleaning ones [9]. Cotton,
linen, silk and wool are well-known natural fibers and padding materials, breathable and resistant [10].
However, they are easily degraded by many microorganisms, like spores, molds and bacteria [11,12].
Special finishes, however, can provide them protection from biodegradation: nanotechnology offers a
good range of effective tools to protect fabrics from bacterial contamination [2]. During the last century,
the discovery and the growing production of polymer-based artificial fibers and paddings completely
eliminated the problems related to biodegradation. Polyurethane foams play a fundamental role in the
production of seats in the automotive sector, of filters for the conditioning and treatment of air and
water, and so on. However, in all these fields, prevention of bacterial adhesion and/or proliferation
is extremely important. Metal and metal oxide nanoparticles (NPs), specifically Cu and its oxides,
have been already used for this purpose [13,14]. Natural fiber modification with copper is rather
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prevalent and different reports are present in literature on this topic, especially for the treatment of
cotton fabrics [14]. Most of them deal with their CuO or Cu2O functionalization [15–23], while the
use of elemental Cu is reported less frequently [24,25]. Cu(0), in fact, easily undergoes oxidation
processes unless suitable stabilizing agents are used. Nevertheless, modification of artificial polymers
by nanostructured Cu is less diffused, and it is generally achieved by adding a copper-containing
additive to the polymers during the master batch preparation stage [26–29]. Silicone fibers [30],
polyester [26,31,32], and nylon [33] have been successfully modified by both nanostructured CuO and
Cu. Polyurethane (PU) has been modified by different types of inorganic clusters, such as Ag [34–44],
CNTs (carbon nanotubes) [45], Zn-Ag bimetallic particles [46], tourmaline [47,48], silica [49] and
ZnO [50]. Ag is nowadays one of the preferred additives to confer antimicrobial properties to
both natural and synthetic fibers, being well known its antiseptic effect against a wide range of
microorganisms. Ag-modified PU foams or fibers are fairly common: in fact, silver is able to confer
antimicrobial properties and to improve polymer mechanical and rheological properties [43]. However,
to the best of our knowledge, only a few reports are present in the literature about the modification of
polyurethanes with antimicrobial CuNPs [51–53].
Here we report on polyurethane foams modified with colloidal CuNPs that were electrochemically
synthesized by means of the so-called sacrificial anode electrolysis (SAE) technique [54].
Post-production functionalization of industrial polyurethane foams was carried out by their
impregnation in diluted CuNP colloids. Samples were morphologically and spectroscopically
investigated and characterized. Their antimicrobial activity was tested towards three model
microorganisms (Staphylococcus aureus, Escherichia coli and Kluyveromyces marxianus), demonstrating
CuNPs capability of strongly inhibiting bacterial growth and proliferation.
2. Results and Discussion
2.1. Synthesis and Characterization of CuNPs
CuNPs, used as additives of industrial polyurethane foams, were prepared by sacrificial
anode electrolysis as described in the experimental section. Cu concentration in the stock colloidal
solution was obtained by differential weighing of working and counter electrodes: it resulted equal
to 0.31 ˘ 0.05 M in as-synthesized Cu-nanocolloids. TOAC (tetraoctylammonium chloride) was chosen
as stabilizing agent, due to the high reaction yield of TOAC-driven syntheses (85% ˘ 5%), excellent
morphological control, and lasting storage times of the colloid up to months; there is only the need to
avoid air exposure and thermal shocks. Moreover, TOAC octyl chains confer lipophilicity to metal NPs,
which become scarcely soluble in water [55]. This attribute can be proficiently used to promote PU
impregnation with CuNPs. With regard to pristine Cu-nanocolloids, the high degree of stabilization
provided by TOAC capping agent was demonstrated by the TEM micrograph reported in Figure 1a.
The electrochemical process resulted in a NP population with a single mode and narrow diameter
dispersion, centered at 2.6 nm (σ ď 0.5 nm), as shown in the size distribution histogram of Figure 1b.
Figure 1. (a) Transmission Electron Microscopy (TEM) micrographs of CuNPs (highlighted by arrows)
synthesized by sacrificial anode electrolysis. A micrograph at higher magnification is reported as insert;
(b) Size distribution histogram of as synthesized CuNPs.
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2.2. Adsorption of Industrial Polyurethane Foams with CuNPs
PU samples were treated with CuNP-colloids as reported in Section 3.3. Two different types of
polyurethane foam were used. For clarity of presentation, they were labeled as follows:
- Sample A: green foam, with large and irregular pores, used as filling material for mattresses
(density: 25 kg/m3,density tolerance ˘5%);
- Sample B: white foam, with small and regular pores, used in the automotive industry (density:
21 kg/m3,density tolerance ˘5%).
Adsorption efficiency was tested by weighing each sample before and after the modification
process. Both samples showed an average weight increase equal to 8.2 ˘ 0.3 mg for type A PU
and 7.8 ˘ 0.2 mg for type B PU, respectively. Pristine and treated foams were subjected to optical
microscopy examination. This aimed at ascertaining that the impregnation process did not alter PU
pores morphology and/or dimension. Typical optical micrographs are reported in Figure 2. A bigger
and more dispersed pore size was observed for pristine samples A (Figure 2a,c,e), while pristine
samples B were characterized by a more regular porous structure (Figure 2b,d,f). These features





Figure 2. Photographs of (a) type A and (b) type B pristine polyurethane (PU) foams. Optical
micrographs of pristine and Cu-treated foams; (c) Low magnification—Pristine type A foam; (d) Low
magnification—Pristine type B foam; (e) High magnification—Pristine type A foam; (f) High
magnification—Pristine type B foam; (g) 1:1000 Cu-modified type A foam; (h) 1:1000 Cu-modified
type B foam.
104
Materials 2016, 9, 544
2.3. Surface Chemical Characterization of CuNP-Modified Industrial Polyurethane Foams
In order to assess the surface chemical composition of CuNP-modified polyurethane foams, XPS
(X-ray photoelectron spectroscopy) analyses were performed. Both A and B PU samples were studied
before and after treatment with CuNPs colloids, purposely suspension dilute 100- and 1000-fold with
pure solvent. Data of Table 1 show that carbon and oxygen were the most abundant elements on the
analyzed surfaces, as expected for an oxygenated polymer dispersing matrix modified by low amounts
of CuNPs.
Table 1. Surface elemental composition estimated by X-ray photoelectron spectroscopy (XPS) of fresh
samples A and B, treated with CuNPs. Error is expressed as the larger value between the error
associated to a single quantification (0.2% for copper, 0.5% for other elements) and one standard
deviation, calculated on at least three replicate analyses. Data about pristine samples are reported
for comparison.
Element











Cu <0.2% 1.3 ˘ 0.2 0.8 ˘ 0.2 <0.2% 0.5 ˘ 0.2 0.3 ˘ 0.2
C 73.7 ˘ 0.5 76.9 ˘ 0.5 79 ˘ 3 72.6 ˘ 0.5 68.4 ˘ 0.5 67.5 ˘ 0.5
N 1.6 ˘ 0.5 1.7 ˘ 0.5 1.3 ˘ 0.5 1.6 ˘ 0.5 1.6 ˘ 0.5 2.8 ˘ 0.5
O 23.3 ˘ 0.5 18.5 ˘ 0.5 18 ˘ 3 20.7 ˘ 0.5 24.4 ˘ 0.5 23.7 ˘ 0.5
Si 1.4 ˘ 0.5 1.6 ˘ 0.5 0.9 ˘ 0.5 4.5 ˘ 0.5 5.1 ˘ 0.5 5.7 ˘ 0.5
Cl – <0.5 <0.5 – <0.5 <0.5
Ca – – – 0.6 ˘ 0.5 <0.5 <0.5
Cu traces could be qualitatively observed on pristine samples, although they were below the XPS
limit of quantification. This evidence is reasonable, considering that extrusion of PU foams is performed
using copper dyes. Small amounts of Si were also identified: this element is characteristic of PU and
PU-based goods production processes [56]. Presence of nitrogen could be attributed to both TOAC
(when present) and polymeric backbone. It is also important to point up how Cu-modified samples
A had in general a higher Cu atomic %, compared to homologous composites B (e.g., composites
obtained by impregnation with the same CuNP dilution). This might be due to the presence of larger
pores, which allowed CuNPs to better penetrate into the bulk material. Chlorine is due to the presence
of CuNP stabilizing agent (i.e., TOAC), while traces of calcium observed in samples B were considered
as a contamination coming from PU industrial production processes.
XP high-resolution (HR) regions were also investigated, in order to obtain detailed information
about PU and CuNPs chemical speciation. HR XP C1s spectra of pristine and treated PU foams
were made of three main components. As an example, Table 2 resumes data obtained on samples
A in terms of peak position (expressed as Binding Energy—BE—values), relative abundance, and
signal attribution.
Table 2. Attributions of C1s chemical environments identified on type A pristine and Cu-modified PU
foams; relative abundance % of each signal component is reported for comparison. Error is expressed
as one standard deviation, calculated on at least three replicate analyses.
Sample BE (eV) Attribution Relative Abundance %
Pristine
284.8 ˘ 0.1 C–C 43 ˘ 2
286.4 ˘ 0.2 C–O, C–N 55.8 ˘ 1.3
289.0 ˘ 0.2 HN–C=O 1.2 ˘ 0.8
PU/CuNPs (1:100)
284.8 ˘ 0.1 C–C 55 ˘ 3
286.4 ˘ 0.2 C–O, C–N 42 ˘ 2
288.8 ˘ 0.2 HN–C=O 3.0 ˘ 1.3
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All components are in agreement with those expected for PU [57,58]. On Cu-modified foams, a
higher relative percentage of aliphatic C–C moieties was observed. This could be explained considering
the presence of octyl- alkyl chains from TOAC. HR XP N1s spectra were characterized by a single
component in all cases, centered at 400.0 ˘ 0.2 eV, compatible with PU urethane functionalities [58].
Typical Cu2p3/2 XP spectra for fresh and aged samples are reported in Figure 3. Soon after sample
preparation (Figure 3a), a single signal falling at 933.2 ˘ 0.2 eV was present. This peak can be ascribed
both to nanodispersed Cu at zero oxidation state [58–60] and/or to cuprous species [57,58]. The
absence of Cu(II) moieties was confirmed by the lack of photoelectronic signals in the region centered
at about 934.0 ˘ 0.2 eV and the shake-up features between 941.0 and 948.0 eV, as well [57]. CuNPs
undergo a certain surface oxidation, as a function of the aging time. This phenomenon led to the
formation of cupric moieties onto modified PU foams. Cu2p3/2 XP high-resolution region showed, for
aged samples (Figure 3b), the presence of a second signal component, at higher binding energy values
(934.4 ˘ 0.3 eV), ascribable to Cu(II) moieties. Shake-up bands were, in this case, barely visible, due to
the very high signal-to-noise ratio.
Figure 3. Typical Cu2p3/2 X-ray photoelectron (XP) high-resolution spectra of fresh (a); and aged (b)
CuNP-modified polyurethane foams.
2.4. Kinetics of Copper Release from CuNP-Modified Industrial Polyurethane Foams
CuNP-modified PUs were exposed to a physiological saline solution in order to mimic a possible
interaction and ionic release of nanocomposites to model contact media. Experiments were carried out
on both freshly prepared and aged samples, which were stored in air for 60 days. The kinetics of Cu
release, relative to all the analyzed samples are shown in Figure 4. The experimental data could be
interpolated, in all cases, by a pseudo-first order kinetic model.
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Figure 4. Copper release in physiologic solution from CuNP-modified polyurethane foams, as a
function of the incubation time. Different columns are relevant to different CuNP concentrations in the
impregnation baths, giving rise to different Cu surface abundance on the composite. Different rows are
relevant to composites obtained by different polyurethane batches or to differently aged samples.
From the analysis of all the curves, it was found that part of the Cu ion release in solution was
quite fast in the first ten minutes. This is reasonably due to the presence of readily soluble Cu species
(such as residual cuprous salts) on the surface of CuNPs. It was also evident, in all cases, that Cu
concentration progressively grew as a function of time up to a plateau value. The extent of the latter
varied according to the concentration of the impregnation bath, and as a function of the aging time,
too. In both samples, in fact, a higher mean plateau value was registered for PU foams treated with
1:100 colloidal dilutions, which had the higher surface Cu concentration. The larger pore size of
composites based on A-type PU might explain the slightly higher and faster Cu release recorded for
materials treated with 1:100 CuNPs dilution, due to a possible easier accessibility of the physiological
solution within samples A. In principle, a larger pore size should allow a deeper and easier penetration
of physiological solution within the foam. Moreover, for both samples A and B, aging resulted in
a considerable decrease of the Cu release. A tentative interpretation of this phenomenon was that
surfactant could, over time, segregate [61–63] and partially occlude PU pores, enhancing the surface
hydrophobicity of the composite and partially limiting the accessibility of the physiological solution
within them. The average values of plateau Cu concentrations, rCus0, and kinetic constants for all
samples are summarized in Table 3.
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Table 3. Average values of plateau Cu concentrations and kinetic constants for samples A and
B. Data about fresh and aged samples are reported. The error is expressed as the largest value




Plateau [Cu]/ppb Kinetic Constant/h´1 [Cu]0/ppb
Fresh Aged Fresh Aged Fresh Aged
Sample A 1:100 1200 ˘ 90 670 ˘ 40 0.20 ˘ 0.04 0.20 ˘ 0.04 0 40 ˘ 30
1:1000 300 ˘ 40 330 ˘ 20 0.8 ˘ 0.3 0.20 ˘ 0.04 50 ˘ 30 0
Sample B 1:100 1100 ˘ 200 550 ˘ 40 0.2 ˘ 0.1 0.40 ˘ 0.09 300 ˘ 100 40 ˘ 30
1:1000 260 ˘ 30 270 ˘ 20 0.5 ˘ 0.1 0.4 ˘ 0.1 30 ˘ 20 20 ˘ 20
2.5. Antimicrobial Tests
The antimicrobial properties of freshly prepared Cu-polyurethane composites were evaluated in
preliminary tests on three target microorganisms selected based on microorganisms characteristics
(Gram-positive, Gram-negative, yeasts) to demonstrate the broad-spectrum of NP antimicrobial
activity. The suitable dilution tested was obtained taking into account the pathogenic role of
microorganisms (mainly S. aureus and E. coli), the spread and persistence of S. aureus on the surfaces,
the assessment of E. coli as hygiene requirement, and the environment ubiquity of K. marxianus. Culture
broths were diluted by different factors, based on the different characteristics of the microorganisms
(107 for S. aureus, 105 for E. coli and 103 for K. marxianus), and then they were left in contact for
fixed times with different samples in order to discriminate the biocidal/biostatic effects of pristine
PU foams, electrolytic solution, and CuNP-treated materials. In any sample, after a contact time
of 24 h, the residual microorganism growth was quantified by counting the number of colony
forming units (CFU). The results are reported in Table 4. As expected, blank experiments on pristine
PU foams did not show any biostatic action, whereas control samples treated with 0.1 M TOAC
solution in Acetonitrile/tetrahydrofuran (ACN/THF) 1/3v/v mixture produced a strong inhibition
effect against S. aureus, causing a complete inhibition of the bacterial growth. This is a reasonable
result, since TOAC salt belongs to the class of common quaternary ammonium disinfectants. Using
Cu-modified polyurethanes induced a marked growth inhibition even in the case of microorganisms
such as E. coli, that did not show any sensitivity to TOAC-impregnated PU. Finally, comparing the
activity of composites treated by colloidal dilutions of 1:100 and 1:1000, it can be concluded that a
higher CuNP loading was generally correlated to a higher concentration of released ions, hence in an
increased inhibition of colony growth. In some experiments apparent discrepancies between ionic
release and bioactivity were observed and attributed to limited reproducibility of the investigated
biological systems.
Table 4. Number of colony forming units (CFU) for the three target microorganisms, exposed to
different samples for 24 h as described in the experimental section. Error on CFU counts is ˘5 in the
last digit.
Sample S. aureus/CFU E. coli/CFU K. marxianus/CFU
Sample A
PU U a U U
PU + 0.1 M TOAC solution 0 U U
PU + 1:1000 CuNPs 0 0 30
PU + 1:100 CuNPs 0 0 25
Sample B
PU U U U
PU + 0.1 M TOAC solution 2 U U
PU + 1:1000 CuNPs U 72 U
PU + 1:100 CuNPs 0 0 U
a U = Uncountable.
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3. Materials and Methods
3.1. Materials
Copper (0.5 mm thick, 99.99+%) and platinum sheets (0.25 mm thick, 99.999%) were
purchased from Goodfellow Ltd. (Cambridge, UK) and cut into 2 ˆ 1 cm pieces. Acetonitrile
(ACN, anhydrous, 99.8%), tetrahydrofuran (THF, anhydrous, ě99.9%, inhibitor-free), and
tetraoctylammonium chloride (TOAC, AT reagent, ě97.0%), were purchased from Sigma Aldrich
(Milan, Italy). Aluminum Oxide (purum p.a., 99.7%), for the mechanical polishing of metallic sheets,
was from Fluka Chemicals (Milan, Italy). Polyurethane foams were obtained from the industrial
partner ME.RES. Meridionale Resine S.r.L (Avellino, Italy).
Escherichia coli ATCC 25922, Staphylococcus aureus FDA 209P (MSSA, with methicillin resistance
0.125 μg¨ mL´1), and Kluyveromyces marxianus CBS 608, selected as target microorganisms for biological
tests, were obtained from BioMérieux Italia S.p.A. (Florence, Italy), and reconstituted in nutrient broth
(Agar Oxoid), purchased from Bio-Chemia (Bari, Italy), as the Plate Count Agar culture medium.
3.2. Electrochemical Synthesis of CuNPs
The electrochemical synthesis of CuNPs was carried out in a three-electrode cell equipped
with a Cu working electrode and an Ag/AgNO3 0.1 M in ACN reference electrode. The counter
electrode was a Pt sheet. The electrolytic solution was composed of 0.1 M TOAC dissolved in an
ACN/THF 1/3 mixture. The electrosynthesis was carried out in nitrogen atmosphere, potentiostatically,
(+1.5 V vs. reference) for 6 h, under vigorous stirring at room temperature, with a CH1140b
potentiostat-galvanostat (CH Instruments, Austin, TX, USA). Other electrochemical parameters such as
electrodes pretreatment, electrolysis cell, process details, etc. were similar to what reported in previous
works [61–63].
3.3. Modification of Industrial Polyurethane Foams with CuNPs
Cubic samples, of approximately 1 cm3, and weighing about 100 mg, were obtained cutting the
as-received materials.
After ascertaining the resistance of each sample towards the solvents used for the electrosynthesis,
each material was treated with CuNPs by immersion in 5 mL of diluted colloids for 30 min. After this
time, each sample was wrung out and left to dry in air for 2 h. Typically, dilution ratios of CuNP stock
solution equal to 1:100 and 1:1000 were used.
3.4. Morphological and Spectroscopic Characterization
Colloidal CuNPs diluted in the ratio 1:10 were sonicated for 30 min, before Transmission
Electron Microscopy (TEM) analysis, in order to prevent possible aggregation. TEM microscopy was
performed with a FEI Tecnai 12 instrument (Hillsboro, OR, USA, high tension: 120 kV; filament: W),
by dropping 10 μL on carbon-coated Cu grids (300 mesh, TAAB Laboratories Equipment Ltd.,
Aldermaston, UK). The microscope was calibrated using the S106 Cross Grating (2160 lines/mm,
3.05 mm) supplied by Agar Scientific (Stansted, UK). Alignment was checked by using factory
settings and routines. Astigmatism was adjusted by means of fast Fourier transform processing.
Size distribution of metal clusters was evaluated using ImageJ software [64]. Treated and pristine
polyurethane materials were characterized by means of X-ray photoelectron spectroscopy (XPS), using
a Thermo Fisher Scientific Theta Probe Spectrometer (Waltham, MA, USA). A monochromatized AlKα
source was used, with a beam spot diameter of 300 μm. Samples were mounted onto the sample holder
by means of a carbon double-side copper tape (Agar Scientific, Stansted, UK). All XPS measurements
were performed in constant analyzer energy (CAE) mode. Survey and high-resolution spectra (C1s,
O1s, Si2p, Cu2p3/2, N1s, Ca2p and Cl2p) were acquired at a pass energy of 150 and 100 eV, respectively,
and with a step size of 1.0 and 0.1 eV, respectively. Detailed spectra processing was performed by
commercial Thermo Avantage software (v. 4.75© 1999–2010 Thermo Fisher Scientific, Waltham, MA,
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USA). Curve-fitting analysis was applied to the Cu2p3/2 high-resolution spectra, in order to assess Cu
chemical state. Surface atomic percentages were determined after Shirley background removal, using
Scofield sensitivity factors. The same peak lineshape parameters (Gaussian/Lorentzian ratio and full
width at half maximum) values were employed for the curve fitting of components belonging to the
same high-resolution spectrum. Spectra were corrected for charge compensation effects by offsetting
the binding energy relative to the aliphatic component of the C1s spectrum, which was set to 284.8 eV.
3.5. Kinetics of Copper Release in Aqueous Solution by Electro-Thermal Atomic Absorption
Spectroscopy (ETAAS)
Copper release from CuNP-modified polyurethane foams was evaluated by electro-thermal
atomic absorption spectroscopy (ETAAS). Cu quantification was achieved by means of a calibration
curve obtained by the analysis, carried out in triplicate and in random sequence, of standard solutions
at known Cu concentration, prepared by subsequent dilution of a stock Cu commercial solution (Fluka,
Milan, Italy, Copper Standard for AAS TraceCERT®, 1000 mg/L Cu in nitric acid). Each PU sample
was immersed in a Pyrex bottle containing 25 mL of contact solution. The latter was obtained as a
1:1 mixture of a 0.85% w/w NaCl aqueous solution (Fluka, purity ě99.5%) with phosphate buffer
(PBS) K2HPO4/NaH2PO4 with known pH and ionic strength (6.4 and 0.1, respectively). At fixed
times (10 min, 1 h, 2 h, 4 h, 7 h, 10 h and 24 h), 200 μL of this solution were taken from each vessel.
These samples were appropriately diluted and acidified by 0.7% HNO3 solution; if needed, additional
dilution was applied in order to keep the measured Cu concentration within the linearity interval of
the calibration curve. Samples were analyzed by a Perkin-Elmer dual-beam spectrophotometer, model
460 (Milan, Italy), using electro-thermal atomization in graphite furnace. Source was a hollow-cathode
lamp (absorption line at 324.7 nm). The signal acquisition mode provided an automatic background
correction by a deuterium lamp, in order to eliminate possible matrix absorption overlapping with
the Cu absorption band. The entire kinetic experiment was carried out at 25 ˝C. The measured data
were fitted by a first order kinetic Equation (1), where rCus0 represented the amount of copper ions
immediately dissolved (and therefore immediately available) in solution, rCusmax was the maximum
copper concentration in solution reached within 24 h, and k was the release kinetic constant. Data
analysis was carried out using SigmaPlot® 12.0 software (Systat Software, San Jose, CA, USA).





The possible Cu release from both vessels/glassware and the untreated polyurethane foams was
also assayed; and the resulting Cu concentrations were all below the limit of quantification (LOQ).
3.6. Antimicrobial Tests
Escherichia coli ATCC 25922, Staphylococcus aureus FDA 209P (MSSA, with methicillin resistance
0.125 μg/mL), and Kluyveromyces marxianus CBS 608 were selected as target microorganisms. Aliquots
of the different lyophilized microorganisms were reconstituted in 0.9% NaCl solution, added to 20 mL
of sterile nutrient broth (Oxoid) and incubated for 24 h at the optimal temperature for microbial growth,
which was 37 ˝C for Staphylococcus aureus, 42 ˝C for Escherichia coli, and 28 ˝C for Kluyveromyces
marxianus. Each sample was then diluted 105 times by saline solution (pH = 6.4, [Cl´] = 0.15 M). 5 mL
of each culture broth were left in contact with each type of CuNP treated foams, and incubated for 24 h,
at the respective optimal growth temperatures. Untreated samples were used as controls. After the
selected incubation times, 1 mL of culture broth was taken from each vessel and inoculated in a Petri
dish containing nutrient agar. After 24 h, bacterial colony count was performed on each Petri dish,
in order to assess the entity of bacterial growth inhibition exerted by treated polyurethane foams.
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4. Conclusions
Sacrificial-anode electrochemical synthesis of TOAC-stabilized CuNPs was used to modify
industrial polyurethane foams. TEM and XPS analyses on Cu-nanocolloids demonstrated that the
surfactant employed was capable of stabilizing freshly dispersed CuNPs from both the morphological
and the chemical point of view. XPS measurements on copper-polyurethane composites revealed
that a simple impregnation protocol employing diluted colloids was effective in modifying industrial
polyurethane foams with CuNPs. These data, along with copper ion release measurements, showed
that the final copper surface availability, along with the release of antibacterial ions in physiological
solution, could be tuned just by changing the CuNP concentration in the impregnation baths. Foam
pore size and aging resulted to affect the ion release to a minor extent, although samples stored for
two months were demonstrated to be still very active in releasing bioactive copper ions. Biological
tests showed that the proposed nano-functionalized materials exert a marked inhibitory effect on the
growth of different target microorganisms such as S. aureus, E. coli and K. marxianus.
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The following abbreviations are used in this manuscript:
BE binding energy
CFU colony forming unit
CNT carbon nanotube
CuNP copper nanoparticle
ETAAS electro-thermal atomic absorption spectroscopy
PBS phosphate buffer saline
PU polyurethane
SAE sacrificial anode electrolysis
TEM transmission electron microscopy
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Abstract: A simple and green method was developed for the biosynthesis of AgCl nanoparticles,
free from Ag nanoparticles, using the exopolysaccharide-based bioflocculant of nitrogen fixing
Azotobacter chroococcum XU1 strain. AgCl nanoparticles were characterized by UV-Vis, X-ray
diffraction (XRD), Fourier Transform-Infra Red (FT-IR) and Scanning electron microscopy-energy
dispersive X-ray (SEM-EDX). The concentration-dependent and controllable method for the synthesis
of AgCl nanoparticles of a certain size and morphology was developed. As-synthesized AgCl
nanoparticles were characterized bya high content of AgCl and exhibited strong antimicrobial activity
towards pathogenic microorganisms such as E. coli, S. aureus and C. albicans. The biofabricated
AgCl nanoparticles can be exploited as a promising new biocidalbionanocomposite against
pathogenic microorganisms.
Keywords: exopolysaccharide-based bioflocculant; AgCl nanoparticles; Azotobacter chroococcum;
antimicrobial activity
1. Introduction
Bioflocculants are organic macromolecular substances secreted by a wide variety of
microorganisms [1–6], and microbial bioflocculants have attracted considerable attention in recent years
due to their biodegradable, harmless and negligible secondary pollution [1]. The polysaccharide-based
bioflocculants are exploitedfor theirhigh efficiency in disposing of different of chemicals [7–10].
The polysaccharide macromolecules in bioflocculants contain monomeric units of sugar molecules
such as glucose, mannose, fructose, or rhamnose, etc. [11]. The hydroxyl groups of these sugars
strongly associate with metal ions leading to the formation of different types of biomaterials. Besides,
they allow the control of shape, size and particle dispersion.
Polysaccharide-based bioflocculants easily form a variety of liquid crystals in aqueous solutions
and bioflocculant-mediated processes are highly profitable. Polysaccharide-based bioflocculants
been reported for the synthesis of silver nanoparticles (AgNPs). Along with AgNPs, silver chloride
nanoparticles (AgCl-NPs) have alsoreceived wide interest. Electrochemical, chemical reduction,
Materials 2016, 9, 528 115 www.mdpi.com/journal/materials
Materials 2016, 9, 528
surfactants, photochemical reduction, ionic liquid microemulsion, ultrasound irradiation, hydrolysis
and ion-exchange reactions and thermal decomposition methods were developed for the synthesis
of AgNPs and AgCl-NPs [12–16]. In recent years, the synthesis of silver halides (AgX) received
considerable attention since they are highly photosensitive semiconductors. They have been extensively
used as photosensitizers andsource materials in photographic films and can also be used as metallic
silver precursors [17–19]. A total “biological” method for the synthesis of face-centered cubic
Ag/AgCl-NPs was documented, using the cellulose of a non-pathogenic Gluconacetobacter xylinum.
As-synthesized nanocomposite exhibited considerable antibacterial activity against S. aureus and
E. coli [20]. Besides, the chitosan oligomers [21], and bacterial [22] and non-bacterial cellulose were
also used as a template to synthesize Ag/AgCl-NPs [23]. These nanocomposites also displayed high
antibacterial activity [22]. Moreover, a controlled synthesis of AgCl-NPs by the polysaccharide-based
bioflocculant of diazotrophic strain Bradyrhizobium japonicum 36 was reported recently, where at equal
molar concentrations of Ag+ and Cl´, the polysaccharide-based bioflocculants act as a template to
assemble only AgCl-NPs with an average diameter of 10 nm [24].
In this study we report the green and controlled synthesis method of AgCl-NPs using the
expolysaccharide-based bioflocculant of diazotrophic nitrogen-fixing bacterial strain Azotobacter
chroococcum XU1. As-synthesized AgCl-NPs further tested as a biocidal agent against pathogenic
microorganisms, namely Candida albicans, Escherichia coli and Staphylococcus aureus.
2. Results
2.1. Biosynthesis and Characterization of AgCl-NPs
Asit was documented, AgCl-NPs develop from a milk-white to a yellowish-brown color in
aqueous solution due to excitation of surface plasmon resonance (SPR) [25,26]. Theirsynthesis can
be monitored by UV-visible absorption spectra. AgCl-NPs exhibit a broad and strong absorption at
200–350 nm, which can be ascribed to the characteristic absorption of the AgCl semiconductors [27].
The shift in the band may have contributed to the different sizes of the AgCl nanoparticles.
Since bioflocculants basically are composed of polysaccharide macromolecules, it is highly possible
to reduce the silver ions and stabilize them into the polysaccharide matrix. This evidence makes the
parallel synthesis of both AgCl-NPs and AgNPs in the presence of chloride ions and polysaccharide
matrix inevitable [21–23]. To biofabricate only AgCl-NPs, a concentration-dependent method was
evaluated. It was observed that the intensive synthesis of AgCl occurred in low concentrations of
Ag+ in aqueous solution. The polysaccharide matrix in the reaction mixture enabled the formation of
AgCl-NPs with absorption bands at 250–260 nm (Figure 1). This resulted in the absence of absorption
within 380–550 nm in the visible-light region, which indicates no synthesis of AgNPs. At a high
concentration of Ag+, as shown in Figure 1, the formation of both AgCl-NPs and AgNPs was observed
(Figure 1; absorption band at 260 and 435 nm assigned as a purple chart). The appearance of the
surface plasmon resonance (SPR) transition at 435 nm confirms the production of AgNPs [28,29].
It can be concluded that synthesis of AgCl-NPs and AgNPs is concentration-dependent and the
formation of nanoparticles is controllable. For the synthesis of only AgCl-NPs, the concentration of
chloride ions plays a key role. Their concentration must be always higher than that of Ag ions in the
reaction mixture. However, it is necessary to point out that the AgCl nanoparticles are aggregated into
large clusters, which prevented an accurate estimation of their morphology and size distributions [30].
An analogical conclusion was made in previous reports onthe controlled synthesis of AgCl-NPs using
the bioflocculant of Bradyrhizobium japonicum [24]. Authors reported that when the Ag+ concentration
exceeded that of Cl´, the formation of AgCl-NPs/AgNPs was observed, and in the presence of
Cl´ ions, the synthesis of AgCl and its assembly over the polysaccharide-based bioflocculant occurs
first. When the chloride ions were depleted in the reaction mixture, the excess amount of silver
ions was reduced and stabilized in the polysaccharide-based bioflocculant, leading the formation of
AgCl-NPs/AgNPs [24].
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Figure 1. UV-vis spectra of AgCl-NPs in different concentration of AgNO3.
2.2. SEM-EDX
The SEM micrographs of AgCl-NPs clearly showed rough agglomerations of polydisperse





Figure 2. (a,b) SEM images of AgCl-NPs.
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The Energy dispersive X-ray (EDX) spectra were recorded in order to provide further confirmation
on the formation of AgCl-NPs on exopolysaccharide template. The x- and y-axis labels were
energy/keV and count/cps, respectively [30]. The EDX spectra of AgCl-NPs–loaded exopolysaccharide
nanocomposite confirm the existence of silver and chlorine atoms. As was seen in the EDX profile,
EPS-stabilized AgCl-NPs showed strong signals at ~3 keV for silver atoms, and at ~2.5 keV for chlorine
atoms (Figure 3). A semi-quantitative analysis showed the atomic ratio of the Ag and Cl elements was
approximately 1:1. This evidence confirms the theoretic stoichiometric atomic ratio between Ag and Cl
atoms in AgCl. The data were in agreement with those documented elsewhere [30].
Figure 3. EDX spectra of AgCl-NPs, synthesized using Ag+ and Cl´ in different concentrations of Ag+
((A)—8 mM AgNO3; (B)—6 mM AgNO3).
2.3. X-ray Diffraction Analysis of AgCl-NPs
AgCl-NPs were characterized using the X-ray diffractometer with Cu-Kα radiation operated at
a voltage of 40 kV in the scan range of 20 to 80 degree. The XRD pattern of AgCl-NPs exhibited several
size-dependent features leading to peak position, height and width. The XRD patterns of AgCl-NPs
nanostructures are presented in Figure 4. The distinct diffraction peaks at a 2θ of 27.64˝, 32.24˝, 46.2˝,
54.78˝, 57.44˝, 67.42˝, 74.4˝ and 76.6˝ can be attributed to the (111), (200), (220), (311), (222), (400),
(331) and (420) planes, which are the typical cubic phase of AgCl crystal (JCPDS file 31-1238) [27,30].
The strong and narrow diffraction peaks in some samples (obtained from relatively high concentrations
of Ag+ solutions) reveal the highly crystalline structure [27].
Figure 4. X-ray diffraction (XRD) pattern of AgCl-NPs, synthesized in different concentrations of AgNO3.
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Analogical data previously reported by other authors [27,30] suggest the existence of AgCl species
in the synthesized nanostructures with the above-mentioned data. Revealed diffraction peaks were
sharp and intense, indicating a high degree of crystallinity of the AgCl species.
2.4. FT-IR of AgCl-NPs
FT-IR estimation was carried out to investigate the possible functional groups and chemical
bonds of AgCl-NPs containing nanobiocomposite. The FT-IR spectra of AgCl-NPs exhibited various
characteristic peaks with ranges from 3420 to 800 cm´1 (Figure 5). The broadest and strongest peak
was observed at 3420 cm´1, due to a stretching vibration of the hydroxyl groups (O–H). The broad
peaks at 1236–1063 cm´1 correspond to the C–O–C stretching from the glycosidic linkages and the
O–H bending from alcohols [31,32], whereas the intense peak at 995 cm´1 confirms the presence of
carbohydrates. Furthermore, weak absorption peaks at 820–972 cm´1 were observed, which confirmed
that linkages had occurred between monosaccharides in a polysaccharide matrix of the bioflocculant.
 
Figure 5. FT-IR spectrum of AgCl-NPs, assembled on the polysaccharide-based bioflocculant of
A. chroococcum XU1 in different concentrations of Ag+.
In some cases, when the polysaccharide matrix is used for the impregnation of nanoparticles, the
absorption maxima of polysaccharides remain unaffected [32,33]. However, when the polysaccharide
template is used as a reducing and stabilizing agent, slight changes in the absorption maxima of
polysaccharides are observed. Kanmani and Lim (2013) report additional absorption peaks of bacterial
exopolysaccharides at 2352 and 1449 cm´1, which were attributed to the presence of the AgNPs [26].
The biosynthesized AgNPs’ influence on the O´H stretching at 3428 cm´1 was also reported [1].
This evidence indicates that Ag/AgCl-NPs’ association with biomolecules is varied due to the nature
of the matrix and chemical bonds.
2.5. Antimicrobial Activity of AgCl-NPs (the Hole Method)
The antibacterial and antifungal activity of AgCl-NPs, fabricated using the polysaccharide-based
bioflocculant of A. chroococcum XU1, was investigated against the pathogen bacterial strains E. coli
ATCC11229, S. aureus ATCC6538 and pathogenic fungi Candida albicans ATCC1023. The AgCl-NPs
samples were tested using the agar well diffusion method and via measuring the radial diameter of
inhibition zones. Different concentrations of AgCl-NPs were applied, from 0.1 to 5 mg/mL. The results
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revealed that all pathogens were inhibited after treatment with AgCl-NPs. The inhibition rate was
proportionally dependent on not only the concentration (dilution) of AgCl-NPs, but also on the
concentration of the bioflocculant and AgNO3, which were used to produce AgCl-NPs. The increase
in the AgCl-NPs’ antibacterial activity towards E. coli ATCC11229 and S. aureus ATCC6538 is shown
in Table 1.
Table 1. Antibacterial activity of AgCl-NPs in 2.5 mg/mL concentration.
Strains Inhibition Zone, mm
E. coli ATCC11229 22
S. aureus ATCC6538 23
C. albicans ATCC10231 15
The maximum antibacterial activity was observed with 2.5 mg/mL AgCl-NPs and it was several
times higher than that of 1 mM of AgNO3 applied as a control. Obtained data are in good agreement
with those reports, where the dose-dependent impact of Ag/AgCl-NPs was evaluated [20–23].
The antifungal activity of nanoparticles also widely discussed in the literature and the impact
of nanoparticles was evaluated against some genus of fungi, such as Candida, Aspergillus and
Penicillium [26]. Some authors reported treatment with low concentrations of AgNPs. Kora and
Arunachalam (2011) report the effective suppression of 4 μg /mL AgNPs against P. aeruginosa [34],
whereas Wei et al. (2012) report 9 μg/mL AgNPs against B. subtilis and E. coli [35]. Bankura et al.
(2012) tested higher concentrations of AgNPs [28]. At a 200 μg/mL concentration of AgNPs, the
inhibition zone diameters of E. coli, P. aeruginosa, B. cereus, and B. subtilis were 21, 24, 28, and 32 mm,
respectively. Similar results were reported by Panacek et al. (2008) [36]. Analogical results were
obtained in our previous research, when the AgCl-NP concentrations ranged from 0.25 to 2.5 μg/mL.
In these concentrations, the maximal inhibition zones in C. albicans ATCC10231 were from 7.5 to
15 mm [24]. The maximum antibacterial activity was observed with 2.5 mg/mL AgCl-NPs and it was
2.5–2.7 times higher than 1 mM AgNO3 applied as a control. A similar dose-dependent impact of
Ag/AgCl-NPs was also evaluated against E. coli and S. aureus [20,23].
In our research, the pathogenic strain C. albicans ATCC10231 was inhibited by AgCl-NPs,
and the antifungal activity proportionally correlated with the concentration of AgCl-NPs applied.
With 0.1 mg/mL of AgCl-NPs, the inhibition zone was 7.5 mm; when concentration reached 2.5 mg/mL,
the inhibition zone was 15 mm.
3. Discussion
Several methods and mechanisms for the green synthesis of AgCl-NPs have been reported.
Apart from the application of polysaccharides [20–23], other reducing agents are also used to reduce
Ag+ and to synthesize AgCl-NPs. Duran et al. (2014) [37] reported the biogenic synthesis of AgCl-NPs
with laccase, whereas Awwad et al. (2015) applied the flowers of Albizia julibrissin extract, rich in
chlorine ions, as a reducing, chlorinated and capping agent in the formation of Ag/AgCl-NPs [38].
In our research, the exopolysaccharide-based bioflocculant of A. chroococcum XU1 was used for the
synthesis and stabilization of AgCl-NPs. The exopolysaccharide-based bioflocculant can reduce Ag+
from AgNO3, and synthesize AgCl-NPs and AgNPs with separate absorption maximums at 250–260
and 435 nm. It was found that the formation of AgCl-NPs and AgNPs was concentration-dependent.
In earlier reports, the formation of a mix of AgCl-NPs/AgNPs was documented, since in most cases
the concentration-dependent synthesis had not been evaluated [18,19,23,27]. In some reports, chlorine
ions were randomly chosen, or controlling theconcentration was not an aim of the surveys [38]. In this
report we tried to strictly control the formation of only one type of nanoparticle—AgCl-NP—and the
synthesis was carried out atcertain concentrations of Ag+ and Cl´. At a fixed concentration of the
exopolysaccharide-based bioflocculant (11.5 mg/mL) with 1 to 8 mM of Ag+ (at the same concentrations
of Cl´), the enhanced synthesis of AgCl-NPs was observed. When the Ag+ concentration exceeded
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that of Cl´, the formation of AgCl-NPs/AgNPs was observed. It is supposed that in the presence of
Cl´ ions, the synthesis of AgCl and its assembly over the exopolysaccharide-based bioflocculant occurs
first. When the chloride ions were depleted in the reaction mixture, an excess amount of silver ions
was reduced and stabilized in the exopolysaccharide-based bioflocculant, leading to the formation of
AgCl-NPs/AgNPs. Concentration dependent and controlled synthesis of AgCl-NPs was also reported
in our previous study [24]. The polysaccharide-based bioflocculant of B. japonicum 36 can reduce
Ag+ from AgNO3, and synthesize AgCl-NPs and AgNPs with separate absorption maximums at 335
and 420 nm. It was found that the formation of AgCl-NPs and AgNPs was concentration-dependent.
From 1 to 7 mM Ag+, the formation of only AgCl-NPs was observed and it exhibited an absorption
band at 335 nm. Further increasing the Ag+ concentration led to the formation of both AgCl-NPs
(335 nm) and AgNPs (420 nm). When the concentrations of both Ag+ and Cl´ were the same, the
AgCl-NPs were the only product, with an absorption band at 335 nm [24].
The XRD analysis of AgCl-NPs exhibited characteristic peaks at 27.64˝, 32.24˝, 46.2˝, 54.78˝, 57.44˝,
67.42˝, 74.4˝ and 76.6˝ which were attributed to planes (111), (200), (220), (311), (222), (400), (331),
and (420) of the cubic phase of the AgCl crystal, and are in good agreement with early reports [27,31].
Further SEM-EDX and FT-IR analyses also confirmed the presence of nanoparticles and their interaction
with some functional groups. The FT-IR analysis showed some new evidence on the influence of
AgCl-NPs on some functional groups. Obtained data varies with those from earlier reports with
AgNPs [1,24,26,33,36].
As-synthesized AgCl-NPs were further examined for antimicrobial activity towards E. coli
ATCC11229, S. aureus ATCC6538 and Candida albicans ATCC1023, and their high biocidal activity
was observed. The antibacterial and antifungal activity of AgCl-NPs was also widely reported and
discussed in recent surveys [20–24]. Despite the AgCl-NPs being synthesized via different reduction
methods and exploiting a wide range of templates, they exhibited considerable antimicrobial activity
toward pathogens, such E. coli, S. aureus and C. albicans [20–24]. It can be concluded from the results
that the AgCl nanoparticles biofabricated on the basis of the exopolysaccharide-based bioflocculant of
Azotobacter chroococcum XU1 can be exploited as a promising new biocidal bionanocomposite against
pathogenic microorganisms.
4. Materials and Methods
4.1. Materials and Microbial Strains
The polysaccharide-based bioflocculant producing diazotrophic strain A. chroococcum XU1, and
pathogenic strains Candida albicans ATCC10231, Escherichia coli ATCC11229, Staphylococcus aureus
ATCC6538 were obtained from the Culture Collection of State Key Laboratory Basis of Xinjiang
Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and
Chemistry, CAS.
All solutions were made of using ultra filtered high purity deionized water. Reagents and
chemicals used in this study were of analytical grade.
4.2. Production of Bioflocculant
Production and purification of bioflocculant by A. chroococcum XU1 was developed in our previous
experiments [24,25,39] and its fractionation into protein, low- and high-molar-weight polysaccharides
was used as a part of protocol for green synthesis of AgNPs [24,25]. Production of bioflocculant carried
out in 2 L flasks containing 1 L of the modified medium with 150 rpm at 30 ˝C under intensive aeration.
The composition of the modified medium was as follows: sucrose, 20 g/L; MgSO4¨ 7H2O, 0.2 g/L;
KH2PO4, 0.2 g/L; NaCl, 0.1 g/L; CaCO3, 10 g/L. The initial pH value of the medium was adjusted to
7.0. Each flask was inoculated with 4% (v/v) of the seed culture and incubated at 30 ˝C with shaking
at 150 rpm for three days. Samples were withdrawn at different time intervals and monitored for cell
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growth and flocculating activity. Culture broth was centrifuged at 10,000 rpm for 15 min to separate
the cells which were washed twice with distilled water.
4.3. Purification of Bioflocculant
Bioflocculant purification was carried out as documented elsewhere [1]. The culture broth was
centrifuged at 10,000 rpm for 20 min. To the supernatant were added three volumes of cold ethanol
instantly, until white cotton-like flocks were formed. The precipitate centrifuged at 10,000 rpm for
15 min. Then, the bioflocculant dialyzed against de-ionized water at 4 ˝C overnight to obtain purified
bioflocculant, free from minerals.
4.4. Synthesis of AgCl-NPs
Preparation of AgCl-NPs was carried by a method, developed by us [24]. Freshly prepared
bioflocculant was mixed with 10 mL of 2 mM NaCl solution with a vaccination needle and exposed
to 10 mM AgNO3 solution. The reaction mixture was left overnight at room temperature. For FT-IR
and XRD analysis the reaction solution was centrifuged at 15,000 rpm for 5 min to obtain AgCl-NPs.
The prepared AgCl-NPs were washed four times with distilled water to remove the impurities absorbed
on the surface of AgCl-NPs.
4.5. Characterization of AgCl-NPs
Polysaccharide-based bioflocculant reduction of Ag+ ions, formation of AgCl-NPs/AgNPs in
aqueous solution was monitored for 12 h, fivedays, 10 days and twomonths by measuring the
ultraviolet-visible absorbance spectrum of the solution using a UV-visible spectrophotometer (TU-1901,
Beijing Purkinje General Instrument Co., Ltd., Beijing, China) in the range of 200–700 nm [24].
Scanning electronmicroscope EDX analysis of the AgCl-NPs was performed using a Hitachi apparatus,
Japan. The phase composition and crystal structure of the AgCl-NPs was determined using XRD
(Bruker D8 advance, Karlsruhe, Germany). For this, the dried sample was prepared by placing on
the microscopic glass slide and the diffractogram was recorded using Cu-K α radiation and a nickel
monochromator filtering wave at a voltage and current of 40 kV and 30 mA, respectively. The FT-IR
spectrum of the polysaccharide-based bioflocculant-stabilized AgCl-NPs were analyzed using FT-IR
spectroscopy (JASCO FT-IR 460, Daejon, Korea) operated at resolution of 4 cm´1. For the measurement
of FT-IR spectrum, the dried sample was powdered by grinding with KBr pellets and pressed into
a mold. The spectrum was recorded at a frequency range of 500–4000 cm´1 [24].
4.6. Antibacterial and Antifungal Activities of AgCl-NPs
4.6.1. Incubation of Pathogenic Strains
All bacterial strains were cultured following manufacturers’ culturing guidelines. Typically,
E. coli ATCC11229 and S. aureus ATCC6538 strains were cultured in Luria-Bertani (LB) culture medium
(tryptone, 10 g/L; yeast extract, 5 g/L; NaCl, 10 g/L) at 37 ˝C. In all the experiments, the concentrations
of bacteria were determined by optical density at 600 nm.
C. albicans ATCC10231 was cultured in culture medium comprising of: glucose, 40 g/L and
peptone, 10 g/L [25,39].
4.6.2. The Hole Method
The antibacterial and antifungal activity of the polysaccharide-based bioflocculant stabilized
AgCl-NPs was measured using the agar well diffusion method. Bacterial and fungal pathogens such as
E. coli, S. aureus and C. albicans were used as indicator strains for this analysis. The bacterial and fungal
strains were aseptically inoculated into respective broth, and then incubated at 37 ˝C. Samples from the
culture liquids of respective pathogen plated on Petri plates and wells were made using an agar well
borer. Different concentrations of AgCl-NPs were added to these wells, and the plates were incubated
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at 37 ˝C for 24 h. Zone of inhibitions were estimated by measuring the diameter of the bacterial growth
inhibition zone. The values were averaged from the three independent experiments [25,39].
5. Conclusions
In conclusion, the polysaccharide-based bioflocculant of A. chroococcum XU1 can reduce Ag+
from AgNO3, and synthesize AgCl-NPs with absorption maximum at 250–260 nm. It was found that
formation of AgCl-NPs and AgNPs was concentration dependent. At equal molar concentrations of
Ag+ and Cl´ of the polysaccharide-based bioflocculant act as a template to assembly only AgCl-NPs
with an average diameter 10–68 nm. XRD analysis of AgCl-NPs exhibited characteristic peaks at 27.64˝,
32.24˝, 46.2˝, 54.78˝, 57.44˝, 67.42˝, 74.4˝ and 76.6˝ can be attributed to the (111), (200), (220), (311),
(222), (400), (331) and (420) of cubic phase of AgCl crystal. When Ag+ concentration exceeded than
that of Cl´ formation of AgCl-NPs/AgNPs observed. It is supposed that in the presence of Cl´ ions,
synthesis of AgCl and its assembly over the polysaccharide-based bioflocculant occurs first. When the
chloride ions depleted in the reaction mixture, excess amount of silver ions are reduced and stabilized
in the polysaccharide-based bioflocculant, leading the formation of AgCl-NPs/AgNPs. As-synthesized
AgCl-NPs exhibited strong antibacterial and antifungal activity against E. coli, S. aureus and C. albicans.
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Abstract: Root canal system disinfection is limited due to anatomical complexities. Better delivery
systems of antimicrobial agents are needed to ensure efficient bacteria eradication. The purpose of
this study was to design chlorhexidine-containing nanoparticles that could steadily release the
drug. The drug chlorhexidine was encapsulated in poly(ethylene glycol)–block–poly(L-lactide)
(PEG–b–PLA) to synthesize bilayer nanoparticles. The encapsulation efficiency was determined
through thermogravimetric analysis (TGA), and particle characterization was performed through
microscopy studies of particle morphology and size. Their antimicrobial effect was assessed over
the endodontic pathogen Enterococcus faecalis. The nanoparticles ranged in size from 300–500 nm,
which is considered small enough for penetration inside small dentin tubules. The nanoparticles
were dispersed in a hydrogel matrix carrier system composed of 1% hydroxyethyl cellulose, and
this hydrogel system was observed to have enhanced bacterial inhibition over longer periods of
time. Chlorhexidine-containing nanoparticles demonstrate potential as a drug carrier for root canal
procedures. Their size and rate of release may allow for sustained inhibition of bacteria in the root
canal system.
Keywords: dentin tubules; dentin permeability; chlorhexidine; nanoparticles; encapsulation
1. Introduction
The treatment of an infected root canal has been based on nonspecific elimination of intraradicular
microorganisms through the application of broad-spectrum antimicrobial approaches [1]. Nevertheless,
it has been shown that it is nearly impossible to obtain complete elimination of microorganisms in
the root canal system [2,3]. Therefore, the continued development of treatments that can effectively
penetrate dentin to eliminate root canal infection is a priority in clinical endodontic research.
Currently, the most frequent intracanal medicaments employed to treat infected root canals
include calcium hydroxide (Ca(OH)2), potassium iodine (KI), and chlorhexidine (CHX). The efficacy of
root canal disinfectants can be influenced by several factors such as pH, serum proteins, collagen, and
dentin among others [4–6]. However, in vitro studies have demonstrated that CHX is more effective
in eliminating bacteria from internal dentinal tubules in comparison to the other disinfectants when
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dispersed in liquid or hydrogel systems [7,8]. Besides its proven antimicrobial activity and non-toxicity
at low dosages, CHX provides substantivity to dentin tissues, which may offer protection against
microbial colonization for extended periods of time after treatment [7,9]. These attributes make CHX
a potent disinfectant in root canal treatment. Dentin permeability and the complex anatomy of the
root canal, however, impose challenges to the penetration and subsequent action of these disinfectants.
Gomes et al. [10] demonstrated in vitro that medicaments containing 2% CHX were able to diffuse into
the dentin, reaching the external root surface. The information on the length of activity time of the
various agents in the root canal is limited.
Nanoparticles in recent years have been employed in several clinical applications [11].
In endodontics, nanoparticles have been suggested to act as irrigants [12], incorporated into intracanal
medicaments [13] or root canal sealers [14,15]. Nanoparticle technology for drug delivery includes
nanoencapsulation, which is the coating of a substance within another material, typically a polymer
based system. It aims to maximize the therapeutic efficacy while minimizing undesirable side
effects due to the control of the drug bioavailability and release [16,17]. There is scarce data in the
current literature on the synthesis, characterization, and application of nanoencapsulated medicaments
that are typically employed in root canal treatment. Shrestha and Kishen [18] evaluated the effect
of rose bengal-functionalized chitosan nanoparticles associated with photodynamic therapy over
monospecies bacteria/biofilms and assessed their antibiofilm efficacy on a multispecies biofilm grown
on dentin. Shrestha et al. [19] examined the ability of the temporally controlled release of bovine serum
albumin from chitosan nanoparticles to regulate the alkaline phosphatase activity in stem cells from
apical papilla.
Nanoparticles produced by drug nanoencapsulation have specific characteristics such as size,
release pattern, and activity, which are factors determined by the synthetic method employed,
polymer system of choice, and polymer molecular weight. Therefore, protocols should be conducted
to achieve proper nanoencapsulation of medicaments, taking into account the stability of the
system or release profile to achieve the desirable antiseptic activity inside a specific target or
tissue. Provided the anatomical complexity of the root canal, permeability of dentin, and limited
penetration of medicaments in the dentin, the goal of this study is to develop and characterize a
novel CHX-encapsulated system for root canal applications. In this work, the biodegradable and
biocompatible block copolymer of choice was poly(ethylene glycol)–block–poly(L-lactide) (PEG–b–PLA)
to create CHX loaded nanoparticles. PEG–b–PLA bilayer nanoparticles have advantages for drug
delivery, such as small size and hydrophobic and hydrophilic functionalities in the polymer backbone
that improves in vivo half-life. These polymeric nanoparticles were characterized for size, morphology,
and drug loading proficiency. The nanoparticles were found to be small enough to penetrate dentin
tubules, dispersed well in a hydrogel matrix used as a carrier system, and enhanced bacterial inhibition
over longer periods of time.
2. Results
2.1. Particle Synthesis
The obtained PEG–b–PLA block copolymer was characterized by 1H NMR. Figure 1 shows
the 1H NMR spectra of the PEG–b–PLA block copolymer and indicates that the block copolymer
was synthesized successfully. The number-average molecular weight of the PEG–b–PLA block
copolymer was 5756 daltons with a ratio of 2 PLA units to 1 PEG unit. The peaks at 3.64 ppm
and 3.38 ppm corresponded to methylene units and CH3O– in the mPEG block, respectively. Signals at
1.47 ppm and 5.16 ppm could be attributed to the hydrogen atoms of CH3– and CH– groups for PLA
segments, respectively.
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Figure 1. 1H NMR spectra of the synthesized poly(ethylene glycol)–block–poly(L-lactide) (PEG–b–PLA)
block copolymer.
2.2. Encapsulation Efficiency
The synthesis employed proved to be a simple and reproducible method to encapsulate CHX
for controlled release of CHX. Investigation of the thermal behavior of synthesized products using
thermogravimetric analysis (TGA) illustrated that the encapsulation of CHX was achieved. The
measured mass drop of the materials as they decomposed using TGA (Figure 2) illustrates that the
encapsulation process resulted in structural changes with the incorporation of CHX in PEG–b–PLA,
as there is a slight shift in the decomposition point of the materials. TGA also provided information on
the encapsulation efficiency of CHX in PEG–b–PLA.
Figure 2. Measurements of the amount of weight change of PEG–b–PLA, chlorhexidine (CHX), and
CHX-encapsulated. Thermogravimetric analysis (TGA) curves showing mass loss as a function of
temperature. Note that thermal transitions for the CHX-encapsulated product most resemble the
behavior and transitions measured for the PEG–b–PLA polymer due to the proportion of PEG–b–PLA
being much higher than CHX.
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The synthetic method employed allowed for an average encapsulation efficiency of 70%. Energy
dispersive X-ray spectroscopy (EDS) analysis confirmed the presence of CHX in the encapsulated
nanoparticles by signal emission of chlorine (Cl) at 2.7 keV (Figure 3).
Figure 3. Nanoparticle composition obtained with energy dispersive X-ray spectroscopy (EDS).
2.3. Particle Morphology and Composition
Scanning electron microscopy (SEM) at 1800ˆ magnification (Figure 4a) was used to verify
the physical characteristics of the nanoparticles and presence of clumps. The analysis showed that
CHX-encapsulated formed large clumps in the dry state, which prevented accurate analysis using
this technique. Atomic force microscopy (AFM) was therefore used to determine size. AFM revealed
that nanoparticles individually ranged in size from 300–500 nm in diameter (Figure 4b,c). The size
was confirmed by probing numerous areas on the glass slides containing the nanoparticles using
topographical and 3D imaging. From dynamic light scattering (DLS) analysis, the nanoparticle’s
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(b)
(c)
Figure 4. (a) Morphological analysis obtained with scanning electron microscopy (SEM) images
of CHX-encapsulated nanoparticles. Note that clumping prevented measurement of individual
nanoparticle size. Atomic force microscopy (AFM) (b) 2D surface topography of nanoparticles and
(c) 3D image.
2.4. Antimicrobial Effectiveness
The ability of the CHX-encapsulated nanoparticles to retain and release CHX was investigated
with zone of inhibition (ZOI) measurements. The ZOI generally became smaller as the filtered
nanoparticles that spent greater time immersed in phosphate buffer saline (PBS) were placed on
bacterial lawns. Control nanoparticles (synthesized without the addition of CHX) showed no ZOI,
indicating that the polymer itself did not have antimicrobial activity. Table 1 shows the proportion of
nanoparticle mass diameter compared to the ZOI. The table shows that nanoparticles immersed for
14 days and those immersed for 21 days displayed similar ZOIs.
Table 1. Zone of inhibitions measured for CHX-encapsulated nanoparticles filtered from phosphate
buffer saline (PBS). The values indicate the results obtained in three trials averaged together.
Days Particles Were
Immersed in PBS
Ratio of Assembled Nanoparticles
Diameter vs. Zone Diameter
1 h 0.436 ˘ 0.042
7 0.584 ˘ 0.019
14 0.659 ˘ 0.042
21 0.675 ˘ 0.043
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The optical density (OD) data from filtered bacterial broth that had contained the nanoparticles
for 7, 14 and 21 days obtained through the plate reader showed the antimicrobial effect displayed
by the CHX-encapsulated nanoparticles. The onset of E. faecalis exponential growth was delayed by
approximately three hours for nanoparticle immersion solutions as compared to the control broth, and
the final OD was slightly lower in the broths that had contained the CHX nanoparticles vs. the control.
The OD data at the intermediate time period when the control was entering the growth phase was
also analyzed using a one-way ANOVA. When the growth curves of the broth that had contained
the nanoparticles were compared to the control, a significant difference was observed (P ď 0.05).
The results also indicated that the nanoparticle mass remained effective for the period investigated
(up to 21 days). However, the final ODs as well as the lag for the growth phases remained nearly the
same (Figure 5).
Figure 5. Optical density curves of E. faecalis. Broth that had contained CHX-encapsulated nanoparticles
show a growth delay compared to the positive control broth that had not contained any nanoparticles.
3. Discussion
The present study discussed the synthesis, characterization, and antimicrobial effectiveness of
a new drug delivery system designed to allow for extended release of CHX inside the root canal
system. It was hypothesized that nanoparticles prepared with an appropriate size and a controlled
CHX-release profile could carry the medicament deep into dentin tubules, allowing for sustained
inhibition of bacteria in the root canal system.
Chlorhexidine has been used previously in hydrogel form and in liquid formulations in root
canal treatment. CHX is well-known to be rapidly released from poly(lactic acid) microparticles [20].
Therefore, in order to enhance bacterial elimination from infected root canal systems and to create an
environment that is ideal for periapical healing, it is highly desirable to extend the release period of
CHX in situ beyond the delivery systems currently in use. Nanoencapsulation can provide better control
while further extending the release period of the medicament in dentin tissues. The antibacterial activity
of CHX in different concentrations and preparation forms has been extensively tested. In endodontics,
CHX has been employed as an intracanal medicament in a 2% concentration, alone or associated with
calcium hydroxide [21]. It should also be emphasized that, the higher the drug concentration, the
higher its side effects.
The bacterial activity of CHX loaded poly(ε-caprolactone) nanocapsules and CHX digluconate
against S. epidermis was studied in [22]. The CHX carrier system was observed to improve drug
targeting of bacteria, further reducing bacterial growth onto skin in relation to CHX digluconate. In the
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present study, CHX was encapsulated in a poly(ethylene glycol)–block–poly(L-lactide) (“PEG–b–PLA”).
The choice of PEG–b–PLA is optimal as poly(L-lactic acid) has long been known for its biocompatibility
and biodegradation properties [23]. It is a common choice to safely encapsulate bioactive drugs and
control their release [24]. PEG has been copolymerized with PLA to create a block polymer and facilitate
drug release due to its dual nature, hydrophilic-hydrophobic, which can increase pore formation in the
nanoparticles along with a rise in the rate of polymer degradation. PLA microspheres degrade through
a hydrolytic chain cleavage reaction affecting both the surface and the bulk properties of spheres while
exhibiting no serious health risks [24]. All these properties make the copolymer a viable candidate
to both encapsulate and release CHX. The PEG–b–PLA nanoparticles were prepared through the
oil-in-water emulsion technique. The goal of this methodology was to synthesize nanoparticles smaller
than 1 μm in order to facilitate penetration of the nanoparticles deep into the tubules. The encapsulation
process resulted in nanoparticles with a size ranging much smaller than the diameter of dentin
tubules [25]. Atomic force microscopy revealed that the size of the nanoparticles ranged from 300 to
500 nm (Figure 4), which was verified by dynamic light scattering (DLS).
The PEG–b–PLA nanoparticles prepared through the oil-in-water emulsion technique resulted in
high material yields and drug encapsulation efficiencies as high as 80%. TGA revealed that CHX was
incorporated into the polymer as demonstrated by weight changes of decomposition reactions of the
CHX-containing nanoparticles in comparison to starting materials—CHX and the PEG–b–PLA block
copolymer (Figure 2).
The presence of chlorine peaks (Figure 3) in the EDS spectra are evidence of CHX-encapsulated
nanoparticles. As this element is characteristic of CHX and not the polymer, there is evidence to
suggest that the CHX is being absorbed on the surface of the nanoparticles and encapsulated. Although
SEM showed that the nanoparticles can form large clumps during the lyophilization process, these
were significantly reduced when the nanoparticles were dispersed in a hydrogel matrix made out of
1% Natrosol™ (hydroxyethyl cellulose) in water.
Nanoparticle disperssion within the hydrogel matrix consists of polymer chains from the hydrogel
forming weak bonds with many nanoparticles. This in turn produces a loosely interlinked network of
polymers and nanoparticles [26]. Since each connection point is rather weak, the bonds breakdown
under mechanical stress, for instance, when injected through syringes [27]. When the shear forces
subside, the polymers and nanoparticles form new connections with the walls of dentinal tubules and
within the hydrogel itself. Now, the high water content and large pore sizes of this hydrogel will be
sufficient to trigger hydrolysis of the backbone ester groups in PLA and the oxidation of the ether
backbone in PEG, thereupon diffusing the chlorhexidine.
Microorganisms may penetrate inside dentin to different extents and may survive inside the
tubules, even after the use of the currently employed disinfection protocols. In a clinical study,
Siqueira et al. [28] demonstrated that chemomechanical preparations with 2.5% NaOCl as irrigant
significantly reduced the number of bacteria in the canal, but allowed for microbial recovery through
cultivation in more than one-half of all cases. Authors also reported that a seven-day intracanal dressing
with Ca(OH)2/camphorated paramonochlorophenol (CPMC) paste significantly increased the number
of culture-negative cases. However, positive cultures were still obtained. Furthermore, Enterococcus
faecalis, a facultative anaerobe that can be isolated from persistent/secondary root canal infections, has
demonstrated to be resistant to calcium hydroxide, especially when in biofilms. They can adapt to
harsh environmental changes and can colonize dentinal tubules where they remain protected from
medicaments. Upadya et al. [29] showed that E. faecalis biofilms were considerably more resistant to
Ca(OH)2 solutions than free-floating cells. A fraction from the biofilm cells persisted viable even after
24-h exposure to a saturated Ca(OH)2 solution. It was pointed out that the increased resistance might
be attributed to the biofilm structure or extrapolimeric substance. Therefore, other antimicrobial agents,
with different mechanisms of action should be employed to enhance the root canal system disinfection,
especially in areas that are difficult to reach with conventional instrumentation and currently employed
intracanal medicament. Chlorhexidine digluconate is water-soluble and readily dissociates at
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physiologic pH releasing the positively charged chlorhexidine component. The bactericidal effect
of the drug is due to the cationic molecule binding to extra microbial complexes and negatively
charged microbial cell walls, thereby altering the cells’ osmotic equilibrium [30,31]. Chlorhexidine
with a concentration of 2%, in both liquid or gel presentations, has been employed as an auxiliary
chemical substance during root canal preparation or as a final irrigant [32–34]. Several in vitro studies
assessed the properties of CHX as an intracanal medicament [10,35,36]. However, there are few clinical
studies that employed CHX hydrogel as an intracanal medicament. Gama et al. [37] evaluated the
incidence of postoperative pain after intracanal dressings with either 0.12% chlorhexidine digluconate
gel or a calcium hydroxide/camphorated paramonochlorophenol/glycerin paste. Therefore, this
study intended to develop a nanoparticle–hydrogel matrix system to be employed as an intracanal
medicament that would carry CHX, allowing for its continuous release inside the root canal system.
Few studies have assessed the antimicrobial effect of antimicrobial-containing nanoparticles
over endodontic pathogens, especially Enterococcus faecalis. The effect of rose bengal-functionalized
chitosan nanoparticles over E. faecalis cells and multispecies biofilm structures was assessed by Shrestha
and Kishen [18]. Despite the quantification of the CHX release from nanoparticles assessed through
analytical methods [38–40], no study has evaluated the residual antimicrobial effect produced by
suspended nanoparticles over time, especially against E. faecalis cells. In the present study, in vitro
studies in E. faecalis were performed to investigate bacterial growth inhibition in the presence of
CHX-encapsulated nanoparticles. The experiment was performed at different time points to investigate
the length of antibacterial activity and effectiveness of the synthesized delivery system. The initial goal
was to maintain CHX release for a minimum period of 7 to 14 days, which corresponds to the period
that an intracanal medicament (such as calcium hydroxide paste) is often kept between appointments.
The synthesized nanoparticles were immersed in both PBS and BHI (brain–heart infusion) broth.
Nanoparticles removed from the PBS and placed on bacterial lawns showed a zone of inhibition after
being immersed for as long as 21 days. These zones of inhibition demonstrate that CHX both elutes
into the solution and remains in the particles after eluting for up to three weeks. They also provide
evidence of the area where bacteria will not come into contact with the material even after eluting the
drug into a solution. The broth containing the nanoparticles demonstrated a lag in the growth phase of
E. faecalis bacteria as well as a decrease in total cell density during this lag phase, indicating inhibition
and demonstrating that CHX was indeed diffusing from the nanoparticles. The diffusion of CHX is
directed by chemical potential gradients arising by osmotic pressure. In addition to diffusion, CHX
could be released by erosion of the polymer matrix, which leads to pore formation [41].
The initial burst release behavior of the nanoparticles could be attributed to the CHX absorbed on
the surface of the nanoparticles, with subsequent releases corresponding to the encapsulated portion.
Both results (ZOI and OD) suggest that the nanoparticles demonstrate a bacteriostatic effect for at
least three weeks. The zone of inhibition tests showed that CHX was eluting from the hydrophobic
core of the PEG–b–PLA nanoparticles into the PBS solution, while some CHX still remained in the
nanoparticles and were still capable of antimicrobial action. Furthermore, the bacterial growth curves
using the OD data demonstrated that eluting CHX into bacterial broth did have an effect on the
E. faecalis bacteria’s growth curve. However, the size of the zones of inhibition decreased over time.
Eventually, the release of CHX reached equilibrium, and the nanoparticles that had been immersed
for 14 days in PBS showed similar-sized zones as those immersed for 21 days. This suggests that
hydrolysis or enzymatic cleavage of the PEG–b–PLA backbone reached the hydrophobic core of the
nanoparticle, which causes bulk erosion, hence releasing the remaining CHX during the time period
between 14 and 21 days. Additionally, the bacterial growth curves in the broth eventually reached
their growth phase after the initial lag and had a final OD similar to the control, albeit slightly lower.
The intent of this nanoparticle-hydrogel matrix system was to develop an intracanal medicament
that allows for the distribution of the nanoparticles through the lateral tubules and accessory canals
that are exposed during the root canal procedure. The nanoparticle–hydrogel matrix system should
not remain in the root canal itself after the endodontist does adequate irrigations prior to canal
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filling. There have been studies on hydrogel formulations and their ability to insert into narrow and
convoluted locations, such as in the inter-tubular dentin matrix [13,42,43]. Thus, we are using this
adhesive property of hydrogels in order to deposit and fasten the nanoparticles to the walls of dentinal
tubules and accessory canals.
Control PEG–b–PLA nanoparticles (synthesized without the addition of CHX) showed no
ZOI, indicating that no reactive oxygen species (ROS) were introduced during the synthesis of the
nanoparticles. ROS are partially reduced metabolites of oxygen, including hydrogen peroxide and
hydroxyl radical, which can result from polymer degradation [44]; this in turn causes additional
oxidative stress in many pathological pathways making them toxic to cells [45]. Free radical generation
in the cell culture containing the nanoparticles can also arise from the cellular uptake of low molecular
weight polymer chains that result from their degradation [46]. This likewise leads to cytotoxicity
due to the stimulation of ROS and/or the accumulation of polymer degradation products inside the
cell. During the 21-day antimicrobial effectiveness study of PEG–b–PLA nanoparticles synthesized
without the addition of CHX, no inhibitory diameter was detected, indicating that, even if the polymer
is degrading, cells are not being affected by its degradation products or triggering ROS production
inside cells. The results from the control in this study are of significant importance in the design of
nano-carrier systems for endodontic drug delivery, thus validating the well-known biodegradability
and biocompatibility of nanoparticles made out of PEG–b–PLA and making this a safe and suitable
system of CHX delivery inside dentinal tubules.
The physiochemical properties of the PEG–b–PLA nanoparticles will need to be further tuned
in order to enhance bacterial inhibition over longer periods of time. This will allow for prolonged
release in the dentin tubules to better ensure the success of a root canal procedure. Future studies
will include increasing the concentration of nanoparticles in medium and assessing the nanoparticle
hydrogel matrix delivery network inside the root canal system.
4. Materials and Methods
4.1. Materials
Poly(ethylene glycol) methyl ether [average molecular weight (Mn) = 2000 g/mol], L-lactide,
toluene, tin (II) 2-ethylhexanoate, chlorhexidine, poly(vinyl alcohol) (PVA) [87%–90% hydrolyzed,
average Mw = 30,000–70,000 g/mol], dichloromethane (DCM), 1x phosphate buffer saline (PBS), and
pentane were used as received without further purification. All chemicals were purchased from
Sigma-Aldrich (St. Louis, MO, USA).
4.2. Nanoparticles Synthesis
The process of preparing bilayer nanoparticles comprised two steps: (1) polymer synthesis
followed by (2) encapsulation of the drug.
4.2.1. Polymer Synthesis
Poly(ethylene glycol)–block–poly(L-lactide) (PEG–b–PLA) was synthesized in house by
introducing poly(ethylene glycol) methyl ether (Mn = 2000) and L-lactide (Lactide-(3S)-cis-3,6-
Dimethyl-1,4-dioxane-2,5-diene) into toluene distilled over sodium benzyl phenol at 25 ˝C. The
mixture was subsequently placed under vacuum to remove moisture. Tin (II) 2-ethylhexanoate was
added as a catalyst during continuous stirring at 100 ˝C for 5 h. The resulting polymer was precipitated
in pentane and air-dried at room temperature overnight. The chemicals used were purchased from
Sigma-Aldrich (St. Louis, MO, USA). The number-average molecular weight of the block copolymer
was determined by 1H NMR (ADVANCE III 500 MHz, Bruker, Santa Barbara, CA, USA). Samples
temperature was regulated for all measurements and was set at 25 ˝C.
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4.2.2. Encapsulation Process
An oil-water-emulsion-evaporation method was carried out for encapsulation of chlorhexidine
(CHX). The oil/organic phase consisted of PEG–b–PLA and CHX in a 5:1 ratio, respectively, dissolved in
dichloromethane (DCM). The water phase was a 1% w/v solution of poly(vinyl alcohol) and deionized
water. The organic and water phases were combined and emulsified using ultra-sonication for 1 min
(Branson Ultrasonics Corporation, Bransonic CPX3800H, Danbury, CT, USA). The resulting emulsion
was stirred for 2 h at 25 ˝C at atmospheric pressure to allow the organic solvent to evaporate. Finally,
the particles were centrifuged, washed, and freeze-dried.
4.3. Characterization
The starting and final products were characterized using multiple techniques: (1) encapsulation
efficiency and (2) microscopy studies of nanoparticle morphology and size.
4.4. Encapsulation Efficiency
Encapsulation efficiency was found using quantitative measurement of mass change from
dehydration, decomposition, and oxidation with time and temperature of the initial polymer
(PEG–b–PLA), CHX, and CHX-encapsulated nanoparticles. Mass changes, from their physiochemical
reactions, were measured using thermogravimetric analysis (TGA, Metler Toledo TGA1, Greifensee,
Switzerland). This instrument detects changes in weight that occur in a material with increasing
temperature (25 ˝C to 800 ˝C). A heating rate of 5 ˝C per minute was applied with about 5 mg of
sample used for each run. The temperatures at which the polymers and CHX characteristic mass
dropped were recorded and compared. For the CHX curve, the temperature at which a significant
mass loss percentage occurred was recorded (CHXTemp) and used as a baseline temperature. As the
percentage loss of CHX at this temperature was determined earlier, the percentage of CHX lost in
the nanoparticles could be found as well. This percentage was used to find the amount of CHX in
the encapsulated nanoparticles and subsequently used to find encapsulated efficiency of the polymer
(Equation (1)). The polymer curve was used to ensure that the polymer mass loss temperature did not
overlap with CHXTemp. CHX was detected when characteristic changes in the thermal decomposition
temperatures were observed for the CHX-encapsulated polymer in comparison to the starting materials
(pure PEG–b–PLA and pure CHX).
Encapsulation E f f iciency “ Mass o f CHX in Particles
Mass o f CHX used in Synthesis
. (1)
4.5. Particle Morphology and Composition
The morphology and size of polymer and encapsulated nanoparticles were observed with
scanning electron microscopy (SEM, JEOL JSM-6010LA, Peabody, MA, USA) and atomic force
microscopy (AFM, Bruker, Bioscope Catalyst, Santa Barbara, CA, USA). For the SEM analysis,
a thin layer of nanoparticles was deposited on a metallic stub. The composition of the materials
was measured with energy dispersive X-ray spectroscopy (EDS, JEOL JSM-6010LA, Peabody, MA,
USA), which enabled detection of the individual elements of the nanoparticles. For AFM analysis,
CHX-encapsulated nanoparticles were dispersed in a hydrogel solution (1% Natrosol™ hydroxyethyl
cellulose in water) and sonicated for about 30 h (Branson Ultrasonics Corporation, Bransonic
CPX3800H, Danbury, CT, USA) to disrupt clumps. A drop of solution containing nanoparticles
was deposited on a glass slide and was allowed to dry forming a thin film. The AFM analysis was
performed by using the quantitative nanomechanics method (QNM) for compositional mapping,
which, besides determining morphological features, enables quantitative measurement of nanoscale
material properties. The nanoparticle’s size and size distribution were also investigated by dynamic
light scattering (DLS) technique, using a non-invasive backscatter optics (NIBS) (Zetasizer Nano ZS,
Malvern, Worcestershire, UK), after suspending 2 mg of the nanoparticles in 10 mL of deionized water.
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4.6. Antimicrobial Effectiveness
The antimicrobial effect of the encapsulated nanoparticles was tested against Enterococcus faecalis
OG1RF. CHX-encapsulated nanoparticles were immersed in phosphate buffer saline (PBS) and agitated
for set time periods (1 h, 7 days, 14 days and 21 days). Then, the nanoparticles were filtered from
the solution using vacuum filtration and air-dried for approximately 24 h. E. faecalis overnight broth
culture was spread onto BHI (brain-heart infusion) agar plates and ~1 mg of dried CHX-encapsulated
nanoparticles filtered previously from the PBS were placed onto the bacterial lawns in a roughly
circular formation to test for zones of growth inhibition (ZOI) around the nanoparticles. The bacterial
lawn plates were incubated for 24 h at 37 ˝C, and the ZOIs were observed. These experiments were
performed with nanoparticles that were immersed in a PBS solution for 1 h, 7 days, 14 days and 21 days
to investigate the potency of bacterial inhibition and whether any drug burst release was present.
Digital calipers, which are measurement tools, were used to determine the diameter of the ZOI and the
diameter of a batch of nanoparticles placed on the plates. As the mass, shape, and area of nanoparticles
placed on the plate were variable (nanoparticles charge made placement difficult on the plate surface),
the relative diameter of an assembled group of nanoparticles was measured and compared to the
diameter of the ZOI. Therefore, if the ratio increased, that meant the ZOI decreased, as this would
signify that the zone was closer to the nanoparticle mass. Three trials of this test were performed.
CHX-encapsulated nanoparticles were also immersed in BHI broth for varied periods (7 days,
14 days and 21 days). These time periods represent how long the nanoparticles would be active inside
dentinal tubules. The nanoparticles were filtered out, and the remaining broth was kept. The broth was
then inoculated with E. faecalis at an initial optical density at 600 nm (OD600) of ~0.001. Afterwards,
200 μL of the inoculated broth was aliquoted in triplicate into a 96-well plate and incubated at 37 ˝C
for 24 h. The OD600 was monitored with a Monochromater-based Multi-Mode Microplate Reader
(Synergy Mx, Winooksi, VT, USA) every 15 min during the 24-h incubation period. The OD data
was used to generate bacterial growth curves made by averaging triplicates from three trials together,
not including clear outliers obtained during the experiments. The mean values of intermediate OD
readings when the control broth was entering the growth phase were analyzed statistically with
one-way ANOVA (analysis of variance) method at a 5% significance level. The OD readings of the
broth that had contained the CHX nanoparticles were compared to the control to verify that the broth
with CHX nanoparticles was indeed causing a delay in the growth phase.
5. Conclusions
In this study, PEG–b–PLA bilayer nanoparticles for CHX delivery were successfully assembled to
improve drug bioavailability and target drug delivery to dentin tubules. This synthesis allowed for
the sustained inhibition of bacteria that could potentially be used in root canal systems. The bilayer
polymeric nanoparticles employed featured a hydrophobic interior space that easily encapsulated
CHX, a hydrophobic drug. CHX release was effective for up to 21 days with an initial burst, which may
be attributed to the CHX absorbed on the surface of the nanoparticles and subsequently predominantly
controlled by diffusion and degradation mechanisms. These results have potential implications for the
design of CHX polymeric nanoparticles for the in situ treatments of the root canal.
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